id	sid	tid	token	lemma	pos
njb-85	1	1	nepal	nepal	ADJ
njb-85	1	2	journal	journal	NOUN
njb-85	1	3	of	of	ADP
njb-85	1	4	biotechnology	biotechnology	NOUN
njb-85	1	5	.	.	PUNCT
njb-85	2	1	d	d	X
njb-85	2	2	e	e	PROPN
njb-85	2	3	c	c	PROPN
njb-85	2	4	.	.	PUNCT
njb-85	3	1	2	2	NUM
njb-85	3	2	0	0	NUM
njb-85	3	3	1	1	NUM
njb-85	3	4	8	8	NUM
njb-85	3	5	vol	vol	NOUN
njb-85	3	6	.	.	PROPN
njb-85	4	1	6	6	NUM
njb-85	4	2	,	,	PUNCT
njb-85	4	3	no	no	NOUN
njb-85	4	4	.	.	NOUN
njb-85	4	5	1	1	NUM
njb-85	4	6	:	:	SYM
njb-85	4	7	33	33	NUM
njb-85	4	8	-	-	SYM
njb-85	4	9	38	38	NUM
njb-85	4	10	issn	issn	PROPN
njb-85	4	11	2091	2091	NUM
njb-85	4	12	-	-	SYM
njb-85	4	13	1130	1130	NUM
njb-85	4	14	(	(	PUNCT
njb-85	4	15	print)/issn	print)/issn	PROPN
njb-85	4	16	2467	2467	NUM
njb-85	4	17	-	-	SYM
njb-85	4	18	9319	9319	NUM
njb-85	4	19	(	(	PUNCT
njb-85	4	20	online	online	ADJ
njb-85	4	21	)	)	PUNCT
njb-85	4	22	original	original	ADJ
njb-85	4	23	research	research	NOUN
njb-85	4	24	article	article	NOUN
njb-85	4	25	©	©	PROPN
njb-85	4	26	njb	njb	PROPN
njb-85	4	27	,	,	PUNCT
njb-85	4	28	biotechnology	biotechnology	NOUN
njb-85	4	29	society	society	NOUN
njb-85	4	30	of	of	ADP
njb-85	4	31	nepal	nepal	ADJ
njb-85	4	32	33	33	NUM
njb-85	4	33	nepjol.info/index.php/njb	nepjol.info/index.php/njb	PROPN
njb-85	4	34	hepatitis	hepatitis	PROPN
njb-85	4	35	b	b	PROPN
njb-85	4	36	and	and	CCONJ
njb-85	4	37	c	c	NOUN
njb-85	4	38	virus	virus	NOUN
njb-85	4	39	infections	infection	NOUN
njb-85	4	40	among	among	ADP
njb-85	4	41	blood	blood	NOUN
njb-85	4	42	donors	donor	NOUN
njb-85	4	43	in	in	ADP
njb-85	4	44	blood	blood	NOUN
njb-85	4	45	transfusion	transfusion	NOUN
njb-85	4	46	center	center	NOUN
njb-85	4	47	,	,	PUNCT
njb-85	4	48	pokhara	pokhara	PROPN
njb-85	4	49	,	,	PUNCT
njb-85	4	50	nepal	nepal	NOUN
njb-85	4	51	:	:	PUNCT
njb-85	4	52	seroprevalence	seroprevalence	NOUN
njb-85	4	53	and	and	CCONJ
njb-85	4	54	its	its	PRON
njb-85	4	55	associated	associated	ADJ
njb-85	4	56	risk	risk	NOUN
njb-85	4	57	factors	factor	NOUN
njb-85	4	58	gyanendra	gyanendra	VERB
njb-85	4	59	bikram	bikram	PROPN
njb-85	4	60	shah1	shah1	PROPN
njb-85	4	61	,	,	PUNCT
njb-85	4	62	2	2	NUM
njb-85	4	63	,	,	PUNCT
njb-85	4	64	krishna	krishna	PROPN
njb-85	4	65	gurung1	gurung1	PROPN
njb-85	4	66	,	,	PUNCT
njb-85	4	67	bharat	bharat	PROPN
njb-85	4	68	prasad	prasad	PROPN
njb-85	4	69	baral1	baral1	PROPN
njb-85	4	70	,	,	PUNCT
njb-85	4	71	ram	ram	PROPN
njb-85	4	72	raja	raja	PROPN
njb-85	4	73	gurung3	gurung3	PROPN
njb-85	4	74	,	,	PUNCT
njb-85	4	75	balkrishna	balkrishna	NOUN
njb-85	4	76	bhattachan4	bhattachan4	PROPN
njb-85	4	77	1pokhara	1pokhara	NUM
njb-85	4	78	bigyan	bigyan	PROPN
njb-85	4	79	tatha	tatha	PROPN
njb-85	4	80	prabidhi	prabidhi	PROPN
njb-85	4	81	campus	campus	PROPN
njb-85	4	82	,	,	PUNCT
njb-85	4	83	pokhara	pokhara	PROPN
njb-85	4	84	nepal	nepal	ADJ
njb-85	4	85	2central	2central	NUM
njb-85	4	86	blood	blood	NOUN
njb-85	4	87	transfusion	transfusion	NOUN
njb-85	4	88	service	service	NOUN
njb-85	4	89	,	,	PUNCT
njb-85	4	90	nepal	nepal	ADJ
njb-85	4	91	red	red	PROPN
njb-85	4	92	cross	cross	PROPN
njb-85	4	93	society	society	PROPN
njb-85	4	94	,	,	PUNCT
njb-85	4	95	pokhara	pokhara	PROPN
njb-85	4	96	,	,	PUNCT
njb-85	4	97	nepal	nepal	ADJ
njb-85	4	98	3deurali	3deurali	NUM
njb-85	4	99	-	-	PUNCT
njb-85	4	100	janata	janata	PROPN
njb-85	4	101	pharmaceutical	pharmaceutical	PROPN
njb-85	4	102	pvt	pvt	PROPN
njb-85	4	103	.	.	PROPN
njb-85	4	104	ltd	ltd	PROPN
njb-85	4	105	.	.	PROPN
njb-85	4	106	,	,	PUNCT
njb-85	4	107	kathmandu	kathmandu	PROPN
njb-85	4	108	,	,	PUNCT
njb-85	4	109	nepal	nepal	ADJ
njb-85	4	110	4siddhi	4siddhi	NUM
njb-85	4	111	memorial	memorial	PROPN
njb-85	4	112	hospital	hospital	PROPN
njb-85	4	113	,	,	PUNCT
njb-85	4	114	bhaktapur	bhaktapur	PROPN
njb-85	4	115	,	,	PUNCT
njb-85	4	116	nepal	nepal	ADJ
njb-85	4	117	abstract	abstract	PROPN
njb-85	4	118	hepatitis	hepatitis	PROPN
njb-85	4	119	b	b	PROPN
njb-85	4	120	virus	virus	PROPN
njb-85	4	121	(	(	PUNCT
njb-85	4	122	hbv	hbv	NOUN
njb-85	4	123	)	)	PUNCT
njb-85	4	124	and	and	CCONJ
njb-85	4	125	hepatitis	hepatitis	PROPN
njb-85	4	126	c	c	PROPN
njb-85	4	127	virus	virus	PROPN
njb-85	4	128	(	(	PUNCT
njb-85	4	129	hcv	hcv	PROPN
njb-85	4	130	)	)	PUNCT
njb-85	4	131	infections	infection	NOUN
njb-85	4	132	lead	lead	VERB
njb-85	4	133	to	to	ADP
njb-85	4	134	chronic	chronic	ADJ
njb-85	4	135	diseases	disease	NOUN
njb-85	4	136	and	and	CCONJ
njb-85	4	137	are	be	AUX
njb-85	4	138	the	the	DET
njb-85	4	139	most	most	ADV
njb-85	4	140	common	common	ADJ
njb-85	4	141	causes	cause	NOUN
njb-85	4	142	of	of	ADP
njb-85	4	143	liver	liver	NOUN
njb-85	4	144	cirrhosis	cirrhosis	NOUN
njb-85	4	145	and	and	CCONJ
njb-85	4	146	cancer	cancer	NOUN
njb-85	4	147	in	in	ADP
njb-85	4	148	developing	develop	VERB
njb-85	4	149	countries	country	NOUN
njb-85	4	150	like	like	ADP
njb-85	4	151	nepal	nepal	ADJ
njb-85	4	152	.	.	PUNCT
njb-85	5	1	the	the	DET
njb-85	5	2	study	study	NOUN
njb-85	5	3	is	be	AUX
njb-85	5	4	carried	carry	VERB
njb-85	5	5	out	out	ADP
njb-85	5	6	to	to	PART
njb-85	5	7	determine	determine	VERB
njb-85	5	8	the	the	DET
njb-85	5	9	seroprevalence	seroprevalence	NOUN
njb-85	5	10	of	of	ADP
njb-85	5	11	hbv	hbv	NOUN
njb-85	5	12	and	and	CCONJ
njb-85	5	13	hcv	hcv	VERB
njb-85	5	14	by	by	ADP
njb-85	5	15	using	use	VERB
njb-85	5	16	a	a	DET
njb-85	5	17	rapid	rapid	ADJ
njb-85	5	18	kit	kit	NOUN
njb-85	5	19	method	method	NOUN
njb-85	5	20	and	and	CCONJ
njb-85	5	21	elisa	elisa	NOUN
njb-85	5	22	method	method	NOUN
njb-85	5	23	to	to	PART
njb-85	5	24	find	find	VERB
njb-85	5	25	out	out	ADP
njb-85	5	26	its	its	PRON
njb-85	5	27	risk	risk	NOUN
njb-85	5	28	factors	factor	NOUN
njb-85	5	29	.	.	PUNCT
njb-85	6	1	the	the	DET
njb-85	6	2	cross	cross	ADJ
njb-85	6	3	-	-	ADJ
njb-85	6	4	sectional	sectional	ADJ
njb-85	6	5	study	study	NOUN
njb-85	6	6	was	be	AUX
njb-85	6	7	done	do	VERB
njb-85	6	8	among	among	ADP
njb-85	6	9	blood	blood	NOUN
njb-85	6	10	donating	donate	VERB
njb-85	6	11	people	people	NOUN
njb-85	6	12	from	from	ADP
njb-85	6	13	16th	16th	ADJ
njb-85	6	14	august	august	PROPN
njb-85	6	15	2016	2016	NUM
njb-85	6	16	to	to	ADP
njb-85	6	17	19th	19th	ADJ
njb-85	6	18	november	november	PROPN
njb-85	6	19	2016	2016	NUM
njb-85	6	20	.	.	PUNCT
njb-85	7	1	blood	blood	NOUN
njb-85	7	2	donors	donor	NOUN
njb-85	7	3	in	in	ADP
njb-85	7	4	pokhara	pokhara	PROPN
njb-85	7	5	valley	valley	PROPN
njb-85	7	6	were	be	AUX
njb-85	7	7	screened	screen	VERB
njb-85	7	8	for	for	ADP
njb-85	7	9	anti	anti	ADJ
njb-85	7	10	-	-	ADJ
njb-85	7	11	hcv	hcv	ADJ
njb-85	7	12	antibodies	antibody	NOUN
njb-85	7	13	,	,	PUNCT
njb-85	7	14	anti	anti	ADJ
njb-85	7	15	-	-	ADJ
njb-85	7	16	hbv	hbv	ADJ
njb-85	7	17	antibodies	antibody	NOUN
njb-85	7	18	using	use	VERB
njb-85	7	19	third	third	ADJ
njb-85	7	20	generation	generation	NOUN
njb-85	7	21	elisa	elisa	NOUN
njb-85	7	22	kits	kit	NOUN
njb-85	7	23	and	and	CCONJ
njb-85	7	24	automated	automate	VERB
njb-85	7	25	elisa	elisa	PROPN
njb-85	7	26	processor	processor	NOUN
njb-85	7	27	in	in	ADP
njb-85	7	28	serology	serology	NOUN
njb-85	7	29	laboratory	laboratory	NOUN
njb-85	7	30	at	at	ADP
njb-85	7	31	central	central	ADJ
njb-85	7	32	blood	blood	NOUN
njb-85	7	33	transfusion	transfusion	NOUN
njb-85	7	34	service	service	NOUN
njb-85	7	35	(	(	PUNCT
njb-85	7	36	cbts	cbts	PROPN
njb-85	7	37	)	)	PUNCT
njb-85	7	38	of	of	ADP
njb-85	7	39	nepal	nepal	ADJ
njb-85	7	40	red	red	PROPN
njb-85	7	41	cross	cross	PROPN
njb-85	7	42	society	society	NOUN
njb-85	7	43	(	(	PUNCT
njb-85	7	44	nrcs	nrcs	PROPN
njb-85	7	45	)	)	PUNCT
njb-85	7	46	in	in	ADP
njb-85	7	47	pokhara	pokhara	PROPN
njb-85	7	48	,	,	PUNCT
njb-85	7	49	nepal	nepal	ADJ
njb-85	7	50	.	.	PUNCT
njb-85	7	51	1777	1777	NUM
njb-85	8	1	(	(	PUNCT
njb-85	8	2	87.2	87.2	NUM
njb-85	8	3	%	%	NOUN
njb-85	8	4	)	)	PUNCT
njb-85	8	5	units	unit	NOUN
njb-85	8	6	were	be	AUX
njb-85	8	7	male	male	ADJ
njb-85	8	8	blood	blood	NOUN
njb-85	8	9	donors	donor	NOUN
njb-85	8	10	and	and	CCONJ
njb-85	8	11	260	260	NUM
njb-85	8	12	(	(	PUNCT
njb-85	8	13	12.6	12.6	NUM
njb-85	8	14	%	%	NOUN
njb-85	8	15	)	)	PUNCT
njb-85	8	16	units	unit	NOUN
njb-85	8	17	were	be	AUX
njb-85	8	18	female	female	ADJ
njb-85	8	19	donors	donor	NOUN
njb-85	8	20	out	out	ADP
njb-85	8	21	of	of	ADP
njb-85	8	22	2037	2037	NUM
njb-85	8	23	participants	participant	NOUN
njb-85	8	24	.	.	PUNCT
njb-85	9	1	gender	gender	PROPN
njb-85	9	2	wise	wise	ADJ
njb-85	9	3	,	,	PUNCT
njb-85	9	4	the	the	DET
njb-85	9	5	ratio	ratio	NOUN
njb-85	9	6	between	between	ADP
njb-85	9	7	male	male	NOUN
njb-85	9	8	and	and	CCONJ
njb-85	9	9	female	female	ADJ
njb-85	9	10	was	be	AUX
njb-85	9	11	1:0.1	1:0.1	NUM
njb-85	9	12	.	.	PUNCT
njb-85	10	1	hbv	hbv	NOUN
njb-85	10	2	and	and	CCONJ
njb-85	10	3	hcv	hcv	VERB
njb-85	10	4	infection	infection	NOUN
njb-85	10	5	rate	rate	NOUN
njb-85	10	6	in	in	ADP
njb-85	10	7	blood	blood	NOUN
njb-85	10	8	donors	donor	NOUN
njb-85	10	9	were	be	AUX
njb-85	10	10	detected	detect	VERB
njb-85	10	11	at	at	ADP
njb-85	10	12	0.7	0.7	NUM
njb-85	10	13	%	%	NOUN
njb-85	10	14	(	(	PUNCT
njb-85	10	15	15/2037	15/2037	NUM
njb-85	10	16	)	)	PUNCT
njb-85	10	17	and	and	CCONJ
njb-85	10	18	0.5	0.5	NUM
njb-85	10	19	%	%	NOUN
njb-85	10	20	(	(	PUNCT
njb-85	10	21	8/2037	8/2037	NUM
njb-85	10	22	)	)	PUNCT
njb-85	10	23	respectively	respectively	ADV
njb-85	10	24	.	.	PUNCT
njb-85	11	1	hbv	hbv	NOUN
njb-85	11	2	infection	infection	NOUN
njb-85	11	3	rate	rate	NOUN
njb-85	11	4	in	in	ADP
njb-85	11	5	volunteer	volunteer	NOUN
njb-85	11	6	blood	blood	NOUN
njb-85	11	7	donor	donor	NOUN
njb-85	11	8	people	people	NOUN
njb-85	11	9	was	be	AUX
njb-85	11	10	0.7	0.7	NUM
njb-85	11	11	%	%	NOUN
njb-85	11	12	(	(	PUNCT
njb-85	11	13	14/1881	14/1881	NUM
njb-85	11	14	)	)	PUNCT
njb-85	11	15	which	which	PRON
njb-85	11	16	was	be	AUX
njb-85	11	17	higher	high	ADJ
njb-85	11	18	than	than	ADP
njb-85	11	19	the	the	DET
njb-85	11	20	replacement	replacement	NOUN
njb-85	11	21	donors	donor	NOUN
njb-85	11	22	i.e.	i.e.	ADP
njb-85	11	23	0.6	0.6	NUM
njb-85	11	24	%	%	NOUN
njb-85	11	25	(	(	PUNCT
njb-85	11	26	1/156	1/156	NUM
njb-85	11	27	)	)	PUNCT
njb-85	11	28	.	.	PUNCT
njb-85	12	1	similarly	similarly	ADV
njb-85	12	2	,	,	PUNCT
njb-85	12	3	in	in	ADP
njb-85	12	4	hcv	hcv	ADJ
njb-85	12	5	infection	infection	NOUN
njb-85	12	6	rate	rate	NOUN
njb-85	12	7	in	in	ADP
njb-85	12	8	volunteer	volunteer	NOUN
njb-85	12	9	donor	donor	NOUN
njb-85	12	10	were	be	AUX
njb-85	12	11	0.4	0.4	NUM
njb-85	12	12	%	%	NOUN
njb-85	12	13	(	(	PUNCT
njb-85	12	14	8/1881	8/1881	NUM
njb-85	12	15	)	)	PUNCT
njb-85	12	16	.	.	PUNCT
njb-85	13	1	hbv	hbv	NOUN
njb-85	13	2	infected	infect	VERB
njb-85	13	3	people	people	NOUN
njb-85	13	4	are	be	AUX
njb-85	13	5	detected	detect	VERB
njb-85	13	6	higher	higher	ADV
njb-85	13	7	than	than	SCONJ
njb-85	13	8	the	the	DET
njb-85	13	9	hcv	hcv	PROPN
njb-85	13	10	infected	infect	VERB
njb-85	13	11	people	people	NOUN
njb-85	13	12	among	among	ADP
njb-85	13	13	the	the	DET
njb-85	13	14	blood	blood	NOUN
njb-85	13	15	donors	donor	NOUN
njb-85	13	16	.	.	PUNCT
njb-85	14	1	in	in	ADP
njb-85	14	2	addition	addition	NOUN
njb-85	14	3	,	,	PUNCT
njb-85	14	4	there	there	PRON
njb-85	14	5	was	be	VERB
njb-85	14	6	no	no	DET
njb-85	14	7	significant	significant	ADJ
njb-85	14	8	relationship	relationship	NOUN
njb-85	14	9	between	between	ADP
njb-85	14	10	positive	positive	ADJ
njb-85	14	11	results	result	NOUN
njb-85	14	12	of	of	ADP
njb-85	14	13	hbv	hbv	NOUN
njb-85	14	14	and	and	CCONJ
njb-85	14	15	hcv	hcv	VERB
njb-85	14	16	tests	test	NOUN
njb-85	14	17	with	with	ADP
njb-85	14	18	the	the	DET
njb-85	14	19	gender	gender	NOUN
njb-85	14	20	,	,	PUNCT
njb-85	14	21	age	age	NOUN
njb-85	14	22	,	,	PUNCT
njb-85	14	23	tattoo	tattoo	NOUN
njb-85	14	24	,	,	PUNCT
njb-85	14	25	donor	donor	NOUN
njb-85	14	26	type	type	NOUN
njb-85	14	27	.	.	PUNCT
njb-85	15	1	keywords	keyword	NOUN
njb-85	15	2	:	:	PUNCT
njb-85	15	3	blood	blood	NOUN
njb-85	15	4	transfusion	transfusion	NOUN
njb-85	15	5	,	,	PUNCT
njb-85	15	6	sera	sera	PROPN
njb-85	15	7	,	,	PUNCT
njb-85	15	8	hcv	hcv	PROPN
njb-85	15	9	,	,	PUNCT
njb-85	15	10	hbv	hbv	NOUN
njb-85	15	11	,	,	PUNCT
njb-85	15	12	elisa	elisa	NOUN
njb-85	15	13	,	,	PUNCT
njb-85	15	14	nepal	nepal	ADJ
njb-85	15	15	*	*	VERB
njb-85	15	16	corresponding	correspond	VERB
njb-85	15	17	author	author	NOUN
njb-85	15	18	email	email	NOUN
njb-85	15	19	:	:	PUNCT
njb-85	15	20	balkrishna_bhattachan@hotmail.com	balkrishna_bhattachan@hotmail.com	X
njb-85	15	21	introduction	introduction	NOUN
njb-85	15	22	hepatitis	hepatitis	PROPN
njb-85	15	23	b	b	PROPN
njb-85	15	24	virus	virus	PROPN
njb-85	15	25	(	(	PUNCT
njb-85	15	26	hbv	hbv	PROPN
njb-85	15	27	)	)	PUNCT
njb-85	15	28	is	be	AUX
njb-85	15	29	an	an	DET
njb-85	15	30	enveloped	envelop	VERB
njb-85	15	31	,	,	PUNCT
njb-85	15	32	hepadnaviridae	hepadnaviridae	VERB
njb-85	15	33	with	with	ADP
njb-85	15	34	partially	partially	ADV
njb-85	15	35	double	double	ADV
njb-85	15	36	-	-	PUNCT
njb-85	15	37	stranded	strand	VERB
njb-85	15	38	dna	dna	NOUN
njb-85	15	39	[	[	X
njb-85	15	40	1	1	NUM
njb-85	15	41	]	]	PUNCT
njb-85	15	42	.	.	PUNCT
njb-85	16	1	it	it	PRON
njb-85	16	2	is	be	AUX
njb-85	16	3	one	one	NUM
njb-85	16	4	of	of	ADP
njb-85	16	5	the	the	DET
njb-85	16	6	cause	cause	NOUN
njb-85	16	7	of	of	ADP
njb-85	16	8	potentially	potentially	ADV
njb-85	16	9	lifethreatening	lifethreatene	VERB
njb-85	16	10	liver	liver	NOUN
njb-85	16	11	infection	infection	NOUN
njb-85	16	12	and	and	CCONJ
njb-85	16	13	is	be	AUX
njb-85	16	14	a	a	DET
njb-85	16	15	major	major	ADJ
njb-85	16	16	global	global	ADJ
njb-85	16	17	health	health	NOUN
njb-85	16	18	problem	problem	NOUN
njb-85	16	19	.	.	PUNCT
njb-85	17	1	it	it	PRON
njb-85	17	2	can	can	AUX
njb-85	17	3	cause	cause	VERB
njb-85	17	4	chronic	chronic	ADJ
njb-85	17	5	liver	liver	NOUN
njb-85	17	6	disease	disease	NOUN
njb-85	17	7	and	and	CCONJ
njb-85	17	8	puts	put	VERB
njb-85	17	9	people	people	NOUN
njb-85	17	10	at	at	ADP
njb-85	17	11	high	high	ADJ
njb-85	17	12	risk	risk	NOUN
njb-85	17	13	of	of	ADP
njb-85	17	14	death	death	NOUN
njb-85	17	15	from	from	ADP
njb-85	17	16	cirrhosis	cirrhosis	NOUN
njb-85	17	17	of	of	ADP
njb-85	17	18	the	the	DET
njb-85	17	19	liver	liver	NOUN
njb-85	17	20	and	and	CCONJ
njb-85	17	21	liver	liver	NOUN
njb-85	17	22	cancer	cancer	NOUN
njb-85	17	23	[	[	X
njb-85	17	24	2	2	NUM
njb-85	17	25	]	]	X
njb-85	17	26	.	.	PUNCT
njb-85	18	1	worldwide	worldwide	ADV
njb-85	18	2	,	,	PUNCT
njb-85	18	3	an	an	DET
njb-85	18	4	estimated	estimate	VERB
njb-85	18	5	two	two	NUM
njb-85	18	6	billion	billion	NUM
njb-85	18	7	people	people	NOUN
njb-85	18	8	have	have	AUX
njb-85	18	9	been	be	AUX
njb-85	18	10	infected	infect	VERB
njb-85	18	11	with	with	ADP
njb-85	18	12	the	the	DET
njb-85	18	13	hepatitis	hepatitis	PROPN
njb-85	18	14	b	b	PROPN
njb-85	18	15	virus	virus	NOUN
njb-85	18	16	and	and	CCONJ
njb-85	18	17	more	more	ADJ
njb-85	18	18	than	than	ADP
njb-85	18	19	240	240	NUM
njb-85	18	20	million	million	NUM
njb-85	18	21	have	have	VERB
njb-85	18	22	chronic	chronic	ADJ
njb-85	18	23	(	(	PUNCT
njb-85	18	24	long	long	ADJ
njb-85	18	25	-	-	PUNCT
njb-85	18	26	term	term	NOUN
njb-85	18	27	)	)	PUNCT
njb-85	18	28	liver	liver	NOUN
njb-85	18	29	infections	infection	NOUN
njb-85	18	30	.	.	PUNCT
njb-85	19	1	in	in	ADP
njb-85	19	2	developing	develop	VERB
njb-85	19	3	countries	country	NOUN
njb-85	19	4	like	like	ADP
njb-85	19	5	nepal	nepal	ADJ
njb-85	19	6	,	,	PUNCT
njb-85	19	7	the	the	DET
njb-85	19	8	highest	high	ADJ
njb-85	19	9	prevalence	prevalence	NOUN
njb-85	19	10	of	of	ADP
njb-85	19	11	hbv	hbv	NOUN
njb-85	19	12	was	be	AUX
njb-85	19	13	found	find	VERB
njb-85	19	14	in	in	ADP
njb-85	19	15	the	the	DET
njb-85	19	16	6	6	NUM
njb-85	19	17	-	-	SYM
njb-85	19	18	15	15	NUM
njb-85	19	19	year	year	NOUN
njb-85	19	20	age	age	NOUN
njb-85	19	21	group	group	NOUN
njb-85	19	22	[	[	X
njb-85	19	23	3	3	NUM
njb-85	19	24	]	]	X
njb-85	19	25	.	.	PUNCT
njb-85	20	1	common	common	ADJ
njb-85	20	2	modes	mode	NOUN
njb-85	20	3	of	of	ADP
njb-85	20	4	transmission	transmission	NOUN
njb-85	20	5	include	include	VERB
njb-85	20	6	perinatal	perinatal	ADJ
njb-85	20	7	,	,	PUNCT
njb-85	20	8	unsafe	unsafe	ADJ
njb-85	20	9	injection	injection	NOUN
njb-85	20	10	practices	practice	NOUN
njb-85	20	11	,	,	PUNCT
njb-85	20	12	unsafe	unsafe	ADJ
njb-85	20	13	blood	blood	NOUN
njb-85	20	14	transfusions	transfusion	NOUN
njb-85	20	15	,	,	PUNCT
njb-85	20	16	and	and	CCONJ
njb-85	20	17	unprotected	unprotected	ADJ
njb-85	20	18	sexual	sexual	ADJ
njb-85	20	19	contact	contact	NOUN
njb-85	20	20	[	[	PUNCT
njb-85	20	21	4	4	NUM
njb-85	20	22	]	]	PUNCT
njb-85	20	23	.	.	PUNCT
njb-85	21	1	hepatitis	hepatitis	PROPN
njb-85	21	2	c	c	PROPN
njb-85	21	3	virus	virus	PROPN
njb-85	21	4	(	(	PUNCT
njb-85	21	5	hcv	hcv	PROPN
njb-85	21	6	)	)	PUNCT
njb-85	21	7	is	be	AUX
njb-85	21	8	single	single	ADV
njb-85	21	9	-	-	PUNCT
njb-85	21	10	stranded	strand	VERB
njb-85	21	11	rna	rna	PROPN
njb-85	21	12	,	,	PUNCT
njb-85	21	13	enveloped	envelop	VERB
njb-85	21	14	flavivirus	flavivirus	NOUN
njb-85	21	15	that	that	PRON
njb-85	21	16	causes	cause	VERB
njb-85	21	17	liver	liver	NOUN
njb-85	21	18	disease	disease	NOUN
njb-85	21	19	[	[	X
njb-85	21	20	5	5	NUM
njb-85	21	21	]	]	PUNCT
njb-85	21	22	.	.	PUNCT
njb-85	22	1	the	the	DET
njb-85	22	2	disease	disease	NOUN
njb-85	22	3	can	can	AUX
njb-85	22	4	range	range	VERB
njb-85	22	5	in	in	ADP
njb-85	22	6	severity	severity	NOUN
njb-85	22	7	from	from	ADP
njb-85	22	8	a	a	DET
njb-85	22	9	mild	mild	ADJ
njb-85	22	10	illness	illness	NOUN
njb-85	22	11	lasting	last	VERB
njb-85	22	12	for	for	ADP
njb-85	22	13	few	few	ADJ
njb-85	22	14	weeks	week	NOUN
njb-85	22	15	to	to	ADP
njb-85	22	16	a	a	DET
njb-85	22	17	serious	serious	ADJ
njb-85	22	18	,	,	PUNCT
njb-85	22	19	lifethreatening	lifethreatene	VERB
njb-85	22	20	condition	condition	NOUN
njb-85	22	21	that	that	PRON
njb-85	22	22	can	can	AUX
njb-85	22	23	lead	lead	VERB
njb-85	22	24	from	from	ADP
njb-85	22	25	cirrhosis	cirrhosis	NOUN
njb-85	22	26	of	of	ADP
njb-85	22	27	the	the	DET
njb-85	22	28	liver	liver	NOUN
njb-85	22	29	to	to	ADP
njb-85	22	30	liver	liver	ADJ
njb-85	22	31	cancer	cancer	NOUN
njb-85	22	32	.	.	PUNCT
njb-85	23	1	about	about	ADV
njb-85	23	2	170	170	NUM
njb-85	23	3	million	million	NUM
njb-85	23	4	people	people	NOUN
njb-85	23	5	are	be	AUX
njb-85	23	6	infected	infect	VERB
njb-85	23	7	worldwide	worldwide	ADV
njb-85	23	8	[	[	X
njb-85	23	9	6	6	NUM
njb-85	23	10	]	]	X
njb-85	23	11	.	.	PUNCT
njb-85	24	1	hcv	hcv	PROPN
njb-85	24	2	is	be	AUX
njb-85	24	3	most	most	ADV
njb-85	24	4	commonly	commonly	ADV
njb-85	24	5	transmitted	transmit	VERB
njb-85	24	6	through	through	ADP
njb-85	24	7	exposure	exposure	NOUN
njb-85	24	8	to	to	ADP
njb-85	24	9	infectious	infectious	ADJ
njb-85	24	10	blood	blood	NOUN
njb-85	24	11	and	and	CCONJ
njb-85	24	12	it	it	PRON
njb-85	24	13	may	may	AUX
njb-85	24	14	be	be	AUX
njb-85	24	15	transmitted	transmit	VERB
njb-85	24	16	through	through	ADP
njb-85	24	17	gender	gender	NOUN
njb-85	24	18	with	with	ADP
njb-85	24	19	an	an	DET
njb-85	24	20	infected	infect	VERB
njb-85	24	21	person	person	NOUN
njb-85	24	22	or	or	CCONJ
njb-85	24	23	sharing	sharing	NOUN
njb-85	24	24	of	of	ADP
njb-85	24	25	personal	personal	ADJ
njb-85	24	26	items	item	NOUN
njb-85	24	27	contaminated	contaminate	VERB
njb-85	24	28	with	with	ADP
njb-85	24	29	infectious	infectious	ADJ
njb-85	24	30	blood	blood	NOUN
njb-85	24	31	,	,	PUNCT
njb-85	24	32	but	but	CCONJ
njb-85	24	33	these	these	PRON
njb-85	24	34	are	be	AUX
njb-85	24	35	less	less	ADV
njb-85	24	36	common	common	ADJ
njb-85	24	37	[	[	X
njb-85	24	38	7	7	NUM
njb-85	24	39	]	]	PUNCT
njb-85	24	40	.	.	PUNCT
njb-85	25	1	this	this	DET
njb-85	25	2	study	study	NOUN
njb-85	25	3	is	be	AUX
njb-85	25	4	conducted	conduct	VERB
njb-85	25	5	among	among	ADP
njb-85	25	6	blood	blood	NOUN
njb-85	25	7	donors	donor	NOUN
njb-85	25	8	in	in	ADP
njb-85	25	9	pokhara	pokhara	PROPN
njb-85	25	10	valley	valley	PROPN
njb-85	25	11	in	in	ADP
njb-85	25	12	order	order	NOUN
njb-85	25	13	to	to	PART
njb-85	25	14	study	study	VERB
njb-85	25	15	the	the	DET
njb-85	25	16	hbv	hbv	NOUN
njb-85	25	17	and	and	CCONJ
njb-85	25	18	hcv	hcv	VERB
njb-85	25	19	seroprevalence	seroprevalence	NOUN
njb-85	25	20	,	,	PUNCT
njb-85	25	21	among	among	ADP
njb-85	25	22	different	different	ADJ
njb-85	25	23	groups	group	NOUN
njb-85	25	24	and	and	CCONJ
njb-85	25	25	subgroups	subgroup	NOUN
njb-85	25	26	of	of	ADP
njb-85	25	27	blood	blood	NOUN
njb-85	25	28	donors	donor	NOUN
njb-85	25	29	.	.	PUNCT
njb-85	26	1	the	the	DET
njb-85	26	2	main	main	ADJ
njb-85	26	3	aim	aim	NOUN
njb-85	26	4	of	of	ADP
njb-85	26	5	this	this	DET
njb-85	26	6	study	study	NOUN
njb-85	26	7	is	be	AUX
njb-85	26	8	to	to	PART
njb-85	26	9	determine	determine	VERB
njb-85	26	10	the	the	DET
njb-85	26	11	seroprevalence	seroprevalence	NOUN
njb-85	26	12	of	of	ADP
njb-85	26	13	hbv	hbv	NOUN
njb-85	26	14	and	and	CCONJ
njb-85	26	15	hcv	hcv	VERB
njb-85	26	16	by	by	ADP
njb-85	26	17	rapid	rapid	ADJ
njb-85	26	18	kit	kit	NOUN
njb-85	26	19	and	and	CCONJ
njb-85	26	20	elisa	elisa	NOUN
njb-85	26	21	method	method	NOUN
njb-85	26	22	and	and	CCONJ
njb-85	26	23	find	find	VERB
njb-85	26	24	out	out	ADP
njb-85	26	25	its	its	PRON
njb-85	26	26	associated	associated	ADJ
njb-85	26	27	risk	risk	NOUN
njb-85	26	28	factors	factor	NOUN
njb-85	26	29	.	.	PUNCT
njb-85	27	1	open	open	ADJ
njb-85	27	2	land	land	NOUN
njb-85	27	3	route	route	NOUN
njb-85	27	4	facilitates	facilitate	VERB
njb-85	27	5	the	the	DET
njb-85	27	6	biological	biological	ADJ
njb-85	27	7	and	and	CCONJ
njb-85	27	8	virological	virological	ADJ
njb-85	27	9	spread	spread	NOUN
njb-85	27	10	of	of	ADP
njb-85	27	11	diseases	disease	NOUN
njb-85	27	12	[	[	PUNCT
njb-85	27	13	8	8	NUM
njb-85	27	14	]	]	PUNCT
njb-85	27	15	.	.	PUNCT
njb-85	28	1	so	so	ADV
njb-85	28	2	,	,	PUNCT
njb-85	28	3	in	in	ADP
njb-85	28	4	the	the	DET
njb-85	28	5	case	case	NOUN
njb-85	28	6	of	of	ADP
njb-85	28	7	hcv	hcv	PROPN
njb-85	28	8	and	and	CCONJ
njb-85	28	9	hbv	hbv	PROPN
njb-85	28	10	,	,	PUNCT
njb-85	28	11	millions	million	NOUN
njb-85	28	12	of	of	ADP
njb-85	28	13	migrant	migrant	ADJ
njb-85	28	14	workers	worker	NOUN
njb-85	28	15	act	act	VERB
njb-85	28	16	as	as	ADP
njb-85	28	17	a	a	DET
njb-85	28	18	biological	biological	ADJ
njb-85	28	19	transporter	transporter	NOUN
njb-85	28	20	.	.	PUNCT
njb-85	29	1	however	however	ADV
njb-85	29	2	,	,	PUNCT
njb-85	29	3	documentation	documentation	NOUN
njb-85	29	4	of	of	ADP
njb-85	29	5	hcv	hcv	PROPN
njb-85	29	6	and	and	CCONJ
njb-85	29	7	hbv	hbv	NOUN
njb-85	29	8	with	with	ADP
njb-85	29	9	past	past	ADJ
njb-85	29	10	infection	infection	NOUN
njb-85	29	11	is	be	AUX
njb-85	29	12	frequent	frequent	ADJ
njb-85	29	13	nepal	nepal	ADJ
njb-85	29	14	journal	journal	NOUN
njb-85	29	15	of	of	ADP
njb-85	29	16	biotechnology	biotechnology	NOUN
njb-85	29	17	.	.	PUNCT
njb-85	30	1	d	d	X
njb-85	30	2	e	e	PROPN
njb-85	30	3	c	c	PROPN
njb-85	30	4	.	.	PUNCT
njb-85	31	1	2	2	NUM
njb-85	31	2	0	0	NUM
njb-85	31	3	1	1	NUM
njb-85	31	4	8	8	NUM
njb-85	31	5	vol	vol	NOUN
njb-85	31	6	.	.	PROPN
njb-85	32	1	6	6	NUM
njb-85	32	2	,	,	PUNCT
njb-85	32	3	no	no	NOUN
njb-85	32	4	.	.	NOUN
njb-85	32	5	1	1	NUM
njb-85	32	6	:	:	SYM
njb-85	32	7	33	33	NUM
njb-85	32	8	-	-	SYM
njb-85	32	9	38	38	NUM
njb-85	32	10	shah	shah	NOUN
njb-85	32	11	et	et	X
njb-85	32	12	al	al	PROPN
njb-85	32	13	.	.	PUNCT
njb-85	33	1	©	©	PROPN
njb-85	33	2	njb	njb	PROPN
njb-85	33	3	,	,	PUNCT
njb-85	33	4	biotechnology	biotechnology	NOUN
njb-85	33	5	society	society	NOUN
njb-85	33	6	of	of	ADP
njb-85	33	7	nepal	nepal	ADJ
njb-85	33	8	34	34	NUM
njb-85	33	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	NOUN
njb-85	33	10	in	in	ADP
njb-85	33	11	person	person	NOUN
njb-85	33	12	with	with	ADP
njb-85	33	13	routine	routine	ADJ
njb-85	33	14	parenteral	parenteral	ADJ
njb-85	33	15	exposures	exposure	NOUN
njb-85	33	16	which	which	PRON
njb-85	33	17	indicate	indicate	VERB
njb-85	33	18	that	that	SCONJ
njb-85	33	19	the	the	DET
njb-85	33	20	transmission	transmission	NOUN
njb-85	33	21	by	by	ADP
njb-85	33	22	this	this	DET
njb-85	33	23	line	line	NOUN
njb-85	33	24	is	be	AUX
njb-85	33	25	prominent	prominent	ADJ
njb-85	33	26	.	.	PUNCT
njb-85	34	1	accidental	accidental	ADJ
njb-85	34	2	parenteral	parenteral	ADJ
njb-85	34	3	exposures	exposure	NOUN
njb-85	34	4	such	such	ADJ
njb-85	34	5	as	as	ADP
njb-85	34	6	needle	needle	NOUN
njb-85	34	7	-	-	PUNCT
njb-85	34	8	stick	stick	NOUN
njb-85	34	9	injuries	injury	NOUN
njb-85	34	10	are	be	AUX
njb-85	34	11	quite	quite	ADV
njb-85	34	12	common	common	ADJ
njb-85	34	13	in	in	ADP
njb-85	34	14	patients	patient	NOUN
njb-85	34	15	.	.	PUNCT
njb-85	35	1	another	another	DET
njb-85	35	2	route	route	NOUN
njb-85	35	3	of	of	ADP
njb-85	35	4	transmission	transmission	NOUN
njb-85	35	5	is	be	AUX
njb-85	35	6	having	have	VERB
njb-85	35	7	tattoos	tattoo	NOUN
njb-85	35	8	,	,	PUNCT
njb-85	35	9	drug	drug	NOUN
njb-85	35	10	addicts	addict	NOUN
njb-85	35	11	,	,	PUNCT
njb-85	35	12	heterosexual	heterosexual	ADJ
njb-85	35	13	and	and	CCONJ
njb-85	35	14	homosexual	homosexual	ADJ
njb-85	35	15	gender	gender	NOUN
njb-85	35	16	,	,	PUNCT
njb-85	35	17	liver	liver	NOUN
njb-85	35	18	diseases	disease	NOUN
njb-85	35	19	,	,	PUNCT
njb-85	35	20	and	and	CCONJ
njb-85	35	21	blood	blood	NOUN
njb-85	35	22	transfusion	transfusion	NOUN
njb-85	35	23	.	.	PUNCT
njb-85	36	1	perception	perception	NOUN
njb-85	36	2	and	and	CCONJ
njb-85	36	3	awareness	awareness	NOUN
njb-85	36	4	level	level	NOUN
njb-85	36	5	of	of	ADP
njb-85	36	6	people	people	NOUN
njb-85	36	7	has	have	AUX
njb-85	36	8	been	be	AUX
njb-85	36	9	changed	change	VERB
njb-85	36	10	after	after	SCONJ
njb-85	36	11	the	the	DET
njb-85	36	12	jaundice	jaundice	NOUN
njb-85	36	13	outbreak	outbreak	NOUN
njb-85	36	14	occurred	occur	VERB
njb-85	36	15	in	in	ADP
njb-85	36	16	biratnagar	biratnagar	NOUN
njb-85	36	17	during	during	ADP
njb-85	36	18	april	april	PROPN
njb-85	36	19	-	-	PUNCT
njb-85	36	20	july	july	PROPN
njb-85	36	21	2014	2014	NUM
njb-85	37	1	[	[	PUNCT
njb-85	37	2	9	9	NUM
njb-85	37	3	]	]	PUNCT
njb-85	37	4	.	.	PUNCT
njb-85	37	5	methods	method	NOUN
njb-85	37	6	and	and	CCONJ
njb-85	37	7	materials	material	NOUN
njb-85	37	8	study	study	NOUN
njb-85	37	9	design	design	NOUN
njb-85	37	10	and	and	CCONJ
njb-85	37	11	setting	set	VERB
njb-85	37	12	cross	cross	ADJ
njb-85	37	13	-	-	ADJ
njb-85	37	14	sectional	sectional	ADJ
njb-85	37	15	and	and	CCONJ
njb-85	37	16	descriptive	descriptive	ADJ
njb-85	37	17	type	type	NOUN
njb-85	37	18	of	of	ADP
njb-85	37	19	study	study	NOUN
njb-85	37	20	was	be	AUX
njb-85	37	21	done	do	VERB
njb-85	37	22	.	.	PUNCT
njb-85	38	1	the	the	DET
njb-85	38	2	study	study	NOUN
njb-85	38	3	sample	sample	NOUN
njb-85	38	4	comprised	comprise	VERB
njb-85	38	5	of	of	ADP
njb-85	38	6	2037	2037	NUM
njb-85	38	7	blood	blood	NOUN
njb-85	38	8	donors	donor	NOUN
njb-85	38	9	.	.	PUNCT
njb-85	39	1	healthy	healthy	ADJ
njb-85	39	2	donors	donor	NOUN
njb-85	39	3	included	include	VERB
njb-85	39	4	in	in	ADP
njb-85	39	5	this	this	DET
njb-85	39	6	study	study	NOUN
njb-85	39	7	were	be	AUX
njb-85	39	8	donating	donate	VERB
njb-85	39	9	blood	blood	NOUN
njb-85	39	10	in	in	ADP
njb-85	39	11	blood	blood	NOUN
njb-85	39	12	transfusion	transfusion	NOUN
njb-85	39	13	center	center	NOUN
njb-85	39	14	,	,	PUNCT
njb-85	39	15	pokhara	pokhara	NOUN
njb-85	39	16	at	at	ADP
njb-85	39	17	mobile	mobile	ADJ
njb-85	39	18	health	health	NOUN
njb-85	39	19	camp	camp	NOUN
njb-85	39	20	organized	organize	VERB
njb-85	39	21	by	by	ADP
njb-85	39	22	red	red	PROPN
njb-85	39	23	cross	cross	PROPN
njb-85	39	24	society	society	NOUN
njb-85	39	25	.	.	PUNCT
njb-85	40	1	this	this	DET
njb-85	40	2	study	study	NOUN
njb-85	40	3	was	be	AUX
njb-85	40	4	conducted	conduct	VERB
njb-85	40	5	from	from	ADP
njb-85	40	6	16th	16th	ADJ
njb-85	40	7	august	august	PROPN
njb-85	40	8	to	to	ADP
njb-85	40	9	19th	19th	ADJ
njb-85	40	10	november	november	PROPN
njb-85	40	11	2016	2016	NUM
njb-85	40	12	.	.	PUNCT
njb-85	41	1	study	study	NOUN
njb-85	41	2	area	area	NOUN
njb-85	41	3	and	and	CCONJ
njb-85	41	4	population	population	NOUN
njb-85	41	5	blood	blood	NOUN
njb-85	41	6	donors	donor	NOUN
njb-85	41	7	were	be	AUX
njb-85	41	8	selected	select	VERB
njb-85	41	9	according	accord	VERB
njb-85	41	10	to	to	ADP
njb-85	41	11	the	the	DET
njb-85	41	12	criteria	criterion	NOUN
njb-85	41	13	of	of	ADP
njb-85	41	14	blood	blood	NOUN
njb-85	41	15	transfusion	transfusion	NOUN
njb-85	41	16	service	service	NOUN
njb-85	41	17	(	(	PUNCT
njb-85	41	18	bts	bts	X
njb-85	41	19	)	)	PUNCT
njb-85	41	20	based	base	VERB
njb-85	41	21	on	on	ADP
njb-85	41	22	the	the	DET
njb-85	41	23	national	national	ADJ
njb-85	41	24	guidelines	guideline	NOUN
njb-85	41	25	for	for	ADP
njb-85	41	26	bts	bts	X
njb-85	41	27	.	.	PUNCT
njb-85	42	1	the	the	DET
njb-85	42	2	categories	category	NOUN
njb-85	42	3	of	of	ADP
njb-85	42	4	donors	donor	NOUN
njb-85	42	5	that	that	PRON
njb-85	42	6	were	be	AUX
njb-85	42	7	present	present	ADJ
njb-85	42	8	in	in	ADP
njb-85	42	9	this	this	DET
njb-85	42	10	study	study	NOUN
njb-85	42	11	were	be	AUX
njb-85	42	12	volunteers	volunteer	NOUN
njb-85	42	13	and	and	CCONJ
njb-85	42	14	replacement	replacement	NOUN
njb-85	42	15	who	who	PRON
njb-85	42	16	may	may	AUX
njb-85	42	17	be	be	AUX
njb-85	42	18	the	the	DET
njb-85	42	19	first	first	ADJ
njb-85	42	20	time	time	NOUN
njb-85	42	21	or	or	CCONJ
njb-85	42	22	repeated	repeat	VERB
njb-85	42	23	donor	donor	NOUN
njb-85	42	24	.	.	PUNCT
njb-85	43	1	individuals	individual	NOUN
njb-85	43	2	selected	select	VERB
njb-85	43	3	by	by	ADP
njb-85	43	4	donor	donor	NOUN
njb-85	43	5	screening	screening	NOUN
njb-85	43	6	criteria	criterion	NOUN
njb-85	43	7	as	as	ADP
njb-85	43	8	per	per	ADP
njb-85	43	9	nrcs	nrcs	NOUN
njb-85	43	10	’	'	PUNCT
njb-85	43	11	standard	standard	ADJ
njb-85	43	12	operating	operating	NOUN
njb-85	43	13	procedure	procedure	NOUN
njb-85	43	14	(	(	PUNCT
njb-85	43	15	sop	sop	PROPN
njb-85	43	16	)	)	PUNCT
njb-85	43	17	of	of	ADP
njb-85	43	18	2006	2006	NUM
njb-85	43	19	ad	ad	NOUN
njb-85	43	20	.	.	PUNCT
njb-85	44	1	participants	participant	NOUN
njb-85	44	2	were	be	AUX
njb-85	44	3	requested	request	VERB
njb-85	44	4	to	to	PART
njb-85	44	5	fill	fill	VERB
njb-85	44	6	a	a	DET
njb-85	44	7	questionnaire	questionnaire	NOUN
njb-85	44	8	form	form	NOUN
njb-85	44	9	along	along	ADP
njb-85	44	10	with	with	ADP
njb-85	44	11	written	write	VERB
njb-85	44	12	consent	consent	NOUN
njb-85	44	13	were	be	AUX
njb-85	44	14	collected	collect	VERB
njb-85	44	15	.	.	PUNCT
njb-85	45	1	each	each	DET
njb-85	45	2	donor	donor	NOUN
njb-85	45	3	was	be	AUX
njb-85	45	4	given	give	VERB
njb-85	45	5	an	an	DET
njb-85	45	6	i	i	NOUN
njb-85	45	7	d	d	NOUN
njb-85	45	8	number	number	NOUN
njb-85	45	9	for	for	ADP
njb-85	45	10	later	later	ADV
njb-85	45	11	trace	trace	NOUN
njb-85	45	12	out	out	ADP
njb-85	45	13	if	if	SCONJ
njb-85	45	14	needed	need	VERB
njb-85	45	15	.	.	PUNCT
njb-85	46	1	inclusion	inclusion	NOUN
njb-85	46	2	criteria	criterion	NOUN
njb-85	46	3	:	:	PUNCT
njb-85	46	4	healthy	healthy	ADJ
njb-85	46	5	donors	donor	NOUN
njb-85	46	6	were	be	AUX
njb-85	46	7	included	include	VERB
njb-85	46	8	for	for	ADP
njb-85	46	9	blood	blood	NOUN
njb-85	46	10	donation	donation	NOUN
njb-85	46	11	after	after	ADP
njb-85	46	12	taking	take	VERB
njb-85	46	13	an	an	DET
njb-85	46	14	interview	interview	NOUN
njb-85	46	15	.	.	PUNCT
njb-85	47	1	the	the	DET
njb-85	47	2	detailed	detailed	ADJ
njb-85	47	3	inclusion	inclusion	NOUN
njb-85	47	4	criteria	criterion	NOUN
njb-85	47	5	for	for	ADP
njb-85	47	6	blood	blood	NOUN
njb-85	47	7	donors	donor	NOUN
njb-85	47	8	are	be	AUX
njb-85	47	9	:	:	PUNCT
njb-85	47	10	donor	donor	NOUN
njb-85	47	11	should	should	AUX
njb-85	47	12	be	be	AUX
njb-85	47	13	in	in	ADP
njb-85	47	14	the	the	DET
njb-85	47	15	age	age	NOUN
njb-85	47	16	group	group	NOUN
njb-85	47	17	between	between	ADP
njb-85	47	18	18	18	NUM
njb-85	47	19	to	to	PART
njb-85	47	20	60	60	NUM
njb-85	47	21	years	year	NOUN
njb-85	47	22	,	,	PUNCT
njb-85	47	23	body	body	NOUN
njb-85	47	24	weight	weight	NOUN
njb-85	47	25	more	more	ADJ
njb-85	47	26	than	than	ADP
njb-85	47	27	45	45	NUM
njb-85	47	28	kg	kg	NOUN
njb-85	47	29	for	for	ADP
njb-85	47	30	male	male	NOUN
njb-85	47	31	and	and	CCONJ
njb-85	47	32	35	35	NUM
njb-85	47	33	kg	kg	NOUN
njb-85	47	34	for	for	ADP
njb-85	47	35	female	female	NOUN
njb-85	47	36	,	,	PUNCT
njb-85	47	37	within	within	ADP
njb-85	47	38	normal	normal	ADJ
njb-85	47	39	range	range	NOUN
njb-85	47	40	blood	blood	NOUN
njb-85	47	41	pressure	pressure	NOUN
njb-85	47	42	120/80	120/80	NUM
njb-85	47	43	mm	mm	NOUN
njb-85	47	44	without	without	ADP
njb-85	47	45	medication	medication	NOUN
njb-85	47	46	and	and	CCONJ
njb-85	47	47	hemoglobin	hemoglobin	NOUN
njb-85	47	48	should	should	AUX
njb-85	47	49	not	not	PART
njb-85	47	50	be	be	AUX
njb-85	47	51	less	less	ADJ
njb-85	47	52	than	than	ADP
njb-85	47	53	12.6	12.6	NUM
njb-85	47	54	g	g	NUM
njb-85	47	55	/	/	SYM
njb-85	47	56	ml	ml	PROPN
njb-85	47	57	.	.	PROPN
njb-85	48	1	exclusion	exclusion	NOUN
njb-85	48	2	criteria	criterion	NOUN
njb-85	48	3	:	:	PUNCT
njb-85	48	4	those	those	PRON
njb-85	48	5	who	who	PRON
njb-85	48	6	are	be	AUX
njb-85	48	7	found	find	VERB
njb-85	48	8	unhealthy	unhealthy	ADJ
njb-85	48	9	on	on	ADP
njb-85	48	10	the	the	DET
njb-85	48	11	interview	interview	NOUN
njb-85	48	12	were	be	AUX
njb-85	48	13	excluded	exclude	VERB
njb-85	48	14	for	for	ADP
njb-85	48	15	donation	donation	NOUN
njb-85	48	16	.	.	PUNCT
njb-85	49	1	the	the	DET
njb-85	49	2	exclusion	exclusion	NOUN
njb-85	49	3	criteria	criterion	NOUN
njb-85	49	4	for	for	ADP
njb-85	49	5	blood	blood	NOUN
njb-85	49	6	donors	donor	NOUN
njb-85	49	7	are	be	AUX
njb-85	49	8	:	:	PUNCT
njb-85	49	9	in	in	ADP
njb-85	49	10	the	the	DET
njb-85	49	11	case	case	NOUN
njb-85	49	12	of	of	ADP
njb-85	49	13	a	a	DET
njb-85	49	14	female	female	NOUN
njb-85	49	15	,	,	PUNCT
njb-85	49	16	menstruating	menstruate	VERB
njb-85	49	17	,	,	PUNCT
njb-85	49	18	pregnant	pregnant	ADJ
njb-85	49	19	and	and	CCONJ
njb-85	49	20	breastfeeding	breastfeed	VERB
njb-85	49	21	mother	mother	NOUN
njb-85	49	22	are	be	AUX
njb-85	49	23	not	not	PART
njb-85	49	24	allowed	allow	VERB
njb-85	49	25	for	for	ADP
njb-85	49	26	donation	donation	NOUN
njb-85	49	27	and	and	CCONJ
njb-85	49	28	patients	patient	NOUN
njb-85	49	29	taking	take	VERB
njb-85	49	30	antibiotics	antibiotic	NOUN
njb-85	49	31	.	.	PUNCT
njb-85	50	1	sample	sample	NOUN
njb-85	50	2	collection	collection	NOUN
njb-85	50	3	and	and	CCONJ
njb-85	50	4	processing	process	VERB
njb-85	50	5	the	the	DET
njb-85	50	6	blood	blood	NOUN
njb-85	50	7	bags	bag	NOUN
njb-85	50	8	were	be	AUX
njb-85	50	9	transported	transport	VERB
njb-85	50	10	from	from	ADP
njb-85	50	11	blood	blood	NOUN
njb-85	50	12	donation	donation	NOUN
njb-85	50	13	campaign	campaign	NOUN
njb-85	50	14	site	site	NOUN
njb-85	50	15	to	to	ADP
njb-85	50	16	blood	blood	NOUN
njb-85	50	17	bank	bank	NOUN
njb-85	50	18	in	in	ADP
njb-85	50	19	igloo	igloo	PROPN
njb-85	50	20	box	box	PROPN
njb-85	50	21	containing	contain	VERB
njb-85	50	22	ice	ice	NOUN
njb-85	50	23	bars	bar	NOUN
njb-85	50	24	to	to	PART
njb-85	50	25	maintain	maintain	VERB
njb-85	50	26	the	the	DET
njb-85	50	27	temperature	temperature	NOUN
njb-85	50	28	near	near	ADP
njb-85	50	29	40c	40c	NUM
njb-85	50	30	.	.	PUNCT
njb-85	51	1	a	a	DET
njb-85	51	2	few	few	ADJ
njb-85	51	3	drops	drop	NOUN
njb-85	51	4	of	of	ADP
njb-85	51	5	blood	blood	NOUN
njb-85	51	6	is	be	AUX
njb-85	51	7	used	use	VERB
njb-85	51	8	for	for	ADP
njb-85	51	9	blood	blood	NOUN
njb-85	51	10	grouping	group	VERB
njb-85	51	11	and	and	CCONJ
njb-85	51	12	5ml	5ml	ADJ
njb-85	51	13	of	of	ADP
njb-85	51	14	blood	blood	NOUN
njb-85	51	15	was	be	AUX
njb-85	51	16	allowed	allow	VERB
njb-85	51	17	to	to	PART
njb-85	51	18	clot	clot	NOUN
njb-85	51	19	or	or	CCONJ
njb-85	51	20	centrifuged	centrifuge	VERB
njb-85	51	21	at	at	ADP
njb-85	51	22	3000	3000	NUM
njb-85	51	23	rpm	rpm	NOUN
njb-85	51	24	for	for	ADP
njb-85	51	25	2	2	NUM
njb-85	51	26	minutes	minute	NOUN
njb-85	51	27	in	in	ADP
njb-85	51	28	a	a	DET
njb-85	51	29	dry	dry	ADJ
njb-85	51	30	screw	screw	NOUN
njb-85	51	31	-	-	PUNCT
njb-85	51	32	capped	cap	VERB
njb-85	51	33	test	test	NOUN
njb-85	51	34	tube	tube	NOUN
njb-85	51	35	to	to	PART
njb-85	51	36	separate	separate	VERB
njb-85	51	37	serum	serum	NOUN
njb-85	51	38	samples	sample	NOUN
njb-85	51	39	to	to	PART
njb-85	51	40	perform	perform	VERB
njb-85	51	41	the	the	DET
njb-85	51	42	test	test	NOUN
njb-85	51	43	for	for	ADP
njb-85	51	44	hbv	hbv	NOUN
njb-85	51	45	and	and	CCONJ
njb-85	51	46	hcv	hcv	PROPN
njb-85	51	47	.	.	PUNCT
njb-85	52	1	detection	detection	NOUN
njb-85	52	2	of	of	ADP
njb-85	52	3	hbv	hbv	NOUN
njb-85	52	4	and	and	CCONJ
njb-85	52	5	hcv	hcv	VERB
njb-85	52	6	by	by	ADP
njb-85	52	7	using	use	VERB
njb-85	52	8	rapid	rapid	ADJ
njb-85	52	9	kit	kit	NOUN
njb-85	52	10	test	test	NOUN
njb-85	52	11	collected	collect	VERB
njb-85	52	12	sera	sera	PROPN
njb-85	52	13	were	be	AUX
njb-85	52	14	subjected	subject	VERB
njb-85	52	15	for	for	ADP
njb-85	52	16	routine	routine	ADJ
njb-85	52	17	mandatory	mandatory	ADJ
njb-85	52	18	screening	screening	NOUN
njb-85	52	19	for	for	ADP
njb-85	52	20	hbsag	hbsag	PROPN
njb-85	52	21	and	and	CCONJ
njb-85	52	22	anti	anti	ADJ
njb-85	52	23	-	-	ADJ
njb-85	52	24	hcv	hcv	ADJ
njb-85	52	25	antibodies	antibody	NOUN
njb-85	52	26	by	by	ADP
njb-85	52	27	enzyme	enzyme	PROPN
njb-85	52	28	immunoassay	immunoassay	NOUN
njb-85	52	29	-	-	PUNCT
njb-85	52	30	based	base	VERB
njb-85	52	31	rapid	rapid	ADJ
njb-85	52	32	tests	test	NOUN
njb-85	52	33	according	accord	VERB
njb-85	52	34	to	to	ADP
njb-85	52	35	the	the	DET
njb-85	52	36	standard	standard	ADJ
njb-85	52	37	protocol	protocol	NOUN
njb-85	52	38	described	describe	VERB
njb-85	52	39	by	by	ADP
njb-85	52	40	respective	respective	ADJ
njb-85	52	41	company	company	NOUN
njb-85	52	42	(	(	PUNCT
njb-85	52	43	hepacard	hepacard	PROPN
njb-85	52	44	,	,	PUNCT
njb-85	52	45	j.	j.	PROPN
njb-85	52	46	mitra	mitra	PROPN
njb-85	52	47	and	and	CCONJ
njb-85	52	48	co.	co.	PROPN
njb-85	52	49	,	,	PUNCT
njb-85	52	50	new	new	PROPN
njb-85	52	51	delhi	delhi	PROPN
njb-85	52	52	,	,	PUNCT
njb-85	52	53	india	india	PROPN
njb-85	52	54	,	,	PUNCT
njb-85	52	55	and	and	CCONJ
njb-85	52	56	hcv	hcv	PROPN
njb-85	52	57	tridot	tridot	PROPN
njb-85	52	58	,	,	PUNCT
njb-85	52	59	j.	j.	PROPN
njb-85	52	60	mitra	mitra	PROPN
njb-85	52	61	and	and	CCONJ
njb-85	52	62	co.	co.	PROPN
njb-85	52	63	,	,	PUNCT
njb-85	52	64	new	new	PROPN
njb-85	52	65	delhi	delhi	PROPN
njb-85	52	66	,	,	PUNCT
njb-85	52	67	india	india	PROPN
njb-85	52	68	)	)	PUNCT
njb-85	53	1	[	[	PUNCT
njb-85	53	2	10	10	NUM
njb-85	53	3	]	]	PUNCT
njb-85	53	4	.	.	PUNCT
njb-85	54	1	detection	detection	NOUN
njb-85	54	2	of	of	ADP
njb-85	54	3	hbv	hbv	NOUN
njb-85	54	4	and	and	CCONJ
njb-85	54	5	hcv	hcv	VERB
njb-85	54	6	by	by	ADP
njb-85	54	7	using	use	VERB
njb-85	54	8	elisa	elisa	PROPN
njb-85	54	9	method	method	PROPN
njb-85	54	10	sera	sera	PROPN
njb-85	54	11	from	from	ADP
njb-85	54	12	blood	blood	NOUN
njb-85	54	13	donors	donor	NOUN
njb-85	54	14	for	for	ADP
njb-85	54	15	hcv	hcv	PROPN
njb-85	54	16	were	be	AUX
njb-85	54	17	tested	test	VERB
njb-85	54	18	against	against	ADP
njb-85	54	19	(	(	PUNCT
njb-85	54	20	anti	anti	ADJ
njb-85	54	21	-	-	ADJ
njb-85	54	22	hcvs	hcvs	ADJ
njb-85	54	23	)	)	PUNCT
njb-85	54	24	antigen	antigen	NOUN
njb-85	54	25	by	by	ADP
njb-85	54	26	third	third	ADJ
njb-85	54	27	generation	generation	NOUN
njb-85	54	28	enzyme	enzyme	NOUN
njb-85	54	29	-	-	PUNCT
njb-85	54	30	linked	link	VERB
njb-85	54	31	immunosorbent	immunosorbent	NOUN
njb-85	54	32	assay	assay	NOUN
njb-85	54	33	(	(	PUNCT
njb-85	54	34	elisa	elisa	NOUN
njb-85	54	35	)	)	PUNCT
njb-85	54	36	and	and	CCONJ
njb-85	54	37	for	for	ADP
njb-85	54	38	detection	detection	NOUN
njb-85	54	39	of	of	ADP
njb-85	54	40	hbv	hbv	NOUN
njb-85	54	41	by	by	ADP
njb-85	54	42	hbsag	hbsag	PROPN
njb-85	54	43	elisa	elisa	PROPN
njb-85	54	44	(	(	PUNCT
njb-85	54	45	hcv	hcv	VERB
njb-85	54	46	tri	tri	ADJ
njb-85	54	47	-	-	ADJ
njb-85	54	48	dot	dot	NOUN
njb-85	54	49	test	test	NOUN
njb-85	54	50	,	,	PUNCT
njb-85	54	51	j.	j.	PROPN
njb-85	54	52	mitra	mitra	PROPN
njb-85	54	53	and	and	CCONJ
njb-85	54	54	co.	co.	PROPN
njb-85	54	55	,	,	PUNCT
njb-85	54	56	new	new	PROPN
njb-85	54	57	delhi	delhi	PROPN
njb-85	54	58	,	,	PUNCT
njb-85	54	59	india	india	PROPN
njb-85	54	60	;	;	PUNCT
njb-85	54	61	hepacard	hepacard	PROPN
njb-85	54	62	,	,	PUNCT
njb-85	54	63	j.	j.	PROPN
njb-85	54	64	mitra	mitra	PROPN
njb-85	54	65	;	;	PUNCT
njb-85	54	66	genedia	genedia	PROPN
njb-85	54	67	hcv	hcv	VERB
njb-85	54	68	elisa.3.0	elisa.3.0	PROPN
njb-85	54	69	,	,	PUNCT
njb-85	54	70	green	green	PROPN
njb-85	54	71	cross	cross	PROPN
njb-85	54	72	,	,	PUNCT
njb-85	54	73	kyunggido	kyunggido	PROPN
njb-85	54	74	,	,	PUNCT
njb-85	54	75	korea	korea	PROPN
njb-85	54	76	;	;	PUNCT
njb-85	54	77	and	and	CCONJ
njb-85	54	78	enzygnost	enzygnost	PROPN
njb-85	54	79	hbsag	hbsag	PROPN
njb-85	54	80	5.0	5.0	NUM
njb-85	54	81	,	,	PUNCT
njb-85	54	82	dade	dade	PROPN
njb-85	54	83	behring	behring	PROPN
njb-85	54	84	,	,	PUNCT
njb-85	54	85	marburg	marburg	PROPN
njb-85	54	86	,	,	PUNCT
njb-85	54	87	germany	germany	PROPN
njb-85	54	88	)	)	PUNCT
njb-85	55	1	[	[	X
njb-85	55	2	11	11	NUM
njb-85	55	3	]	]	PUNCT
njb-85	55	4	.	.	PUNCT
njb-85	56	1	statistical	statistical	ADJ
njb-85	56	2	analysis	analysis	NOUN
njb-85	56	3	pearson	pearson	PROPN
njb-85	56	4	's	's	PART
njb-85	56	5	chi	chi	ADJ
njb-85	56	6	-	-	PUNCT
njb-85	56	7	square	square	ADJ
njb-85	56	8	test	test	NOUN
njb-85	56	9	was	be	AUX
njb-85	56	10	used	use	VERB
njb-85	56	11	to	to	PART
njb-85	56	12	determine	determine	VERB
njb-85	56	13	the	the	DET
njb-85	56	14	significant	significant	ADJ
njb-85	56	15	association	association	NOUN
njb-85	56	16	of	of	ADP
njb-85	56	17	dependable	dependable	ADJ
njb-85	56	18	variables	variable	NOUN
njb-85	56	19	.	.	PUNCT
njb-85	57	1	winpepi	winpepi	PROPN
njb-85	57	2	software	software	PROPN
njb-85	57	3	(	(	PUNCT
njb-85	57	4	version	version	NOUN
njb-85	57	5	11.65	11.65	NUM
njb-85	57	6	)	)	PUNCT
njb-85	57	7	was	be	AUX
njb-85	57	8	used	use	VERB
njb-85	57	9	for	for	ADP
njb-85	57	10	quantitative	quantitative	ADJ
njb-85	57	11	data	datum	NOUN
njb-85	57	12	analysis	analysis	NOUN
njb-85	57	13	.	.	PUNCT
njb-85	58	1	a	a	DET
njb-85	58	2	p	p	NOUN
njb-85	58	3	-	-	PUNCT
njb-85	58	4	value	value	NOUN
njb-85	58	5	<	<	X
njb-85	58	6	0.05	0.05	NUM
njb-85	58	7	was	be	AUX
njb-85	58	8	considered	consider	VERB
njb-85	58	9	to	to	PART
njb-85	58	10	be	be	AUX
njb-85	58	11	statistically	statistically	ADV
njb-85	58	12	significant	significant	ADJ
njb-85	58	13	at	at	ADP
njb-85	58	14	95	95	NUM
njb-85	58	15	%	%	NOUN
njb-85	58	16	ci	ci	NOUN
njb-85	58	17	.	.	PUNCT
njb-85	58	18	results	result	VERB
njb-85	58	19	a	a	DET
njb-85	58	20	total	total	NOUN
njb-85	58	21	of	of	ADP
njb-85	58	22	2037	2037	NUM
njb-85	58	23	blood	blood	NOUN
njb-85	58	24	samples	sample	NOUN
njb-85	58	25	were	be	AUX
njb-85	58	26	collected	collect	VERB
njb-85	58	27	from	from	ADP
njb-85	58	28	donors	donor	NOUN
njb-85	58	29	.	.	PUNCT
njb-85	59	1	the	the	DET
njb-85	59	2	blood	blood	NOUN
njb-85	59	3	was	be	AUX
njb-85	59	4	screened	screen	VERB
njb-85	59	5	by	by	ADP
njb-85	59	6	rapid	rapid	ADJ
njb-85	59	7	test	test	NOUN
njb-85	59	8	and	and	CCONJ
njb-85	59	9	elisa	elisa	NOUN
njb-85	59	10	test	test	VERB
njb-85	59	11	to	to	PART
njb-85	59	12	detect	detect	VERB
njb-85	59	13	hbv	hbv	NOUN
njb-85	59	14	and	and	CCONJ
njb-85	59	15	hcv	hcv	VERB
njb-85	59	16	infection	infection	NOUN
njb-85	59	17	.	.	PUNCT
njb-85	60	1	gender	gender	PROPN
njb-85	60	2	wise	wise	ADJ
njb-85	60	3	,	,	PUNCT
njb-85	60	4	the	the	DET
njb-85	60	5	ratio	ratio	NOUN
njb-85	60	6	between	between	ADP
njb-85	60	7	male	male	NOUN
njb-85	60	8	and	and	CCONJ
njb-85	60	9	female	female	ADJ
njb-85	60	10	was	be	AUX
njb-85	60	11	at	at	ADP
njb-85	60	12	1:0.1	1:0.1	NUM
njb-85	60	13	.	.	PUNCT
njb-85	61	1	the	the	DET
njb-85	61	2	infection	infection	NOUN
njb-85	61	3	rate	rate	NOUN
njb-85	61	4	of	of	ADP
njb-85	61	5	hbv	hbv	NOUN
njb-85	61	6	and	and	CCONJ
njb-85	61	7	hcv	hcv	PROPN
njb-85	61	8	in	in	ADP
njb-85	61	9	blood	blood	NOUN
njb-85	61	10	donors	donor	NOUN
njb-85	61	11	were	be	AUX
njb-85	61	12	detected	detect	VERB
njb-85	61	13	to	to	PART
njb-85	61	14	be	be	AUX
njb-85	61	15	0.7	0.7	NUM
njb-85	61	16	%	%	NOUN
njb-85	61	17	(	(	PUNCT
njb-85	61	18	15/2037	15/2037	NUM
njb-85	61	19	)	)	PUNCT
njb-85	61	20	and	and	CCONJ
njb-85	61	21	0.5	0.5	NUM
njb-85	61	22	%	%	NOUN
njb-85	61	23	(	(	PUNCT
njb-85	61	24	8/2037	8/2037	NUM
njb-85	61	25	)	)	PUNCT
njb-85	61	26	respectively	respectively	ADV
njb-85	61	27	(	(	PUNCT
njb-85	61	28	figure	figure	NOUN
njb-85	61	29	1	1	NUM
njb-85	61	30	)	)	PUNCT
njb-85	61	31	.	.	PUNCT
njb-85	62	1	nepal	nepal	ADJ
njb-85	62	2	journal	journal	PROPN
njb-85	62	3	of	of	ADP
njb-85	62	4	biotechnology	biotechnology	NOUN
njb-85	62	5	.	.	PUNCT
njb-85	63	1	d	d	X
njb-85	63	2	e	e	PROPN
njb-85	63	3	c	c	PROPN
njb-85	63	4	.	.	PUNCT
njb-85	64	1	2	2	NUM
njb-85	64	2	0	0	NUM
njb-85	64	3	1	1	NUM
njb-85	64	4	8	8	NUM
njb-85	64	5	vol	vol	NOUN
njb-85	64	6	.	.	PROPN
njb-85	65	1	6	6	NUM
njb-85	65	2	,	,	PUNCT
njb-85	65	3	no	no	NOUN
njb-85	65	4	.	.	NOUN
njb-85	65	5	1	1	NUM
njb-85	65	6	:	:	SYM
njb-85	65	7	33	33	NUM
njb-85	65	8	-	-	SYM
njb-85	65	9	38	38	NUM
njb-85	65	10	shah	shah	NOUN
njb-85	65	11	et	et	X
njb-85	65	12	al	al	PROPN
njb-85	65	13	.	.	PUNCT
njb-85	66	1	©	©	PROPN
njb-85	66	2	njb	njb	PROPN
njb-85	66	3	,	,	PUNCT
njb-85	66	4	biotechnology	biotechnology	NOUN
njb-85	66	5	society	society	NOUN
njb-85	66	6	of	of	ADP
njb-85	66	7	nepal	nepal	ADJ
njb-85	66	8	35	35	NUM
njb-85	66	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	ADJ
njb-85	66	10	figure	figure	NOUN
njb-85	66	11	1	1	NUM
njb-85	66	12	:	:	PUNCT
njb-85	66	13	infection	infection	NOUN
njb-85	66	14	of	of	ADP
njb-85	66	15	hepatitis	hepatitis	PROPN
njb-85	66	16	b	b	PROPN
njb-85	66	17	virus	virus	PROPN
njb-85	66	18	and	and	CCONJ
njb-85	66	19	hepatitis	hepatitis	PROPN
njb-85	66	20	c	c	PROPN
njb-85	66	21	virus	virus	NOUN
njb-85	66	22	in	in	ADP
njb-85	66	23	blood	blood	NOUN
njb-85	66	24	donors	donor	NOUN
njb-85	66	25	(	(	PUNCT
njb-85	66	26	confirm	confirm	VERB
njb-85	66	27	by	by	ADP
njb-85	66	28	elisa	elisa	PROPN
njb-85	66	29	method	method	NOUN
njb-85	66	30	)	)	PUNCT
njb-85	66	31	the	the	DET
njb-85	66	32	infection	infection	NOUN
njb-85	66	33	rate	rate	NOUN
njb-85	66	34	in	in	ADP
njb-85	66	35	a	a	DET
njb-85	66	36	male	male	NOUN
njb-85	66	37	for	for	ADP
njb-85	66	38	hbv	hbv	NOUN
njb-85	66	39	is	be	AUX
njb-85	66	40	0.7	0.7	NUM
njb-85	66	41	%	%	NOUN
njb-85	66	42	(	(	PUNCT
njb-85	66	43	13/1777	13/1777	NUM
njb-85	66	44	)	)	PUNCT
njb-85	66	45	which	which	PRON
njb-85	66	46	was	be	AUX
njb-85	66	47	higher	high	ADJ
njb-85	66	48	than	than	ADP
njb-85	66	49	hcv	hcv	PROPN
njb-85	66	50	0.4	0.4	NUM
njb-85	66	51	%	%	NOUN
njb-85	66	52	(	(	PUNCT
njb-85	66	53	8/1777	8/1777	NUM
njb-85	66	54	)	)	PUNCT
njb-85	66	55	.	.	PUNCT
njb-85	67	1	similarly	similarly	ADV
njb-85	67	2	,	,	PUNCT
njb-85	67	3	the	the	DET
njb-85	67	4	infection	infection	NOUN
njb-85	67	5	rate	rate	NOUN
njb-85	67	6	in	in	ADP
njb-85	67	7	the	the	DET
njb-85	67	8	female	female	NOUN
njb-85	67	9	for	for	ADP
njb-85	67	10	hbv	hbv	NOUN
njb-85	67	11	is	be	AUX
njb-85	67	12	0.7	0.7	NUM
njb-85	67	13	%	%	NOUN
njb-85	67	14	(	(	PUNCT
njb-85	67	15	2/260	2/260	NUM
njb-85	67	16	)	)	PUNCT
njb-85	67	17	which	which	PRON
njb-85	67	18	was	be	AUX
njb-85	67	19	also	also	ADV
njb-85	67	20	higher	high	ADJ
njb-85	67	21	than	than	ADP
njb-85	67	22	hcv	hcv	PROPN
njb-85	67	23	(	(	PUNCT
njb-85	67	24	0.0	0.0	NUM
njb-85	67	25	%	%	NOUN
njb-85	67	26	)	)	PUNCT
njb-85	67	27	but	but	CCONJ
njb-85	67	28	no	no	DET
njb-85	67	29	statistically	statistically	ADV
njb-85	67	30	significant	significant	ADJ
njb-85	67	31	,	,	PUNCT
njb-85	67	32	(	(	PUNCT
njb-85	67	33	p=0.280	p=0.280	NOUN
njb-85	67	34	)	)	PUNCT
njb-85	67	35	result	result	NOUN
njb-85	67	36	was	be	AUX
njb-85	67	37	obtained	obtain	VERB
njb-85	67	38	(	(	PUNCT
njb-85	67	39	table	table	NOUN
njb-85	67	40	1	1	NUM
njb-85	67	41	)	)	PUNCT
njb-85	67	42	.	.	PUNCT
njb-85	68	1	in	in	ADP
njb-85	68	2	hbv	hbv	NOUN
njb-85	68	3	,	,	PUNCT
njb-85	68	4	the	the	DET
njb-85	68	5	highest	high	ADJ
njb-85	68	6	rate	rate	NOUN
njb-85	68	7	of	of	ADP
njb-85	68	8	infection	infection	NOUN
njb-85	68	9	was	be	AUX
njb-85	68	10	detected	detect	VERB
njb-85	68	11	0.9	0.9	NUM
njb-85	68	12	%	%	NOUN
njb-85	68	13	(	(	PUNCT
njb-85	68	14	7/764	7/764	NUM
njb-85	68	15	)	)	PUNCT
njb-85	68	16	in	in	ADP
njb-85	68	17	31	31	NUM
njb-85	68	18	-	-	SYM
njb-85	68	19	45	45	NUM
njb-85	68	20	year	year	NOUN
njb-85	68	21	old	old	ADJ
njb-85	68	22	of	of	ADP
njb-85	68	23	blood	blood	NOUN
njb-85	68	24	donors	donor	NOUN
njb-85	68	25	which	which	PRON
njb-85	68	26	was	be	AUX
njb-85	68	27	followed	follow	VERB
njb-85	68	28	by	by	ADP
njb-85	68	29	0.7	0.7	NUM
njb-85	68	30	%	%	NOUN
njb-85	68	31	(	(	PUNCT
njb-85	68	32	1/138	1/138	NUM
njb-85	68	33	)	)	PUNCT
njb-85	68	34	in	in	ADP
njb-85	68	35	46	46	NUM
njb-85	68	36	-	-	SYM
njb-85	68	37	60	60	NUM
njb-85	68	38	year	year	NOUN
njb-85	68	39	old	old	ADJ
njb-85	68	40	,	,	PUNCT
njb-85	68	41	and	and	CCONJ
njb-85	68	42	0.6	0.6	NUM
njb-85	68	43	%	%	NOUN
njb-85	68	44	(	(	PUNCT
njb-85	68	45	7/1135	7/1135	NUM
njb-85	68	46	)	)	PUNCT
njb-85	68	47	in	in	ADP
njb-85	68	48	18	18	NUM
njb-85	68	49	-	-	SYM
njb-85	68	50	30	30	NUM
njb-85	68	51	-	-	PUNCT
njb-85	68	52	year	year	NOUN
njb-85	68	53	-	-	PUNCT
njb-85	68	54	old	old	ADJ
njb-85	68	55	people	people	NOUN
njb-85	68	56	.	.	PUNCT
njb-85	69	1	similarly	similarly	ADV
njb-85	69	2	,	,	PUNCT
njb-85	69	3	the	the	DET
njb-85	69	4	highest	high	ADJ
njb-85	69	5	rate	rate	NOUN
njb-85	69	6	of	of	ADP
njb-85	69	7	hcv	hcv	ADJ
njb-85	69	8	infection	infection	NOUN
njb-85	69	9	were	be	AUX
njb-85	69	10	detected	detect	VERB
njb-85	69	11	0.7	0.7	NUM
njb-85	69	12	%	%	NOUN
njb-85	69	13	(	(	PUNCT
njb-85	69	14	1/138	1/138	NUM
njb-85	69	15	)	)	PUNCT
njb-85	69	16	in	in	ADP
njb-85	69	17	46	46	NUM
njb-85	69	18	-	-	SYM
njb-85	69	19	60	60	NUM
njb-85	69	20	years	year	NOUN
njb-85	69	21	old	old	ADJ
njb-85	69	22	people	people	NOUN
njb-85	69	23	followed	follow	VERB
njb-85	69	24	by	by	ADP
njb-85	69	25	0.6	0.6	NUM
njb-85	69	26	%	%	NOUN
njb-85	69	27	(	(	PUNCT
njb-85	69	28	5/764	5/764	NUM
njb-85	69	29	)	)	PUNCT
njb-85	69	30	in	in	ADP
njb-85	69	31	3145	3145	NUM
njb-85	69	32	-	-	PUNCT
njb-85	69	33	year	year	NOUN
njb-85	69	34	-	-	PUNCT
njb-85	69	35	old	old	ADJ
njb-85	69	36	and	and	CCONJ
njb-85	69	37	0.2	0.2	NUM
njb-85	69	38	%	%	NOUN
njb-85	69	39	(	(	PUNCT
njb-85	69	40	2/1135	2/1135	NUM
njb-85	69	41	)	)	PUNCT
njb-85	69	42	in	in	ADP
njb-85	69	43	18	18	NUM
njb-85	69	44	-	-	SYM
njb-85	69	45	30	30	NUM
njb-85	69	46	years	year	NOUN
njb-85	69	47	old	old	ADJ
njb-85	69	48	people	people	NOUN
njb-85	69	49	,	,	PUNCT
njb-85	69	50	p=0.588	p=0.588	PROPN
njb-85	69	51	,	,	PUNCT
njb-85	69	52	(	(	PUNCT
njb-85	69	53	figure	figure	NOUN
njb-85	69	54	2	2	X
njb-85	69	55	)	)	PUNCT
njb-85	69	56	figure	figure	NOUN
njb-85	69	57	2	2	NUM
njb-85	69	58	.	.	PUNCT
njb-85	69	59	age	age	NOUN
njb-85	69	60	wise	wise	ADJ
njb-85	69	61	distribution	distribution	NOUN
njb-85	69	62	with	with	ADP
njb-85	69	63	hbv	hbv	NOUN
njb-85	69	64	and	and	CCONJ
njb-85	69	65	hcv	hcv	VERB
njb-85	69	66	among	among	ADP
njb-85	69	67	blood	blood	NOUN
njb-85	69	68	donors	donor	NOUN
njb-85	69	69	hbv	hbv	NOUN
njb-85	69	70	infection	infection	NOUN
njb-85	69	71	rate	rate	NOUN
njb-85	69	72	of	of	ADP
njb-85	69	73	volunteer	volunteer	NOUN
njb-85	69	74	donor	donor	NOUN
njb-85	69	75	people	people	NOUN
njb-85	69	76	was	be	AUX
njb-85	69	77	0.7	0.7	NUM
njb-85	69	78	%	%	NOUN
njb-85	69	79	(	(	PUNCT
njb-85	69	80	14/1881	14/1881	NUM
njb-85	69	81	)	)	PUNCT
njb-85	69	82	,	,	PUNCT
njb-85	69	83	which	which	PRON
njb-85	69	84	is	be	AUX
njb-85	69	85	higher	high	ADJ
njb-85	69	86	than	than	ADP
njb-85	69	87	the	the	DET
njb-85	69	88	replacement	replacement	NOUN
njb-85	69	89	donor	donor	NOUN
njb-85	69	90	0.6	0.6	NUM
njb-85	69	91	%	%	NOUN
njb-85	69	92	(	(	PUNCT
njb-85	69	93	1/156	1/156	NUM
njb-85	69	94	)	)	PUNCT
njb-85	69	95	.	.	PUNCT
njb-85	70	1	similarly	similarly	ADV
njb-85	70	2	,	,	PUNCT
njb-85	70	3	hcv	hcv	ADJ
njb-85	70	4	infection	infection	NOUN
njb-85	70	5	rate	rate	NOUN
njb-85	70	6	of	of	ADP
njb-85	70	7	volunteer	volunteer	NOUN
njb-85	70	8	donor	donor	NOUN
njb-85	70	9	was	be	AUX
njb-85	70	10	0.4	0.4	NUM
njb-85	70	11	%	%	NOUN
njb-85	70	12	(	(	PUNCT
njb-85	70	13	8/1881	8/1881	NUM
njb-85	70	14	)	)	PUNCT
njb-85	70	15	with	with	ADP
njb-85	70	16	p=0.455	p=0.455	PROPN
njb-85	70	17	(	(	PUNCT
njb-85	70	18	table	table	NOUN
njb-85	70	19	2	2	NUM
njb-85	70	20	)	)	PUNCT
njb-85	70	21	.	.	PUNCT
njb-85	71	1	table	table	NOUN
njb-85	71	2	2	2	NUM
njb-85	71	3	:	:	PUNCT
njb-85	71	4	donor	donor	NOUN
njb-85	71	5	type	type	NOUN
njb-85	71	6	-	-	PUNCT
njb-85	71	7	wise	wise	ADJ
njb-85	71	8	distribution	distribution	NOUN
njb-85	71	9	with	with	ADP
njb-85	71	10	hepatitis	hepatitis	NOUN
njb-85	71	11	infections	infection	NOUN
njb-85	71	12	among	among	ADP
njb-85	71	13	blood	blood	NOUN
njb-85	71	14	donors	donor	NOUN
njb-85	71	15	donor	donor	NOUN
njb-85	71	16	type	type	NOUN
njb-85	71	17	disease	disease	NOUN
njb-85	71	18	total	total	VERB
njb-85	71	19	no	no	INTJ
njb-85	71	20	.	.	PUNCT
njb-85	72	1	pvalue	pvalue	PROPN
njb-85	72	2	hbv	hbv	PROPN
njb-85	72	3	no	no	NOUN
njb-85	72	4	.	.	PUNCT
njb-85	73	1	(	(	PUNCT
njb-85	73	2	%	%	NOUN
njb-85	73	3	)	)	PUNCT
njb-85	73	4	hcv	hcv	VERB
njb-85	73	5	no	no	INTJ
njb-85	73	6	.	.	PUNCT
njb-85	74	1	(	(	PUNCT
njb-85	74	2	%	%	INTJ
njb-85	74	3	)	)	PUNCT
njb-85	74	4	replacement	replacement	NOUN
njb-85	74	5	donor	donor	NOUN
njb-85	74	6	1	1	NUM
njb-85	74	7	(	(	PUNCT
njb-85	74	8	0.6	0.6	NUM
njb-85	74	9	)	)	PUNCT
njb-85	74	10	0	0	NUM
njb-85	74	11	(	(	PUNCT
njb-85	74	12	0.0	0.0	NUM
njb-85	74	13	)	)	PUNCT
njb-85	74	14	156	156	NUM
njb-85	74	15	0.455	0.455	NUM
njb-85	74	16	volunteer	volunteer	NOUN
njb-85	74	17	donor	donor	NOUN
njb-85	74	18	14(0.7	14(0.7	NUM
njb-85	74	19	)	)	PUNCT
njb-85	74	20	8	8	NUM
njb-85	74	21	(	(	PUNCT
njb-85	74	22	0.4	0.4	NUM
njb-85	74	23	)	)	PUNCT
njb-85	74	24	1881	1881	NUM
njb-85	74	25	total	total	ADJ
njb-85	74	26	15	15	NUM
njb-85	74	27	(	(	PUNCT
njb-85	74	28	0.7	0.7	NUM
njb-85	74	29	)	)	PUNCT
njb-85	74	30	8	8	NUM
njb-85	74	31	(	(	PUNCT
njb-85	74	32	0.4	0.4	NUM
njb-85	74	33	)	)	PUNCT
njb-85	74	34	2037	2037	NUM
njb-85	74	35	hbv	hbv	NOUN
njb-85	74	36	infection	infection	NOUN
njb-85	74	37	rate	rate	NOUN
njb-85	74	38	in	in	ADP
njb-85	74	39	people	people	NOUN
njb-85	74	40	without	without	ADP
njb-85	74	41	tattoo	tattoo	ADV
njb-85	74	42	was	be	AUX
njb-85	74	43	0.7	0.7	NUM
njb-85	74	44	%	%	NOUN
njb-85	74	45	(	(	PUNCT
njb-85	74	46	14/1847	14/1847	NUM
njb-85	74	47	)	)	PUNCT
njb-85	74	48	higher	high	ADJ
njb-85	74	49	than	than	ADP
njb-85	74	50	the	the	DET
njb-85	74	51	people	people	NOUN
njb-85	74	52	with	with	ADP
njb-85	74	53	tattoo	tattoo	NOUN
njb-85	74	54	0.5	0.5	NUM
njb-85	74	55	%	%	NOUN
njb-85	74	56	(	(	PUNCT
njb-85	74	57	1/190	1/190	NUM
njb-85	74	58	)	)	PUNCT
njb-85	74	59	.	.	PUNCT
njb-85	75	1	similarly	similarly	ADV
njb-85	75	2	,	,	PUNCT
njb-85	75	3	hcv	hcv	VERB
njb-85	75	4	infection	infection	NOUN
njb-85	75	5	rate	rate	NOUN
njb-85	75	6	in	in	ADP
njb-85	75	7	people	people	NOUN
njb-85	75	8	without	without	ADP
njb-85	75	9	tattoo	tattoo	ADV
njb-85	75	10	was	be	AUX
njb-85	75	11	0.3	0.3	NUM
njb-85	75	12	%	%	NOUN
njb-85	75	13	(	(	PUNCT
njb-85	75	14	6/1847	6/1847	NUM
njb-85	75	15	)	)	PUNCT
njb-85	75	16	higher	high	ADJ
njb-85	75	17	than	than	ADP
njb-85	75	18	0.1	0.1	NUM
njb-85	75	19	%	%	NOUN
njb-85	75	20	(	(	PUNCT
njb-85	75	21	2/190	2/190	NUM
njb-85	75	22	)	)	PUNCT
njb-85	75	23	in	in	ADP
njb-85	75	24	people	people	NOUN
njb-85	75	25	with	with	ADP
njb-85	75	26	a	a	DET
njb-85	75	27	tattoo	tattoo	NOUN
njb-85	75	28	with	with	ADP
njb-85	75	29	p=0.214	p=0.214	ADJ
njb-85	75	30	(	(	PUNCT
njb-85	75	31	table	table	NOUN
njb-85	75	32	3	3	NUM
njb-85	75	33	)	)	PUNCT
njb-85	75	34	.	.	PUNCT
njb-85	76	1	hbv	hbv	NOUN
njb-85	76	2	infection	infection	NOUN
njb-85	76	3	rate	rate	NOUN
njb-85	76	4	of	of	ADP
njb-85	76	5	married	married	ADJ
njb-85	76	6	blood	blood	NOUN
njb-85	76	7	donors	donor	NOUN
njb-85	76	8	was	be	AUX
njb-85	76	9	0.9	0.9	NUM
njb-85	76	10	%	%	NOUN
njb-85	76	11	(	(	PUNCT
njb-85	76	12	12/1262	12/1262	NUM
njb-85	76	13	)	)	PUNCT
njb-85	76	14	whereas	whereas	SCONJ
njb-85	76	15	0.3	0.3	NUM
njb-85	76	16	%	%	NOUN
njb-85	76	17	(	(	PUNCT
njb-85	76	18	3/775	3/775	NUM
njb-85	76	19	)	)	PUNCT
njb-85	76	20	was	be	AUX
njb-85	76	21	found	find	VERB
njb-85	76	22	in	in	ADP
njb-85	76	23	unmarried	unmarried	ADJ
njb-85	76	24	blood	blood	NOUN
njb-85	76	25	donors	donor	NOUN
njb-85	76	26	.	.	PUNCT
njb-85	77	1	similarly	similarly	ADV
njb-85	77	2	,	,	PUNCT
njb-85	77	3	hcv	hcv	ADJ
njb-85	77	4	infection	infection	NOUN
njb-85	77	5	rate	rate	NOUN
njb-85	77	6	of	of	ADP
njb-85	77	7	married	married	ADJ
njb-85	77	8	blood	blood	NOUN
njb-85	77	9	donors	donor	NOUN
njb-85	77	10	was	be	AUX
njb-85	77	11	0.7	0.7	NUM
njb-85	77	12	%	%	NOUN
njb-85	77	13	(	(	PUNCT
njb-85	77	14	7/1262	7/1262	NUM
njb-85	77	15	)	)	PUNCT
njb-85	77	16	whereas	whereas	SCONJ
njb-85	77	17	0.1	0.1	NUM
njb-85	77	18	%	%	NOUN
njb-85	77	19	(	(	PUNCT
njb-85	77	20	1/775	1/775	NUM
njb-85	77	21	)	)	PUNCT
njb-85	77	22	was	be	AUX
njb-85	77	23	found	find	VERB
njb-85	77	24	in	in	ADP
njb-85	77	25	unmarried	unmarried	ADJ
njb-85	77	26	blood	blood	NOUN
njb-85	77	27	donor	donor	NOUN
njb-85	77	28	with	with	ADP
njb-85	77	29	p=0.65	p=0.65	NOUN
njb-85	77	30	(	(	PUNCT
njb-85	77	31	table	table	NOUN
njb-85	77	32	4	4	NUM
njb-85	77	33	)	)	PUNCT
njb-85	77	34	.	.	PUNCT
njb-85	78	1	table	table	NOUN
njb-85	78	2	4	4	NUM
njb-85	78	3	.	.	PUNCT
njb-85	79	1	marital	marital	ADJ
njb-85	79	2	status	status	NOUN
njb-85	79	3	wise	wise	ADJ
njb-85	79	4	distribution	distribution	NOUN
njb-85	79	5	with	with	ADP
njb-85	79	6	hepatitis	hepatitis	NOUN
njb-85	79	7	infection	infection	NOUN
njb-85	79	8	among	among	ADP
njb-85	79	9	blood	blood	NOUN
njb-85	79	10	donors	donor	NOUN
njb-85	79	11	disease	disease	VERB
njb-85	79	12	total	total	ADJ
njb-85	79	13	p	p	NOUN
njb-85	79	14	-	-	PUNCT
njb-85	79	15	value	value	NOUN
njb-85	79	16	marital	marital	ADJ
njb-85	79	17	status	status	NOUN
njb-85	79	18	hbv	hbv	NOUN
njb-85	79	19	no	no	INTJ
njb-85	79	20	.	.	PUNCT
njb-85	80	1	(	(	PUNCT
njb-85	80	2	%	%	NOUN
njb-85	80	3	)	)	PUNCT
njb-85	80	4	hcv	hcv	VERB
njb-85	80	5	no	no	INTJ
njb-85	80	6	.	.	PUNCT
njb-85	81	1	(	(	PUNCT
njb-85	81	2	%	%	INTJ
njb-85	81	3	)	)	PUNCT
njb-85	81	4	no	no	DET
njb-85	81	5	3	3	NUM
njb-85	81	6	(	(	PUNCT
njb-85	81	7	0.3	0.3	NUM
njb-85	81	8	)	)	PUNCT
njb-85	81	9	1	1	NUM
njb-85	81	10	(	(	PUNCT
njb-85	81	11	0.1	0.1	NUM
njb-85	81	12	)	)	PUNCT
njb-85	81	13	775	775	NUM
njb-85	81	14	0.651	0.651	NUM
njb-85	81	15	yes	yes	NOUN
njb-85	81	16	12	12	NUM
njb-85	81	17	(	(	PUNCT
njb-85	81	18	0.9	0.9	NUM
njb-85	81	19	)	)	PUNCT
njb-85	81	20	7	7	NUM
njb-85	81	21	(	(	PUNCT
njb-85	81	22	0.7	0.7	NUM
njb-85	81	23	)	)	PUNCT
njb-85	81	24	1262	1262	NUM
njb-85	81	25	total	total	NOUN
njb-85	81	26	15	15	NUM
njb-85	81	27	(	(	PUNCT
njb-85	81	28	0.7	0.7	NUM
njb-85	81	29	)	)	PUNCT
njb-85	81	30	8	8	NUM
njb-85	81	31	(	(	PUNCT
njb-85	81	32	0.4	0.4	NUM
njb-85	81	33	)	)	PUNCT
njb-85	81	34	2037	2037	NUM
njb-85	81	35	discussion	discussion	NOUN
njb-85	81	36	the	the	DET
njb-85	81	37	group	group	NOUN
njb-85	81	38	of	of	ADP
njb-85	81	39	viruses	virus	NOUN
njb-85	81	40	(	(	PUNCT
njb-85	81	41	hepatitis	hepatitis	PROPN
njb-85	81	42	a	a	PROPN
njb-85	81	43	,	,	PUNCT
njb-85	81	44	b	b	PROPN
njb-85	81	45	,	,	PUNCT
njb-85	81	46	c	c	PROPN
njb-85	81	47	,	,	PUNCT
njb-85	81	48	d	d	PROPN
njb-85	81	49	,	,	PUNCT
njb-85	81	50	and	and	CCONJ
njb-85	81	51	e	e	X
njb-85	81	52	)	)	PUNCT
njb-85	81	53	that	that	PRON
njb-85	81	54	cause	cause	VERB
njb-85	81	55	acute	acute	ADJ
njb-85	81	56	and/or	and/or	CCONJ
njb-85	81	57	chronic	chronic	ADJ
njb-85	81	58	infection	infection	NOUN
njb-85	81	59	and	and	CCONJ
njb-85	81	60	inflammation	inflammation	NOUN
njb-85	81	61	of	of	ADP
njb-85	81	62	the	the	DET
njb-85	81	63	liver	liver	NOUN
njb-85	81	64	give	give	VERB
njb-85	81	65	rise	rise	NOUN
njb-85	81	66	to	to	ADP
njb-85	81	67	a	a	DET
njb-85	81	68	major	major	ADJ
njb-85	81	69	public	public	ADJ
njb-85	81	70	health	health	NOUN
njb-85	81	71	problem	problem	NOUN
njb-85	81	72	globally	globally	ADV
njb-85	81	73	[	[	X
njb-85	81	74	12	12	NUM
njb-85	81	75	]	]	PUNCT
njb-85	81	76	.	.	PUNCT
njb-85	82	1	hepatitis	hepatitis	PROPN
njb-85	82	2	b	b	PROPN
njb-85	82	3	and	and	CCONJ
njb-85	82	4	c	c	NOUN
njb-85	82	5	viruses	virus	NOUN
njb-85	82	6	are	be	AUX
njb-85	82	7	major	major	ADJ
njb-85	82	8	agents	agent	NOUN
njb-85	82	9	of	of	ADP
njb-85	82	10	severe	severe	ADJ
njb-85	82	11	illness	illness	NOUN
njb-85	82	12	and	and	CCONJ
njb-85	82	13	death	death	NOUN
njb-85	82	14	.	.	PUNCT
njb-85	83	1	the	the	DET
njb-85	83	2	burden	burden	NOUN
njb-85	83	3	of	of	ADP
njb-85	83	4	acute	acute	ADJ
njb-85	83	5	hepatitis	hepatitis	NOUN
njb-85	83	6	,	,	PUNCT
njb-85	83	7	liver	liver	NOUN
njb-85	83	8	0.7	0.7	NUM
njb-85	83	9	0.4	0.4	NUM
njb-85	83	10	0	0	NUM
njb-85	83	11	0.2	0.2	NUM
njb-85	83	12	0.4	0.4	NUM
njb-85	83	13	0.6	0.6	NUM
njb-85	83	14	0.8	0.8	NUM
njb-85	83	15	hbv	hbv	NOUN
njb-85	83	16	hcv	hcv	VERB
njb-85	83	17	p	p	PROPN
njb-85	83	18	e	e	PROPN
njb-85	83	19	rc	rc	PROPN
njb-85	83	20	e	e	PROPN
njb-85	83	21	n	n	NOUN
njb-85	83	22	ta	ta	PROPN
njb-85	83	23	g	g	PROPN
njb-85	83	24	e	e	PROPN
njb-85	83	25	hepatitis	hepatitis	PROPN
njb-85	83	26	types	type	NOUN
njb-85	83	27	positive	positive	ADJ
njb-85	83	28	(	(	PUNCT
njb-85	83	29	%	%	INTJ
njb-85	83	30	)	)	PUNCT
njb-85	83	31	table	table	NOUN
njb-85	83	32	1	1	NUM
njb-85	83	33	:	:	PUNCT
njb-85	83	34	sex	sex	NOUN
njb-85	83	35	-	-	PUNCT
njb-85	83	36	wise	wise	ADJ
njb-85	83	37	distribution	distribution	NOUN
njb-85	83	38	with	with	ADP
njb-85	83	39	hepatitis	hepatitis	NOUN
njb-85	83	40	diseases	disease	NOUN
njb-85	83	41	among	among	ADP
njb-85	83	42	blood	blood	NOUN
njb-85	83	43	donors	donor	NOUN
njb-85	83	44	gender	gender	NOUN
njb-85	83	45	hepatitis	hepatitis	PROPN
njb-85	83	46	total	total	NOUN
njb-85	83	47	no	no	INTJ
njb-85	83	48	.	.	PUNCT
njb-85	84	1	pvalue	pvalue	PROPN
njb-85	84	2	hbv	hbv	PROPN
njb-85	84	3	no	no	NOUN
njb-85	84	4	.	.	PUNCT
njb-85	85	1	(	(	PUNCT
njb-85	85	2	%	%	NOUN
njb-85	85	3	)	)	PUNCT
njb-85	85	4	hcv	hcv	VERB
njb-85	85	5	no	no	INTJ
njb-85	85	6	.	.	PUNCT
njb-85	86	1	(	(	PUNCT
njb-85	86	2	%	%	INTJ
njb-85	86	3	)	)	PUNCT
njb-85	86	4	male	male	NOUN
njb-85	86	5	13	13	NUM
njb-85	86	6	(	(	PUNCT
njb-85	86	7	0.7	0.7	NUM
njb-85	86	8	)	)	PUNCT
njb-85	86	9	8	8	NUM
njb-85	86	10	(	(	PUNCT
njb-85	86	11	0.4	0.4	NUM
njb-85	86	12	)	)	PUNCT
njb-85	86	13	1777	1777	NUM
njb-85	86	14	0.280	0.280	NUM
njb-85	86	15	female	female	ADJ
njb-85	86	16	2	2	NUM
njb-85	86	17	(	(	PUNCT
njb-85	86	18	0.7	0.7	NUM
njb-85	86	19	)	)	PUNCT
njb-85	86	20	0	0	NUM
njb-85	86	21	(	(	PUNCT
njb-85	86	22	0.0	0.0	NUM
njb-85	86	23	)	)	PUNCT
njb-85	86	24	260	260	NUM
njb-85	86	25	total	total	ADJ
njb-85	86	26	15	15	NUM
njb-85	86	27	(	(	PUNCT
njb-85	86	28	0.7	0.7	NUM
njb-85	86	29	)	)	PUNCT
njb-85	86	30	8	8	NUM
njb-85	86	31	(	(	PUNCT
njb-85	86	32	0.4	0.4	NUM
njb-85	86	33	)	)	PUNCT
njb-85	86	34	2037	2037	NUM
njb-85	86	35	table	table	NOUN
njb-85	86	36	3	3	NUM
njb-85	86	37	.	.	PUNCT
njb-85	87	1	tattoo	tattoo	ADV
njb-85	87	2	wise	wise	ADJ
njb-85	87	3	distribution	distribution	NOUN
njb-85	87	4	with	with	ADP
njb-85	87	5	hepatitis	hepatitis	NOUN
njb-85	87	6	infection	infection	NOUN
njb-85	87	7	among	among	ADP
njb-85	87	8	blood	blood	NOUN
njb-85	87	9	donors	donor	NOUN
njb-85	87	10	disease	disease	VERB
njb-85	87	11	total	total	ADJ
njb-85	87	12	p	p	NOUN
njb-85	87	13	-	-	PUNCT
njb-85	87	14	value	value	NOUN
njb-85	87	15	tattoo	tattoo	NOUN
njb-85	87	16	used	use	VERB
njb-85	87	17	hbv	hbv	NOUN
njb-85	87	18	no	no	NOUN
njb-85	87	19	.	.	PUNCT
njb-85	88	1	(	(	PUNCT
njb-85	88	2	%	%	NOUN
njb-85	88	3	)	)	PUNCT
njb-85	88	4	hcv	hcv	VERB
njb-85	88	5	no	no	INTJ
njb-85	88	6	.	.	PUNCT
njb-85	89	1	(	(	PUNCT
njb-85	89	2	%	%	INTJ
njb-85	89	3	)	)	PUNCT
njb-85	89	4	no	no	DET
njb-85	89	5	14	14	NUM
njb-85	89	6	(	(	PUNCT
njb-85	89	7	0.7	0.7	NUM
njb-85	89	8	)	)	PUNCT
njb-85	89	9	6	6	NUM
njb-85	89	10	(	(	PUNCT
njb-85	89	11	0.3	0.3	NUM
njb-85	89	12	)	)	PUNCT
njb-85	89	13	1847	1847	NUM
njb-85	89	14	0.214	0.214	NUM
njb-85	89	15	yes	yes	INTJ
njb-85	89	16	1	1	NUM
njb-85	89	17	(	(	PUNCT
njb-85	89	18	0.5	0.5	NUM
njb-85	89	19	)	)	PUNCT
njb-85	89	20	2	2	NUM
njb-85	89	21	(	(	PUNCT
njb-85	89	22	0.1	0.1	NUM
njb-85	89	23	)	)	PUNCT
njb-85	89	24	190	190	NUM
njb-85	89	25	total	total	ADJ
njb-85	89	26	15	15	NUM
njb-85	89	27	(	(	PUNCT
njb-85	89	28	0.7	0.7	NUM
njb-85	89	29	)	)	PUNCT
njb-85	89	30	8	8	NUM
njb-85	89	31	(	(	PUNCT
njb-85	89	32	0.4	0.4	NUM
njb-85	89	33	)	)	PUNCT
njb-85	89	34	2037	2037	NUM
njb-85	89	35	0.6	0.6	NUM
njb-85	89	36	0.9	0.9	NUM
njb-85	89	37	0.7	0.7	NUM
njb-85	89	38	0.2	0.2	NUM
njb-85	89	39	0.6	0.6	NUM
njb-85	89	40	0.7	0.7	NUM
njb-85	89	41	0	0	NUM
njb-85	89	42	0.2	0.2	NUM
njb-85	89	43	0.4	0.4	NUM
njb-85	89	44	0.6	0.6	NUM
njb-85	89	45	0.8	0.8	NUM
njb-85	89	46	1	1	NUM
njb-85	89	47	18	18	NUM
njb-85	89	48	-	-	SYM
njb-85	89	49	30	30	NUM
njb-85	89	50	year	year	NOUN
njb-85	89	51	31	31	NUM
njb-85	89	52	-	-	SYM
njb-85	89	53	45	45	NUM
njb-85	89	54	year	year	NOUN
njb-85	89	55	46	46	NUM
njb-85	89	56	-	-	SYM
njb-85	89	57	60	60	NUM
njb-85	89	58	year	year	NOUN
njb-85	89	59	p	p	PROPN
njb-85	89	60	e	e	PROPN
njb-85	89	61	rc	rc	PROPN
njb-85	89	62	e	e	PROPN
njb-85	89	63	n	n	NOUN
njb-85	89	64	ta	ta	PROPN
njb-85	89	65	g	g	PROPN
njb-85	89	66	e	e	PROPN
njb-85	89	67	age	age	NOUN
njb-85	89	68	group	group	NOUN
njb-85	89	69	hbv	hbv	NOUN
njb-85	89	70	(	(	PUNCT
njb-85	89	71	%	%	INTJ
njb-85	89	72	)	)	PUNCT
njb-85	89	73	hcv(%	hcv(%	PROPN
njb-85	89	74	)	)	PUNCT
njb-85	89	75	nepal	nepal	ADJ
njb-85	89	76	journal	journal	NOUN
njb-85	89	77	of	of	ADP
njb-85	89	78	biotechnology	biotechnology	NOUN
njb-85	89	79	.	.	PUNCT
njb-85	90	1	d	d	X
njb-85	90	2	e	e	PROPN
njb-85	90	3	c	c	PROPN
njb-85	90	4	.	.	PUNCT
njb-85	91	1	2	2	NUM
njb-85	91	2	0	0	NUM
njb-85	91	3	1	1	NUM
njb-85	91	4	8	8	NUM
njb-85	91	5	vol	vol	NOUN
njb-85	91	6	.	.	PROPN
njb-85	92	1	6	6	NUM
njb-85	92	2	,	,	PUNCT
njb-85	92	3	no	no	NOUN
njb-85	92	4	.	.	NOUN
njb-85	92	5	1	1	NUM
njb-85	92	6	:	:	SYM
njb-85	92	7	33	33	NUM
njb-85	92	8	-	-	SYM
njb-85	92	9	38	38	NUM
njb-85	92	10	shah	shah	NOUN
njb-85	92	11	et	et	X
njb-85	92	12	al	al	PROPN
njb-85	92	13	.	.	PUNCT
njb-85	93	1	©	©	PROPN
njb-85	93	2	njb	njb	PROPN
njb-85	93	3	,	,	PUNCT
njb-85	93	4	biotechnology	biotechnology	NOUN
njb-85	93	5	society	society	NOUN
njb-85	93	6	of	of	ADP
njb-85	93	7	nepal	nepal	ADJ
njb-85	93	8	36	36	NUM
njb-85	93	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	ADJ
njb-85	93	10	cirrhosis	cirrhosis	NOUN
njb-85	93	11	and	and	CCONJ
njb-85	93	12	cancer	cancer	NOUN
njb-85	93	13	due	due	ADP
njb-85	93	14	to	to	ADP
njb-85	93	15	this	this	DET
njb-85	93	16	hepatitis	hepatitis	PROPN
njb-85	93	17	b	b	PROPN
njb-85	93	18	and	and	CCONJ
njb-85	93	19	c	c	NOUN
njb-85	93	20	viruses	virus	NOUN
njb-85	93	21	is	be	AUX
njb-85	93	22	high	high	ADJ
njb-85	93	23	worldwide	worldwide	ADV
njb-85	93	24	(	(	PUNCT
njb-85	93	25	about	about	ADV
njb-85	93	26	2.7	2.7	NUM
njb-85	93	27	%	%	NOUN
njb-85	93	28	of	of	ADP
njb-85	93	29	all	all	DET
njb-85	93	30	deaths	death	NOUN
njb-85	93	31	)	)	PUNCT
njb-85	93	32	and	and	CCONJ
njb-85	93	33	is	be	AUX
njb-85	93	34	forecasted	forecast	VERB
njb-85	93	35	to	to	PART
njb-85	93	36	become	become	VERB
njb-85	93	37	a	a	DET
njb-85	93	38	higher	high	ADJ
njb-85	93	39	ranked	ranked	ADJ
njb-85	93	40	cause	cause	NOUN
njb-85	93	41	of	of	ADP
njb-85	93	42	death	death	NOUN
njb-85	93	43	over	over	ADP
njb-85	93	44	the	the	DET
njb-85	93	45	next	next	ADJ
njb-85	93	46	two	two	NUM
njb-85	93	47	decades	decade	NOUN
njb-85	93	48	.	.	PUNCT
njb-85	94	1	it	it	PRON
njb-85	94	2	is	be	AUX
njb-85	94	3	estimated	estimate	VERB
njb-85	94	4	that	that	SCONJ
njb-85	94	5	57.0	57.0	NUM
njb-85	94	6	%	%	NOUN
njb-85	94	7	of	of	ADP
njb-85	94	8	cases	case	NOUN
njb-85	94	9	of	of	ADP
njb-85	94	10	liver	liver	NOUN
njb-85	94	11	cirrhosis	cirrhosis	NOUN
njb-85	94	12	and	and	CCONJ
njb-85	94	13	78.0	78.0	NUM
njb-85	94	14	%	%	NOUN
njb-85	94	15	of	of	ADP
njb-85	94	16	cases	case	NOUN
njb-85	94	17	of	of	ADP
njb-85	94	18	primary	primary	ADJ
njb-85	94	19	liver	liver	NOUN
njb-85	94	20	cancer	cancer	NOUN
njb-85	94	21	have	have	AUX
njb-85	94	22	resulted	result	VERB
njb-85	94	23	from	from	ADP
njb-85	94	24	hepatitis	hepatitis	PROPN
njb-85	94	25	b	b	PROPN
njb-85	94	26	or	or	CCONJ
njb-85	94	27	c	c	NOUN
njb-85	94	28	virus	virus	NOUN
njb-85	94	29	infection	infection	NOUN
njb-85	94	30	[	[	X
njb-85	94	31	13	13	NUM
njb-85	94	32	]	]	PUNCT
njb-85	94	33	.	.	PUNCT
njb-85	95	1	the	the	DET
njb-85	95	2	infection	infection	NOUN
njb-85	95	3	rate	rate	NOUN
njb-85	95	4	of	of	ADP
njb-85	95	5	hbv	hbv	NOUN
njb-85	95	6	and	and	CCONJ
njb-85	95	7	hcv	hcv	PROPN
njb-85	95	8	in	in	ADP
njb-85	95	9	blood	blood	NOUN
njb-85	95	10	donors	donor	NOUN
njb-85	95	11	were	be	AUX
njb-85	95	12	detected	detect	VERB
njb-85	95	13	on	on	ADP
njb-85	95	14	0.7	0.7	NUM
njb-85	95	15	%	%	NOUN
njb-85	95	16	and	and	CCONJ
njb-85	95	17	0.5	0.5	NUM
njb-85	95	18	%	%	NOUN
njb-85	95	19	respectively	respectively	ADV
njb-85	95	20	.	.	PUNCT
njb-85	96	1	in	in	ADP
njb-85	96	2	the	the	DET
njb-85	96	3	previous	previous	ADJ
njb-85	96	4	study	study	NOUN
njb-85	96	5	reported	report	VERB
njb-85	96	6	that	that	SCONJ
njb-85	96	7	the	the	DET
njb-85	96	8	hepatitis	hepatitis	PROPN
njb-85	96	9	b	b	PROPN
njb-85	96	10	and	and	CCONJ
njb-85	96	11	hepatitis	hepatitis	NOUN
njb-85	96	12	c	c	PROPN
njb-85	96	13	infection	infection	NOUN
njb-85	96	14	rate	rate	NOUN
njb-85	96	15	was	be	AUX
njb-85	96	16	detected	detect	VERB
njb-85	96	17	by	by	ADP
njb-85	96	18	2.6	2.6	NUM
njb-85	96	19	%	%	NOUN
njb-85	96	20	and	and	CCONJ
njb-85	96	21	0.3	0.3	NUM
njb-85	96	22	%	%	NOUN
njb-85	96	23	respectively	respectively	ADV
njb-85	96	24	out	out	ADP
njb-85	96	25	of	of	ADP
njb-85	96	26	307	307	NUM
njb-85	96	27	tested	test	VERB
njb-85	96	28	patients	patient	NOUN
njb-85	96	29	[	[	PUNCT
njb-85	96	30	14	14	NUM
njb-85	96	31	]	]	PUNCT
njb-85	96	32	.	.	PUNCT
njb-85	97	1	the	the	DET
njb-85	97	2	high	high	ADJ
njb-85	97	3	percentage	percentage	NOUN
njb-85	97	4	of	of	ADP
njb-85	97	5	hbv	hbv	NOUN
njb-85	97	6	and	and	CCONJ
njb-85	97	7	hcv	hcv	VERB
njb-85	97	8	infection	infection	NOUN
njb-85	97	9	was	be	AUX
njb-85	97	10	obtained	obtain	VERB
njb-85	97	11	may	may	AUX
njb-85	97	12	be	be	AUX
njb-85	97	13	due	due	ADJ
njb-85	97	14	to	to	ADP
njb-85	97	15	less	less	ADJ
njb-85	97	16	no	no	NOUN
njb-85	97	17	.	.	NOUN
njb-85	97	18	of	of	ADP
njb-85	97	19	public	public	ADJ
njb-85	97	20	awareness	awareness	NOUN
njb-85	97	21	of	of	ADP
njb-85	97	22	hepatitis	hepatitis	PROPN
njb-85	97	23	known	know	VERB
njb-85	97	24	infected	infect	VERB
njb-85	97	25	person	person	NOUN
njb-85	97	26	did	do	AUX
njb-85	97	27	not	not	PART
njb-85	97	28	participated	participate	VERB
njb-85	97	29	in	in	ADP
njb-85	97	30	the	the	DET
njb-85	97	31	blood	blood	NOUN
njb-85	97	32	donation	donation	NOUN
njb-85	97	33	.	.	PUNCT
njb-85	98	1	the	the	DET
njb-85	98	2	unsafe	unsafe	ADJ
njb-85	98	3	behavioral	behavioral	ADJ
njb-85	98	4	practices	practice	NOUN
njb-85	98	5	such	such	ADJ
njb-85	98	6	as	as	ADP
njb-85	98	7	body	body	NOUN
njb-85	98	8	pierce	pierce	NOUN
njb-85	98	9	,	,	PUNCT
njb-85	98	10	tattoo	tattoo	ADV
njb-85	98	11	,	,	PUNCT
njb-85	98	12	use	use	NOUN
njb-85	98	13	of	of	ADP
njb-85	98	14	injectable	injectable	ADJ
njb-85	98	15	drug	drug	NOUN
njb-85	98	16	,	,	PUNCT
njb-85	98	17	unprotected	unprotected	ADJ
njb-85	98	18	sex	sex	NOUN
njb-85	98	19	etc	etc	NOUN
njb-85	98	20	.	.	X
njb-85	98	21	also	also	ADV
njb-85	98	22	led	lead	VERB
njb-85	98	23	to	to	PART
njb-85	98	24	increase	increase	VERB
njb-85	98	25	the	the	DET
njb-85	98	26	transmission	transmission	NOUN
njb-85	98	27	of	of	ADP
njb-85	98	28	infection	infection	NOUN
njb-85	98	29	.	.	PUNCT
njb-85	99	1	the	the	DET
njb-85	99	2	positive	positive	ADJ
njb-85	99	3	rate	rate	NOUN
njb-85	99	4	of	of	ADP
njb-85	99	5	hepatitis	hepatitis	NOUN
njb-85	99	6	infection	infection	NOUN
njb-85	99	7	was	be	AUX
njb-85	99	8	found	find	VERB
njb-85	99	9	to	to	PART
njb-85	99	10	be	be	AUX
njb-85	99	11	higher	high	ADJ
njb-85	99	12	in	in	ADP
njb-85	99	13	a	a	DET
njb-85	99	14	male	male	ADJ
njb-85	99	15	patient	patient	NOUN
njb-85	99	16	than	than	ADP
njb-85	99	17	female	female	ADJ
njb-85	99	18	but	but	CCONJ
njb-85	99	19	there	there	PRON
njb-85	99	20	is	be	VERB
njb-85	99	21	no	no	DET
njb-85	99	22	statistical	statistical	ADJ
njb-85	99	23	significant	significant	ADJ
njb-85	99	24	relationship	relationship	NOUN
njb-85	99	25	found	find	VERB
njb-85	99	26	between	between	ADP
njb-85	99	27	gender	gender	NOUN
njb-85	99	28	and	and	CCONJ
njb-85	99	29	hepatitis	hepatitis	NOUN
njb-85	99	30	[	[	PUNCT
njb-85	99	31	14	14	NUM
njb-85	99	32	]	]	PUNCT
njb-85	99	33	.	.	PUNCT
njb-85	100	1	in	in	ADP
njb-85	100	2	hbv	hbv	NOUN
njb-85	100	3	infection	infection	NOUN
njb-85	100	4	,	,	PUNCT
njb-85	100	5	most	most	ADJ
njb-85	100	6	of	of	ADP
njb-85	100	7	the	the	DET
njb-85	100	8	infection	infection	NOUN
njb-85	100	9	rate	rate	NOUN
njb-85	100	10	(	(	PUNCT
njb-85	100	11	0.9	0.9	NUM
njb-85	100	12	%	%	NOUN
njb-85	100	13	)	)	PUNCT
njb-85	100	14	was	be	AUX
njb-85	100	15	detected	detect	VERB
njb-85	100	16	in	in	ADP
njb-85	100	17	age	age	NOUN
njb-85	100	18	group	group	NOUN
njb-85	100	19	ranging	range	VERB
njb-85	100	20	31	31	NUM
njb-85	100	21	-	-	SYM
njb-85	100	22	45	45	NUM
njb-85	100	23	years	year	NOUN
njb-85	100	24	old	old	ADJ
njb-85	100	25	whereas	whereas	SCONJ
njb-85	100	26	most	most	ADJ
njb-85	100	27	of	of	ADP
njb-85	100	28	the	the	DET
njb-85	100	29	infection	infection	NOUN
njb-85	100	30	rate	rate	NOUN
njb-85	100	31	in	in	ADP
njb-85	100	32	46	46	NUM
njb-85	100	33	-	-	SYM
njb-85	100	34	60	60	NUM
njb-85	100	35	years	year	NOUN
njb-85	100	36	old	old	ADJ
njb-85	100	37	people	people	NOUN
njb-85	100	38	in	in	ADP
njb-85	100	39	hcv	hcv	PROPN
njb-85	100	40	was	be	AUX
njb-85	100	41	detected	detect	VERB
njb-85	100	42	at	at	ADP
njb-85	100	43	0.7	0.7	NUM
njb-85	100	44	%	%	NOUN
njb-85	100	45	.	.	PUNCT
njb-85	101	1	the	the	DET
njb-85	101	2	highest	high	ADJ
njb-85	101	3	positive	positive	ADJ
njb-85	101	4	rate	rate	NOUN
njb-85	101	5	was	be	AUX
njb-85	101	6	found	find	VERB
njb-85	101	7	in	in	ADP
njb-85	101	8	the	the	DET
njb-85	101	9	patients	patient	NOUN
njb-85	101	10	of	of	ADP
njb-85	101	11	age	age	NOUN
njb-85	101	12	group	group	NOUN
njb-85	101	13	31	31	NUM
njb-85	101	14	-	-	SYM
njb-85	101	15	60	60	NUM
njb-85	101	16	years	year	NOUN
njb-85	101	17	old	old	ADJ
njb-85	101	18	[	[	PUNCT
njb-85	101	19	14	14	NUM
njb-85	101	20	]	]	PUNCT
njb-85	101	21	.	.	PUNCT
njb-85	102	1	the	the	DET
njb-85	102	2	infection	infection	NOUN
njb-85	102	3	rate	rate	NOUN
njb-85	102	4	of	of	ADP
njb-85	102	5	hbv	hbv	NOUN
njb-85	102	6	and	and	CCONJ
njb-85	102	7	hcv	hcv	PROPN
njb-85	102	8	in	in	ADP
njb-85	102	9	volunteer	volunteer	NOUN
njb-85	102	10	donor	donor	NOUN
njb-85	102	11	people	people	NOUN
njb-85	102	12	were	be	AUX
njb-85	102	13	found	find	VERB
njb-85	102	14	to	to	PART
njb-85	102	15	be	be	AUX
njb-85	102	16	0.7	0.7	NUM
njb-85	102	17	%	%	NOUN
njb-85	102	18	,	,	PUNCT
njb-85	102	19	and	and	CCONJ
njb-85	102	20	0.4	0.4	NUM
njb-85	102	21	%	%	NOUN
njb-85	102	22	respectively	respectively	ADV
njb-85	102	23	.	.	PUNCT
njb-85	103	1	it	it	PRON
njb-85	103	2	may	may	AUX
njb-85	103	3	be	be	AUX
njb-85	103	4	,	,	PUNCT
njb-85	103	5	due	due	ADP
njb-85	103	6	to	to	ADP
njb-85	103	7	blood	blood	NOUN
njb-85	103	8	transfusion	transfusion	NOUN
njb-85	103	9	,	,	PUNCT
njb-85	103	10	hepatitis	hepatitis	NOUN
njb-85	103	11	can	can	AUX
njb-85	103	12	be	be	AUX
njb-85	103	13	transmitted	transmit	VERB
njb-85	103	14	in	in	ADP
njb-85	103	15	another	another	DET
njb-85	103	16	body	body	NOUN
njb-85	103	17	.	.	PUNCT
njb-85	104	1	study	study	NOUN
njb-85	104	2	also	also	ADV
njb-85	104	3	revealed	reveal	VERB
njb-85	104	4	that	that	SCONJ
njb-85	104	5	the	the	DET
njb-85	104	6	eastern	eastern	ADJ
njb-85	104	7	region	region	NOUN
njb-85	104	8	of	of	ADP
njb-85	104	9	nepal	nepal	PROPN
njb-85	104	10	had	have	VERB
njb-85	104	11	the	the	DET
njb-85	104	12	highest	high	ADJ
njb-85	104	13	percentage	percentage	NOUN
njb-85	104	14	of	of	ADP
njb-85	104	15	hcv	hcv	ADJ
njb-85	104	16	infection	infection	NOUN
njb-85	104	17	(	(	PUNCT
njb-85	104	18	48.0	48.0	NUM
njb-85	104	19	%	%	NOUN
njb-85	104	20	)	)	PUNCT
njb-85	105	1	[	[	X
njb-85	105	2	15	15	NUM
njb-85	105	3	]	]	PUNCT
njb-85	105	4	.	.	PUNCT
njb-85	106	1	seroprevalence	seroprevalence	NOUN
njb-85	106	2	of	of	ADP
njb-85	106	3	hbv	hbv	NOUN
njb-85	106	4	among	among	ADP
njb-85	106	5	mothers	mother	NOUN
njb-85	106	6	were	be	AUX
njb-85	106	7	found	find	VERB
njb-85	106	8	17.9	17.9	NUM
njb-85	106	9	%	%	NOUN
njb-85	106	10	in	in	ADP
njb-85	106	11	151	151	NUM
njb-85	106	12	mothers	mother	NOUN
njb-85	106	13	of	of	ADP
njb-85	106	14	the	the	DET
njb-85	106	15	total	total	ADJ
njb-85	106	16	study	study	NOUN
njb-85	106	17	population	population	NOUN
njb-85	106	18	in	in	ADP
njb-85	106	19	the	the	DET
njb-85	106	20	selected	select	VERB
njb-85	106	21	village	village	NOUN
njb-85	106	22	development	development	NOUN
njb-85	106	23	committees	committee	NOUN
njb-85	106	24	(	(	PUNCT
njb-85	106	25	vdcs	vdcs	PROPN
njb-85	106	26	)	)	PUNCT
njb-85	107	1	[	[	PUNCT
njb-85	107	2	16	16	NUM
njb-85	107	3	]	]	PUNCT
njb-85	107	4	.	.	PUNCT
njb-85	108	1	the	the	DET
njb-85	108	2	highest	high	ADJ
njb-85	108	3	rates	rate	NOUN
njb-85	108	4	of	of	ADP
njb-85	108	5	hcv	hcv	PROPN
njb-85	108	6	and	and	CCONJ
njb-85	108	7	hbv	hbv	NOUN
njb-85	108	8	co	co	NOUN
njb-85	108	9	-	-	NOUN
njb-85	108	10	infection	infection	NOUN
njb-85	108	11	was	be	AUX
njb-85	108	12	found	find	VERB
njb-85	108	13	to	to	PART
njb-85	108	14	be	be	AUX
njb-85	108	15	58	58	NUM
njb-85	108	16	%	%	NOUN
njb-85	108	17	and	and	CCONJ
njb-85	108	18	70	70	NUM
njb-85	108	19	%	%	NOUN
njb-85	108	20	respectively	respectively	ADV
njb-85	108	21	30	30	NUM
njb-85	108	22	-	-	SYM
njb-85	108	23	39	39	NUM
njb-85	108	24	years	year	NOUN
njb-85	108	25	age	age	NOUN
njb-85	108	26	group	group	NOUN
njb-85	108	27	.	.	PUNCT
njb-85	109	1	hbv	hbv	NOUN
njb-85	109	2	infection	infection	NOUN
njb-85	109	3	rate	rate	NOUN
njb-85	109	4	was	be	AUX
njb-85	109	5	0.7	0.7	NUM
njb-85	109	6	%	%	NOUN
njb-85	109	7	higher	high	ADJ
njb-85	109	8	in	in	ADP
njb-85	109	9	people	people	NOUN
njb-85	109	10	without	without	ADP
njb-85	109	11	tattoo	tattoo	NOUN
njb-85	109	12	whereas	whereas	SCONJ
njb-85	109	13	the	the	DET
njb-85	109	14	hcv	hcv	ADJ
njb-85	109	15	infection	infection	NOUN
njb-85	109	16	rate	rate	NOUN
njb-85	109	17	in	in	ADP
njb-85	109	18	people	people	NOUN
njb-85	109	19	without	without	ADP
njb-85	109	20	tattoo	tattoo	ADV
njb-85	109	21	was	be	AUX
njb-85	109	22	0.3	0.3	NUM
njb-85	109	23	%	%	NOUN
njb-85	109	24	higher	high	ADJ
njb-85	109	25	.	.	PUNCT
njb-85	110	1	because	because	SCONJ
njb-85	110	2	in	in	ADP
njb-85	110	3	our	our	PRON
njb-85	110	4	case	case	NOUN
njb-85	110	5	,	,	PUNCT
njb-85	110	6	the	the	DET
njb-85	110	7	number	number	NOUN
njb-85	110	8	of	of	ADP
njb-85	110	9	participants	participant	NOUN
njb-85	110	10	without	without	ADP
njb-85	110	11	tattoo	tattoo	NOUN
njb-85	110	12	was	be	AUX
njb-85	110	13	higher	high	ADJ
njb-85	110	14	than	than	ADP
njb-85	110	15	the	the	DET
njb-85	110	16	number	number	NOUN
njb-85	110	17	of	of	ADP
njb-85	110	18	blood	blood	NOUN
njb-85	110	19	donors	donor	NOUN
njb-85	110	20	with	with	ADP
njb-85	110	21	tattoo	tattoo	NOUN
njb-85	110	22	.	.	PUNCT
njb-85	111	1	although	although	SCONJ
njb-85	111	2	,	,	PUNCT
njb-85	111	3	it	it	PRON
njb-85	111	4	is	be	AUX
njb-85	111	5	widely	widely	ADV
njb-85	111	6	known	know	VERB
njb-85	111	7	fact	fact	NOUN
njb-85	111	8	that	that	SCONJ
njb-85	111	9	cosmetic	cosmetic	ADJ
njb-85	111	10	procedure	procedure	NOUN
njb-85	111	11	,	,	PUNCT
njb-85	111	12	tattooing	tattoo	VERB
njb-85	111	13	on	on	ADP
njb-85	111	14	a	a	DET
njb-85	111	15	body	body	NOUN
njb-85	111	16	can	can	AUX
njb-85	111	17	result	result	VERB
njb-85	111	18	in	in	ADP
njb-85	111	19	a	a	DET
njb-85	111	20	hbv	hbv	NOUN
njb-85	111	21	and	and	CCONJ
njb-85	111	22	hcv	hcv	VERB
njb-85	111	23	infection	infection	NOUN
njb-85	111	24	if	if	SCONJ
njb-85	111	25	the	the	DET
njb-85	111	26	needles	needle	NOUN
njb-85	111	27	and	and	CCONJ
njb-85	111	28	equipment	equipment	NOUN
njb-85	111	29	used	use	VERB
njb-85	111	30	are	be	AUX
njb-85	111	31	not	not	PART
njb-85	111	32	properly	properly	ADV
njb-85	111	33	sanitized	sanitize	VERB
njb-85	111	34	.	.	PUNCT
njb-85	112	1	besides	besides	SCONJ
njb-85	112	2	,	,	PUNCT
njb-85	112	3	the	the	DET
njb-85	112	4	poor	poor	ADJ
njb-85	112	5	tattooing	tattooing	NOUN
njb-85	112	6	procedure	procedure	NOUN
njb-85	112	7	may	may	AUX
njb-85	112	8	have	have	VERB
njb-85	112	9	chances	chance	NOUN
njb-85	112	10	of	of	ADP
njb-85	112	11	microbial	microbial	ADJ
njb-85	112	12	contamination	contamination	NOUN
njb-85	112	13	.	.	PUNCT
njb-85	113	1	hbv	hbv	NOUN
njb-85	113	2	and	and	CCONJ
njb-85	113	3	hcv	hcv	VERB
njb-85	113	4	infection	infection	NOUN
njb-85	113	5	rate	rate	NOUN
njb-85	113	6	in	in	ADP
njb-85	113	7	married	married	ADJ
njb-85	113	8	blood	blood	NOUN
njb-85	113	9	donors	donor	NOUN
njb-85	113	10	were	be	AUX
njb-85	113	11	0.9	0.9	NUM
njb-85	113	12	%	%	NOUN
njb-85	113	13	and	and	CCONJ
njb-85	113	14	0.7	0.7	NUM
njb-85	113	15	%	%	NOUN
njb-85	113	16	respectively	respectively	ADV
njb-85	113	17	.	.	PUNCT
njb-85	114	1	researchers	researcher	NOUN
njb-85	114	2	concluded	conclude	VERB
njb-85	114	3	the	the	DET
njb-85	114	4	marital	marital	ADJ
njb-85	114	5	status	status	NOUN
njb-85	114	6	is	be	AUX
njb-85	114	7	a	a	DET
njb-85	114	8	significant	significant	ADJ
njb-85	114	9	risk	risk	NOUN
njb-85	114	10	factor	factor	NOUN
njb-85	114	11	[	[	PUNCT
njb-85	114	12	18	18	NUM
njb-85	114	13	]	]	PUNCT
njb-85	114	14	.	.	PUNCT
njb-85	115	1	they	they	PRON
njb-85	115	2	detected	detect	VERB
njb-85	115	3	hbv	hbv	NOUN
njb-85	115	4	and	and	CCONJ
njb-85	115	5	hcv	hcv	PROPN
njb-85	115	6	were	be	AUX
njb-85	115	7	found	find	VERB
njb-85	115	8	1.7	1.7	NUM
njb-85	115	9	%	%	NOUN
njb-85	115	10	and	and	CCONJ
njb-85	115	11	1.0	1.0	NUM
njb-85	115	12	%	%	NOUN
njb-85	115	13	respectively	respectively	ADV
njb-85	115	14	in	in	ADP
njb-85	115	15	a	a	DET
njb-85	115	16	married	married	ADJ
njb-85	115	17	participant	participant	NOUN
njb-85	115	18	.	.	PUNCT
njb-85	116	1	hbv	hbv	NOUN
njb-85	116	2	and	and	CCONJ
njb-85	116	3	hcv	hcv	PROPN
njb-85	116	4	can	can	AUX
njb-85	116	5	be	be	AUX
njb-85	116	6	transferred	transfer	VERB
njb-85	116	7	from	from	ADP
njb-85	116	8	unprotected	unprotected	ADJ
njb-85	116	9	sexual	sexual	ADJ
njb-85	116	10	contact	contact	NOUN
njb-85	116	11	if	if	SCONJ
njb-85	116	12	their	their	PRON
njb-85	116	13	partner	partner	NOUN
njb-85	116	14	is	be	AUX
njb-85	116	15	infected	infect	VERB
njb-85	116	16	with	with	ADP
njb-85	116	17	the	the	DET
njb-85	116	18	hepatitis	hepatitis	NOUN
njb-85	116	19	virus	virus	NOUN
njb-85	116	20	.	.	PUNCT
njb-85	117	1	people	people	NOUN
njb-85	117	2	with	with	ADP
njb-85	117	3	unsafe	unsafe	ADJ
njb-85	117	4	sexual	sexual	ADJ
njb-85	117	5	relationships	relationship	NOUN
njb-85	117	6	and	and	CCONJ
njb-85	117	7	addiction	addiction	NOUN
njb-85	117	8	to	to	PART
njb-85	117	9	injectable	injectable	VERB
njb-85	117	10	drug	drug	NOUN
njb-85	117	11	users	user	NOUN
njb-85	117	12	should	should	AUX
njb-85	117	13	always	always	ADV
njb-85	117	14	be	be	AUX
njb-85	117	15	careful	careful	ADJ
njb-85	117	16	as	as	SCONJ
njb-85	117	17	the	the	DET
njb-85	117	18	chances	chance	NOUN
njb-85	117	19	of	of	ADP
njb-85	117	20	the	the	DET
njb-85	117	21	virus	virus	NOUN
njb-85	117	22	getting	getting	AUX
njb-85	117	23	transmitted	transmit	VERB
njb-85	117	24	are	be	AUX
njb-85	117	25	high	high	ADJ
njb-85	117	26	among	among	ADP
njb-85	117	27	them	they	PRON
njb-85	117	28	.	.	PUNCT
njb-85	118	1	this	this	DET
njb-85	118	2	severity	severity	NOUN
njb-85	118	3	of	of	ADP
njb-85	118	4	cases	case	NOUN
njb-85	118	5	may	may	AUX
njb-85	118	6	be	be	AUX
njb-85	118	7	due	due	ADJ
njb-85	118	8	to	to	ADP
njb-85	118	9	the	the	DET
njb-85	118	10	lack	lack	NOUN
njb-85	118	11	of	of	ADP
njb-85	118	12	vaccination	vaccination	NOUN
njb-85	118	13	information	information	NOUN
njb-85	118	14	in	in	ADP
njb-85	118	15	the	the	DET
njb-85	118	16	population	population	NOUN
njb-85	118	17	.	.	PUNCT
njb-85	119	1	the	the	DET
njb-85	119	2	replication	replication	NOUN
njb-85	119	3	of	of	ADP
njb-85	119	4	hbv	hbv	NOUN
njb-85	119	5	and	and	CCONJ
njb-85	119	6	hcv	hcv	PROPN
njb-85	119	7	in	in	ADP
njb-85	119	8	hiv	hiv	PROPN
njb-85	119	9	patients	patient	NOUN
njb-85	119	10	should	should	AUX
njb-85	119	11	be	be	AUX
njb-85	119	12	actively	actively	ADV
njb-85	119	13	monitored	monitor	VERB
njb-85	119	14	while	while	SCONJ
njb-85	119	15	receiving	receive	VERB
njb-85	119	16	antiviral	antiviral	ADJ
njb-85	119	17	therapy	therapy	NOUN
njb-85	119	18	and	and	CCONJ
njb-85	119	19	this	this	DET
njb-85	119	20	monitoring	monitoring	NOUN
njb-85	119	21	system	system	NOUN
njb-85	119	22	should	should	AUX
njb-85	119	23	be	be	AUX
njb-85	119	24	made	make	VERB
njb-85	119	25	a	a	DET
njb-85	119	26	part	part	NOUN
njb-85	119	27	of	of	ADP
njb-85	119	28	clinical	clinical	ADJ
njb-85	119	29	care	care	NOUN
njb-85	120	1	[	[	PUNCT
njb-85	120	2	17	17	NUM
njb-85	120	3	]	]	PUNCT
njb-85	120	4	.	.	PUNCT
njb-85	121	1	in	in	ADP
njb-85	121	2	the	the	DET
njb-85	121	3	context	context	NOUN
njb-85	121	4	of	of	ADP
njb-85	121	5	nepal	nepal	NOUN
njb-85	121	6	,	,	PUNCT
njb-85	121	7	people	people	NOUN
njb-85	121	8	have	have	AUX
njb-85	121	9	has	have	VERB
njb-85	121	10	less	less	ADJ
njb-85	121	11	knowledge	knowledge	NOUN
njb-85	121	12	of	of	ADP
njb-85	121	13	vaccination	vaccination	NOUN
njb-85	121	14	and	and	CCONJ
njb-85	121	15	those	those	PRON
njb-85	121	16	who	who	PRON
njb-85	121	17	knows	know	VERB
njb-85	121	18	avoid	avoid	VERB
njb-85	121	19	it	it	PRON
njb-85	121	20	because	because	SCONJ
njb-85	121	21	of	of	ADP
njb-85	121	22	hepatitis	hepatitis	NOUN
njb-85	121	23	vaccination	vaccination	NOUN
njb-85	121	24	cost	cost	NOUN
njb-85	121	25	and	and	CCONJ
njb-85	121	26	no	no	INTJ
njb-85	121	27	.	.	NOUN
njb-85	121	28	of	of	ADP
njb-85	121	29	clinic	clinic	NOUN
njb-85	121	30	visits	visit	NOUN
njb-85	121	31	to	to	PART
njb-85	121	32	complete	complete	VERB
njb-85	121	33	vaccination	vaccination	NOUN
njb-85	121	34	doses	dose	NOUN
njb-85	121	35	.	.	PUNCT
njb-85	122	1	the	the	DET
njb-85	122	2	implications	implication	NOUN
njb-85	122	3	of	of	ADP
njb-85	122	4	screening	screen	VERB
njb-85	122	5	tests	test	NOUN
njb-85	122	6	for	for	ADP
njb-85	122	7	hbv	hbv	NOUN
njb-85	122	8	or	or	CCONJ
njb-85	122	9	hcv	hcv	VERB
njb-85	122	10	co	co	NOUN
njb-85	122	11	-	-	NOUN
njb-85	122	12	infection	infection	NOUN
njb-85	122	13	in	in	ADP
njb-85	122	14	hiv	hiv	PROPN
njb-85	122	15	patients	patient	NOUN
njb-85	122	16	are	be	AUX
njb-85	122	17	of	of	ADP
njb-85	122	18	great	great	ADJ
njb-85	122	19	need	need	NOUN
njb-85	122	20	in	in	ADP
njb-85	122	21	nepal	nepal	ADJ
njb-85	122	22	[	[	X
njb-85	122	23	18	18	NUM
njb-85	122	24	]	]	PUNCT
njb-85	122	25	.	.	PUNCT
njb-85	123	1	limitations	limitation	NOUN
njb-85	123	2	of	of	ADP
njb-85	123	3	the	the	DET
njb-85	123	4	study	study	NOUN
njb-85	123	5	:	:	PUNCT
njb-85	123	6	this	this	DET
njb-85	123	7	study	study	NOUN
njb-85	123	8	was	be	AUX
njb-85	123	9	carried	carry	VERB
njb-85	123	10	out	out	ADP
njb-85	123	11	in	in	ADP
njb-85	123	12	a	a	DET
njb-85	123	13	limited	limited	ADJ
njb-85	123	14	population	population	NOUN
njb-85	123	15	and	and	CCONJ
njb-85	123	16	only	only	ADV
njb-85	123	17	involved	involve	VERB
njb-85	123	18	the	the	DET
njb-85	123	19	donors	donor	NOUN
njb-85	123	20	attending	attend	VERB
njb-85	123	21	on	on	ADP
njb-85	123	22	mobile	mobile	ADJ
njb-85	123	23	health	health	NOUN
njb-85	123	24	camp	camp	NOUN
njb-85	123	25	organized	organize	VERB
njb-85	123	26	by	by	ADP
njb-85	123	27	bts	bt	VERB
njb-85	123	28	-	-	PUNCT
njb-85	123	29	nrs	nrs	NOUN
njb-85	123	30	.	.	PUNCT
njb-85	124	1	so	so	ADV
njb-85	124	2	,	,	PUNCT
njb-85	124	3	the	the	DET
njb-85	124	4	results	result	NOUN
njb-85	124	5	obtained	obtain	VERB
njb-85	124	6	from	from	ADP
njb-85	124	7	this	this	DET
njb-85	124	8	study	study	NOUN
njb-85	124	9	might	might	AUX
njb-85	124	10	not	not	PART
njb-85	124	11	be	be	AUX
njb-85	124	12	enough	enough	ADJ
njb-85	124	13	to	to	PART
njb-85	124	14	indicate	indicate	VERB
njb-85	124	15	the	the	DET
njb-85	124	16	actual	actual	ADJ
njb-85	124	17	burden	burden	NOUN
njb-85	124	18	of	of	ADP
njb-85	124	19	the	the	DET
njb-85	124	20	disease	disease	NOUN
njb-85	124	21	in	in	ADP
njb-85	124	22	the	the	DET
njb-85	124	23	large	large	ADJ
njb-85	124	24	population	population	NOUN
njb-85	124	25	.	.	PUNCT
njb-85	125	1	still	still	ADV
njb-85	125	2	,	,	PUNCT
njb-85	125	3	the	the	DET
njb-85	125	4	study	study	NOUN
njb-85	125	5	found	find	VERB
njb-85	125	6	the	the	DET
njb-85	125	7	existence	existence	NOUN
njb-85	125	8	of	of	ADP
njb-85	125	9	endemic	endemic	ADJ
njb-85	125	10	viral	viral	ADJ
njb-85	125	11	hepatitis	hepatitis	NOUN
njb-85	125	12	among	among	ADP
njb-85	125	13	the	the	DET
njb-85	125	14	people	people	NOUN
njb-85	125	15	and	and	CCONJ
njb-85	125	16	need	need	VERB
njb-85	125	17	health	health	NOUN
njb-85	125	18	policies	policy	NOUN
njb-85	125	19	to	to	PART
njb-85	125	20	reduce	reduce	VERB
njb-85	125	21	the	the	DET
njb-85	125	22	burden	burden	NOUN
njb-85	125	23	of	of	ADP
njb-85	125	24	viral	viral	ADJ
njb-85	125	25	hepatitis	hepatitis	NOUN
njb-85	125	26	in	in	ADP
njb-85	125	27	society	society	NOUN
njb-85	125	28	.	.	PUNCT
njb-85	126	1	pcr	pcr	PROPN
njb-85	126	2	based	base	VERB
njb-85	126	3	detection	detection	NOUN
njb-85	126	4	method	method	NOUN
njb-85	126	5	was	be	AUX
njb-85	126	6	not	not	PART
njb-85	126	7	incorporated	incorporate	VERB
njb-85	126	8	due	due	ADP
njb-85	126	9	to	to	ADP
njb-85	126	10	feasibility	feasibility	NOUN
njb-85	126	11	issues	issue	NOUN
njb-85	126	12	regarding	regard	VERB
njb-85	126	13	time	time	NOUN
njb-85	126	14	and	and	CCONJ
njb-85	126	15	resources	resource	NOUN
njb-85	126	16	constrain	constrain	VERB
njb-85	126	17	.	.	PUNCT
njb-85	127	1	conclusions	conclusion	NOUN
njb-85	127	2	hbv	hbv	PROPN
njb-85	127	3	and	and	CCONJ
njb-85	127	4	hcv	hcv	VERB
njb-85	127	5	infections	infection	NOUN
njb-85	127	6	can	can	AUX
njb-85	127	7	be	be	AUX
njb-85	127	8	transfer	transfer	NOUN
njb-85	127	9	by	by	ADP
njb-85	127	10	piercing	pierce	VERB
njb-85	127	11	needles	needle	NOUN
njb-85	127	12	,	,	PUNCT
njb-85	127	13	general	general	ADJ
njb-85	127	14	contact	contact	NOUN
njb-85	127	15	,	,	PUNCT
njb-85	127	16	blood	blood	NOUN
njb-85	127	17	nepal	nepal	ADJ
njb-85	127	18	journal	journal	NOUN
njb-85	127	19	of	of	ADP
njb-85	127	20	biotechnology	biotechnology	NOUN
njb-85	127	21	.	.	PUNCT
njb-85	128	1	d	d	X
njb-85	128	2	e	e	PROPN
njb-85	128	3	c	c	PROPN
njb-85	128	4	.	.	PUNCT
njb-85	129	1	2	2	NUM
njb-85	129	2	0	0	NUM
njb-85	129	3	1	1	NUM
njb-85	129	4	8	8	NUM
njb-85	129	5	vol	vol	NOUN
njb-85	129	6	.	.	PROPN
njb-85	130	1	6	6	NUM
njb-85	130	2	,	,	PUNCT
njb-85	130	3	no	no	NOUN
njb-85	130	4	.	.	NOUN
njb-85	130	5	1	1	NUM
njb-85	130	6	:	:	SYM
njb-85	130	7	33	33	NUM
njb-85	130	8	-	-	SYM
njb-85	130	9	38	38	NUM
njb-85	130	10	shah	shah	NOUN
njb-85	130	11	et	et	X
njb-85	130	12	al	al	PROPN
njb-85	130	13	.	.	PUNCT
njb-85	131	1	©	©	PROPN
njb-85	131	2	njb	njb	PROPN
njb-85	131	3	,	,	PUNCT
njb-85	131	4	biotechnology	biotechnology	NOUN
njb-85	131	5	society	society	NOUN
njb-85	131	6	of	of	ADP
njb-85	131	7	nepal	nepal	ADJ
njb-85	131	8	37	37	NUM
njb-85	131	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	ADJ
njb-85	131	10	transfusion	transfusion	NOUN
njb-85	131	11	,	,	PUNCT
njb-85	131	12	drug	drug	NOUN
njb-85	131	13	users	user	NOUN
njb-85	131	14	.	.	PUNCT
njb-85	132	1	therefore	therefore	ADV
njb-85	132	2	,	,	PUNCT
njb-85	132	3	policymaker	policymaker	NOUN
njb-85	132	4	should	should	AUX
njb-85	132	5	provide	provide	VERB
njb-85	132	6	awareness	awareness	NOUN
njb-85	132	7	and	and	CCONJ
njb-85	132	8	knowledge	knowledge	NOUN
njb-85	132	9	for	for	ADP
njb-85	132	10	people	people	NOUN
njb-85	132	11	about	about	ADP
njb-85	132	12	it	it	PRON
njb-85	132	13	.	.	PUNCT
njb-85	133	1	general	general	ADJ
njb-85	133	2	people	people	NOUN
njb-85	133	3	must	must	AUX
njb-85	133	4	take	take	VERB
njb-85	133	5	a	a	DET
njb-85	133	6	hepatitis	hepatitis	NOUN
njb-85	133	7	vaccine	vaccine	NOUN
njb-85	133	8	.	.	PUNCT
njb-85	134	1	government	government	NOUN
njb-85	134	2	should	should	AUX
njb-85	134	3	provide	provide	VERB
njb-85	134	4	hepatitis	hepatitis	NOUN
njb-85	134	5	vaccine	vaccine	NOUN
njb-85	134	6	at	at	ADP
njb-85	134	7	an	an	DET
njb-85	134	8	affordable	affordable	ADJ
njb-85	134	9	price	price	NOUN
njb-85	134	10	.	.	PUNCT
njb-85	135	1	government	government	NOUN
njb-85	135	2	and	and	CCONJ
njb-85	135	3	its	its	PRON
njb-85	135	4	allied	ally	VERB
njb-85	135	5	body	body	NOUN
njb-85	135	6	should	should	AUX
njb-85	135	7	provide	provide	VERB
njb-85	135	8	infection	infection	NOUN
njb-85	135	9	control	control	NOUN
njb-85	135	10	support	support	NOUN
njb-85	135	11	.	.	PUNCT
njb-85	136	1	finally	finally	ADV
njb-85	136	2	,	,	PUNCT
njb-85	136	3	people	people	NOUN
njb-85	136	4	should	should	AUX
njb-85	136	5	be	be	AUX
njb-85	136	6	aware	aware	ADJ
njb-85	136	7	of	of	ADP
njb-85	136	8	its	its	PRON
njb-85	136	9	associated	associated	ADJ
njb-85	136	10	risk	risk	NOUN
njb-85	136	11	factors	factor	NOUN
njb-85	136	12	.	.	PUNCT
njb-85	137	1	the	the	DET
njb-85	137	2	infection	infection	NOUN
njb-85	137	3	rate	rate	NOUN
njb-85	137	4	in	in	ADP
njb-85	137	5	prior	prior	ADJ
njb-85	137	6	blood	blood	NOUN
njb-85	137	7	transfusion	transfusion	NOUN
njb-85	137	8	people	people	NOUN
njb-85	137	9	,	,	PUNCT
njb-85	137	10	hbv	hbv	NOUN
njb-85	137	11	and	and	CCONJ
njb-85	137	12	hcv	hcv	VERB
njb-85	137	13	infections	infection	NOUN
njb-85	137	14	found	find	VERB
njb-85	137	15	in	in	ADP
njb-85	137	16	the	the	DET
njb-85	137	17	same	same	ADJ
njb-85	137	18	ratio	ratio	NOUN
njb-85	137	19	.	.	PUNCT
njb-85	138	1	moreover	moreover	ADV
njb-85	138	2	,	,	PUNCT
njb-85	138	3	due	due	ADP
njb-85	138	4	to	to	ADP
njb-85	138	5	its	its	PRON
njb-85	138	6	risk	risk	NOUN
njb-85	138	7	factors	factor	NOUN
njb-85	138	8	,	,	PUNCT
njb-85	138	9	like	like	ADP
njb-85	138	10	age	age	NOUN
njb-85	138	11	,	,	PUNCT
njb-85	138	12	gender	gender	NOUN
njb-85	138	13	,	,	PUNCT
njb-85	138	14	tattoo	tattoo	ADJ
njb-85	138	15	,	,	PUNCT
njb-85	138	16	marital	marital	ADJ
njb-85	138	17	status	status	NOUN
njb-85	138	18	,	,	PUNCT
njb-85	138	19	donor	donor	NOUN
njb-85	138	20	type	type	NOUN
njb-85	138	21	can	can	AUX
njb-85	138	22	be	be	AUX
njb-85	138	23	transmitted	transmit	VERB
njb-85	138	24	the	the	DET
njb-85	138	25	vital	vital	ADJ
njb-85	138	26	role	role	NOUN
njb-85	138	27	in	in	ADP
njb-85	138	28	the	the	DET
njb-85	138	29	mode	mode	NOUN
njb-85	138	30	of	of	ADP
njb-85	138	31	transmission	transmission	NOUN
njb-85	138	32	of	of	ADP
njb-85	138	33	hepatitis	hepatitis	NOUN
njb-85	138	34	.	.	PUNCT
njb-85	139	1	conflict	conflict	NOUN
njb-85	139	2	of	of	ADP
njb-85	139	3	interest	interest	NOUN
njb-85	139	4	the	the	DET
njb-85	139	5	authors	author	NOUN
njb-85	139	6	declare	declare	VERB
njb-85	139	7	that	that	SCONJ
njb-85	139	8	they	they	PRON
njb-85	139	9	have	have	VERB
njb-85	139	10	no	no	DET
njb-85	139	11	competing	compete	VERB
njb-85	139	12	interests	interest	NOUN
njb-85	139	13	.	.	PUNCT
njb-85	140	1	acknowledgments	acknowledgment	VERB
njb-85	140	2	we	we	PRON
njb-85	140	3	would	would	AUX
njb-85	140	4	like	like	VERB
njb-85	140	5	to	to	PART
njb-85	140	6	convey	convey	VERB
njb-85	140	7	our	our	PRON
njb-85	140	8	gratitude	gratitude	NOUN
njb-85	140	9	to	to	ADP
njb-85	140	10	mr	mr	PROPN
njb-85	140	11	.	.	PROPN
njb-85	140	12	dhrubamadi	dhrubamadi	PROPN
njb-85	140	13	lamichhane	lamichhane	PROPN
njb-85	140	14	,	,	PUNCT
njb-85	140	15	coordinator	coordinator	NOUN
njb-85	140	16	of	of	ADP
njb-85	140	17	central	central	ADJ
njb-85	140	18	blood	blood	NOUN
njb-85	140	19	transfusion	transfusion	NOUN
njb-85	140	20	service	service	NOUN
njb-85	140	21	and	and	CCONJ
njb-85	140	22	all	all	DET
njb-85	140	23	the	the	DET
njb-85	140	24	members	member	NOUN
njb-85	140	25	of	of	ADP
njb-85	140	26	nrcs	nrcs	PROPN
njb-85	140	27	(	(	PUNCT
njb-85	140	28	cbts	cbts	PROPN
njb-85	140	29	)	)	PUNCT
njb-85	140	30	who	who	PRON
njb-85	140	31	were	be	AUX
njb-85	140	32	helpful	helpful	ADJ
njb-85	140	33	and	and	CCONJ
njb-85	140	34	made	make	VERB
njb-85	140	35	my	my	PRON
njb-85	140	36	lab	lab	NOUN
njb-85	140	37	work	work	VERB
njb-85	140	38	possible	possible	ADJ
njb-85	140	39	.	.	PUNCT
njb-85	141	1	and	and	CCONJ
njb-85	141	2	,	,	PUNCT
njb-85	141	3	thankfulness	thankfulness	NOUN
njb-85	141	4	to	to	ADP
njb-85	141	5	mr	mr	PROPN
njb-85	141	6	.	.	PROPN
njb-85	141	7	arjun	arjun	PROPN
njb-85	141	8	gyawali	gyawali	PROPN
njb-85	141	9	and	and	CCONJ
njb-85	141	10	allied	ally	VERB
njb-85	141	11	staffs	staff	NOUN
njb-85	141	12	.	.	PUNCT
njb-85	142	1	without	without	ADP
njb-85	142	2	their	their	PRON
njb-85	142	3	support	support	NOUN
njb-85	142	4	,	,	PUNCT
njb-85	142	5	we	we	PRON
njb-85	142	6	could	could	AUX
njb-85	142	7	not	not	PART
njb-85	142	8	able	able	ADJ
njb-85	142	9	to	to	PART
njb-85	142	10	conduct	conduct	VERB
njb-85	142	11	this	this	DET
njb-85	142	12	study	study	NOUN
njb-85	142	13	.	.	PUNCT
njb-85	143	1	consent	consent	NOUN
njb-85	143	2	for	for	ADP
njb-85	143	3	publication	publication	NOUN
njb-85	143	4	not	not	PART
njb-85	143	5	applicable	applicable	ADJ
njb-85	143	6	ethical	ethical	ADJ
njb-85	143	7	approval	approval	NOUN
njb-85	143	8	and	and	CCONJ
njb-85	143	9	consent	consent	NOUN
njb-85	143	10	to	to	ADP
njb-85	143	11	the	the	DET
njb-85	143	12	participant	participant	NOUN
njb-85	143	13	no	no	DET
njb-85	143	14	patient	patient	NOUN
njb-85	143	15	-	-	PUNCT
njb-85	143	16	related	relate	VERB
njb-85	143	17	data	datum	NOUN
njb-85	143	18	were	be	AUX
njb-85	143	19	collected	collect	VERB
njb-85	143	20	.	.	PUNCT
njb-85	144	1	ethical	ethical	ADJ
njb-85	144	2	approval	approval	NOUN
njb-85	144	3	was	be	AUX
njb-85	144	4	therefore	therefore	ADV
njb-85	144	5	not	not	PART
njb-85	144	6	required	require	VERB
njb-85	144	7	.	.	PUNCT
njb-85	145	1	the	the	DET
njb-85	145	2	study	study	NOUN
njb-85	145	3	was	be	AUX
njb-85	145	4	laboratory	laboratory	NOUN
njb-85	145	5	-	-	PUNCT
njb-85	145	6	based	base	VERB
njb-85	145	7	basic	basic	ADJ
njb-85	145	8	science	science	NOUN
njb-85	145	9	study	study	NOUN
njb-85	145	10	.	.	PUNCT
njb-85	146	1	written	write	VERB
njb-85	146	2	informed	informed	ADJ
njb-85	146	3	consent	consent	NOUN
njb-85	146	4	was	be	AUX
njb-85	146	5	taken	take	VERB
njb-85	146	6	from	from	ADP
njb-85	146	7	all	all	DET
njb-85	146	8	participating	participate	VERB
njb-85	146	9	patients	patient	NOUN
njb-85	146	10	or	or	CCONJ
njb-85	146	11	from	from	ADP
njb-85	146	12	guardian	guardian	NOUN
njb-85	146	13	on	on	ADP
njb-85	146	14	the	the	DET
njb-85	146	15	behalf	behalf	NOUN
njb-85	146	16	of	of	ADP
njb-85	146	17	their	their	PRON
njb-85	146	18	children	child	NOUN
njb-85	146	19	.	.	PUNCT
njb-85	147	1	availability	availability	NOUN
njb-85	147	2	of	of	ADP
njb-85	147	3	data	datum	NOUN
njb-85	147	4	and	and	CCONJ
njb-85	147	5	materials	material	NOUN
njb-85	147	6	all	all	DET
njb-85	147	7	supplementary	supplementary	ADJ
njb-85	147	8	files	file	NOUN
njb-85	147	9	,	,	PUNCT
njb-85	147	10	data	datum	NOUN
njb-85	147	11	generated	generate	VERB
njb-85	147	12	and	and	CCONJ
njb-85	147	13	analyzed	analyze	VERB
njb-85	147	14	during	during	ADP
njb-85	147	15	this	this	DET
njb-85	147	16	study	study	NOUN
njb-85	147	17	will	will	AUX
njb-85	147	18	be	be	AUX
njb-85	147	19	made	make	VERB
njb-85	147	20	available	available	ADJ
njb-85	147	21	as	as	ADP
njb-85	147	22	per	per	ADP
njb-85	147	23	reasonable	reasonable	ADJ
njb-85	147	24	request	request	NOUN
njb-85	147	25	to	to	ADP
njb-85	147	26	the	the	DET
njb-85	147	27	corresponding	correspond	VERB
njb-85	147	28	author	author	NOUN
njb-85	147	29	.	.	PUNCT
njb-85	148	1	source	source	NOUN
njb-85	148	2	of	of	ADP
njb-85	148	3	support	support	NOUN
njb-85	148	4	no	no	DET
njb-85	148	5	funding	funding	NOUN
njb-85	148	6	author	author	NOUN
njb-85	148	7	’s	’s	PART
njb-85	148	8	contributions	contribution	NOUN
njb-85	148	9	gbs	gbs	PROPN
njb-85	148	10	and	and	CCONJ
njb-85	148	11	kg	kg	NOUN
njb-85	148	12	designed	design	VERB
njb-85	148	13	the	the	DET
njb-85	148	14	study	study	NOUN
njb-85	148	15	.	.	PUNCT
njb-85	149	1	gbs	gbs	PROPN
njb-85	149	2	collected	collect	VERB
njb-85	149	3	sample	sample	NOUN
njb-85	149	4	at	at	ADP
njb-85	149	5	nrcs	nrcs	PROPN
njb-85	149	6	-	-	PUNCT
njb-85	149	7	cbts	cbts	PROPN
njb-85	149	8	.	.	PUNCT
njb-85	150	1	gbs	gbs	PROPN
njb-85	150	2	and	and	CCONJ
njb-85	150	3	bpb	bpb	PROPN
njb-85	150	4	performed	perform	VERB
njb-85	150	5	investigation	investigation	NOUN
njb-85	150	6	and	and	CCONJ
njb-85	150	7	recorded	record	VERB
njb-85	150	8	the	the	DET
njb-85	150	9	laboratory	laboratory	NOUN
njb-85	150	10	findings	finding	NOUN
njb-85	150	11	with	with	ADP
njb-85	150	12	the	the	DET
njb-85	150	13	validation	validation	NOUN
njb-85	150	14	.	.	PUNCT
njb-85	151	1	kg	kg	NOUN
njb-85	151	2	supervised	supervise	VERB
njb-85	151	3	and	and	CCONJ
njb-85	151	4	provided	provide	VERB
njb-85	151	5	a	a	DET
njb-85	151	6	methodology	methodology	NOUN
njb-85	151	7	for	for	ADP
njb-85	151	8	the	the	DET
njb-85	151	9	study	study	NOUN
njb-85	151	10	.	.	PUNCT
njb-85	152	1	bpb	bpb	PROPN
njb-85	152	2	,	,	PUNCT
njb-85	152	3	bb	bb	PROPN
njb-85	152	4	&	&	CCONJ
njb-85	152	5	rrg	rrg	PROPN
njb-85	152	6	administered	administer	VERB
njb-85	152	7	the	the	DET
njb-85	152	8	project	project	NOUN
njb-85	152	9	,	,	PUNCT
njb-85	152	10	reviewed	review	VERB
njb-85	152	11	literature	literature	NOUN
njb-85	152	12	,	,	PUNCT
njb-85	152	13	and	and	CCONJ
njb-85	152	14	wrote	write	VERB
njb-85	152	15	original	original	ADJ
njb-85	152	16	manuscript	manuscript	NOUN
njb-85	152	17	bb	bb	PROPN
njb-85	152	18	and	and	CCONJ
njb-85	152	19	rrg	rrg	PROPN
njb-85	152	20	curated	curate	VERB
njb-85	152	21	data	datum	NOUN
njb-85	152	22	to	to	PART
njb-85	152	23	perform	perform	VERB
njb-85	152	24	statistical	statistical	ADJ
njb-85	152	25	data	datum	NOUN
njb-85	152	26	analysis	analysis	NOUN
njb-85	152	27	and	and	CCONJ
njb-85	152	28	data	datum	NOUN
njb-85	152	29	interpretation	interpretation	NOUN
njb-85	152	30	.	.	PUNCT
njb-85	153	1	rrg	rrg	PROPN
njb-85	153	2	&	&	CCONJ
njb-85	153	3	bb	bb	PROPN
njb-85	153	4	also	also	ADV
njb-85	153	5	reviewed	review	VERB
njb-85	153	6	,	,	PUNCT
njb-85	153	7	proofread	proofread	VERB
njb-85	153	8	,	,	PUNCT
njb-85	153	9	and	and	CCONJ
njb-85	153	10	revision	revision	NOUN
njb-85	153	11	of	of	ADP
njb-85	153	12	the	the	DET
njb-85	153	13	draft	draft	NOUN
njb-85	153	14	by	by	ADP
njb-85	153	15	compiling	compile	VERB
njb-85	153	16	,	,	PUNCT
njb-85	153	17	formatting	formatting	NOUN
njb-85	153	18	,	,	PUNCT
njb-85	153	19	editing	edit	VERB
njb-85	153	20	and	and	CCONJ
njb-85	153	21	writing	write	VERB
njb-85	153	22	the	the	DET
njb-85	153	23	final	final	ADJ
njb-85	153	24	version	version	NOUN
njb-85	153	25	of	of	ADP
njb-85	153	26	the	the	DET
njb-85	153	27	article	article	NOUN
njb-85	153	28	.	.	PUNCT
njb-85	154	1	thus	thus	ADV
njb-85	154	2	,	,	PUNCT
njb-85	154	3	all	all	DET
njb-85	154	4	authors	author	NOUN
njb-85	154	5	made	make	VERB
njb-85	154	6	a	a	DET
njb-85	154	7	substantial	substantial	ADJ
njb-85	154	8	contribution	contribution	NOUN
njb-85	154	9	to	to	ADP
njb-85	154	10	the	the	DET
njb-85	154	11	study	study	NOUN
njb-85	154	12	.	.	PUNCT
njb-85	155	1	all	all	PRON
njb-85	155	2	of	of	ADP
njb-85	155	3	them	they	PRON
njb-85	155	4	read	read	VERB
njb-85	155	5	and	and	CCONJ
njb-85	155	6	approved	approve	VERB
njb-85	155	7	the	the	DET
njb-85	155	8	final	final	ADJ
njb-85	155	9	manuscript	manuscript	NOUN
njb-85	155	10	.	.	PUNCT
njb-85	156	1	references	reference	NOUN
njb-85	156	2	1	1	NUM
njb-85	156	3	.	.	PUNCT
njb-85	157	1	brooks	brooks	PROPN
njb-85	157	2	g	g	PROPN
njb-85	157	3	,	,	PUNCT
njb-85	157	4	carroll	carroll	VERB
njb-85	157	5	kc	kc	PROPN
njb-85	157	6	,	,	PUNCT
njb-85	157	7	butel	butel	NOUN
njb-85	157	8	j	j	NOUN
njb-85	157	9	,	,	PUNCT
njb-85	157	10	and	and	CCONJ
njb-85	157	11	morse	morse	PROPN
njb-85	157	12	s	s	PROPN
njb-85	157	13	:	:	PUNCT
njb-85	157	14	jawetz	jawetz	PROPN
njb-85	157	15	melnick	melnick	PROPN
njb-85	157	16	&	&	CCONJ
njb-85	157	17	adelberg	adelberg	PROPN
njb-85	157	18	’s	’s	PART
njb-85	157	19	medical	medical	ADJ
njb-85	157	20	microbiology	microbiology	NOUN
njb-85	157	21	(	(	PUNCT
njb-85	157	22	26th	26th	ADJ
njb-85	157	23	ed	ed	NOUN
njb-85	157	24	.	.	PUNCT
njb-85	157	25	)	)	PUNCT
njb-85	158	1	2012	2012	NUM
njb-85	158	2	usa	usa	PROPN
njb-85	158	3	:	:	PUNCT
njb-85	158	4	mcgrawhill	mcgrawhill	PROPN
njb-85	158	5	.	.	PROPN
njb-85	159	1	2	2	X
njb-85	159	2	.	.	X
njb-85	159	3	jindal	jindal	PROPN
njb-85	159	4	a	a	PROPN
njb-85	159	5	,	,	PUNCT
njb-85	159	6	kumar	kumar	PROPN
njb-85	159	7	m	m	PROPN
njb-85	159	8	,	,	PUNCT
njb-85	159	9	and	and	CCONJ
njb-85	159	10	sarin	sarin	NOUN
njb-85	159	11	sk	sk	NOUN
njb-85	159	12	:	:	PUNCT
njb-85	159	13	management	management	NOUN
njb-85	159	14	of	of	ADP
njb-85	159	15	acute	acute	PROPN
njb-85	159	16	hepatitis	hepatitis	PROPN
njb-85	159	17	b	b	PROPN
njb-85	159	18	and	and	CCONJ
njb-85	159	19	reactivation	reactivation	NOUN
njb-85	159	20	of	of	ADP
njb-85	159	21	hepatitis	hepatitis	PROPN
njb-85	159	22	b.	b.	PROPN
njb-85	159	23	liver	liver	PROPN
njb-85	159	24	international	international	PROPN
njb-85	159	25	.	.	PUNCT
njb-85	159	26	official	official	ADJ
njb-85	159	27	journal	journal	NOUN
njb-85	159	28	of	of	ADP
njb-85	159	29	the	the	DET
njb-85	159	30	international	international	ADJ
njb-85	159	31	association	association	NOUN
njb-85	159	32	for	for	ADP
njb-85	159	33	the	the	DET
njb-85	159	34	study	study	NOUN
njb-85	159	35	of	of	ADP
njb-85	159	36	the	the	DET
njb-85	159	37	liver	liver	NOUN
njb-85	159	38	2013	2013	NUM
njb-85	159	39	33	33	NUM
njb-85	159	40	(	(	PUNCT
njb-85	159	41	suppl	suppl	ADJ
njb-85	159	42	1):164	1):164	NUM
njb-85	159	43	-	-	PUNCT
njb-85	159	44	175	175	NUM
njb-85	159	45	.	.	PUNCT
njb-85	159	46	3	3	X
njb-85	159	47	.	.	PUNCT
njb-85	159	48	shrestha	shrestha	PROPN
njb-85	159	49	sm	sm	INTJ
njb-85	159	50	,	,	PUNCT
njb-85	159	51	and	and	CCONJ
njb-85	159	52	shrestha	shrestha	PROPN
njb-85	159	53	s	s	PROPN
njb-85	159	54	:	:	PUNCT
njb-85	159	55	chronic	chronic	PROPN
njb-85	159	56	hepatitis	hepatitis	PROPN
njb-85	159	57	b	b	PROPN
njb-85	159	58	in	in	ADP
njb-85	159	59	nepal	nepal	NOUN
njb-85	159	60	:	:	PUNCT
njb-85	159	61	an	an	DET
njb-85	159	62	asian	asian	ADJ
njb-85	159	63	country	country	NOUN
njb-85	159	64	with	with	ADP
njb-85	159	65	a	a	DET
njb-85	159	66	low	low	ADJ
njb-85	159	67	prevalence	prevalence	NOUN
njb-85	159	68	of	of	ADP
njb-85	159	69	hbv	hbv	NOUN
njb-85	159	70	infection	infection	NOUN
njb-85	159	71	.	.	PUNCT
njb-85	160	1	trop	trop	PROPN
njb-85	160	2	gastroenterol	gastroenterol	PROPN
njb-85	160	3	.	.	PUNCT
njb-85	161	1	2012	2012	NUM
njb-85	161	2	33:95–101	33:95–101	NUM
njb-85	161	3	.	.	PUNCT
njb-85	161	4	4	4	NUM
njb-85	161	5	.	.	X
njb-85	162	1	who	who	PRON
njb-85	162	2	(	(	PUNCT
njb-85	162	3	2013	2013	NUM
njb-85	162	4	)	)	PUNCT
njb-85	162	5	.	.	PUNCT
njb-85	163	1	hepatitis	hepatitis	PROPN
njb-85	163	2	,	,	PUNCT
njb-85	163	3	(	(	PUNCT
njb-85	163	4	access	access	NOUN
njb-85	163	5	on	on	ADP
njb-85	163	6	www.who.int/topics/hepatitis/factsheets/en	www.who.int/topics/hepatitis/factsheets/en	NOUN
njb-85	163	7	/	/	PUNCT
njb-85	163	8	)	)	PUNCT
njb-85	163	9	.	.	PUNCT
njb-85	164	1	5	5	X
njb-85	164	2	.	.	PUNCT
njb-85	164	3	younossi	younossi	PROPN
njb-85	164	4	zm	zm	PROPN
njb-85	164	5	,	,	PUNCT
njb-85	164	6	stepanova	stepanova	PROPN
njb-85	164	7	m	m	PROPN
njb-85	164	8	,	,	PUNCT
njb-85	164	9	mishra	mishra	PROPN
njb-85	164	10	a	a	DET
njb-85	164	11	,	,	PUNCT
njb-85	164	12	venkatesan	venkatesan	PROPN
njb-85	164	13	c	c	PROPN
njb-85	164	14	,	,	PUNCT
njb-85	164	15	henry	henry	PROPN
njb-85	164	16	l	l	PROPN
njb-85	164	17	,	,	PUNCT
njb-85	164	18	hunt	hunt	PROPN
njb-85	164	19	s	s	PROPN
njb-85	164	20	:	:	PUNCT
njb-85	164	21	the	the	DET
njb-85	164	22	impact	impact	NOUN
njb-85	164	23	of	of	ADP
njb-85	164	24	chronic	chronic	PROPN
njb-85	164	25	hepatitis	hepatitis	PROPN
njb-85	164	26	c	c	PROPN
njb-85	164	27	on	on	ADP
njb-85	164	28	resource	resource	NOUN
njb-85	164	29	utilization	utilization	NOUN
njb-85	164	30	and	and	CCONJ
njb-85	164	31	inpatient	inpatient	NOUN
njb-85	164	32	mortality	mortality	NOUN
njb-85	164	33	for	for	ADP
njb-85	164	34	medicare	medicare	PROPN
njb-85	164	35	beneficiaries	beneficiary	NOUN
njb-85	164	36	between	between	ADP
njb-85	164	37	2005	2005	NUM
njb-85	164	38	and	and	CCONJ
njb-85	164	39	2010	2010	NUM
njb-85	164	40	.	.	PUNCT
njb-85	165	1	alimentary	alimentary	PROPN
njb-85	165	2	pharmacology	pharmacology	PROPN
njb-85	165	3	&	&	CCONJ
njb-85	165	4	therapeutics	therapeutics	PROPN
njb-85	165	5	,	,	PUNCT
njb-85	165	6	2013	2013	NUM
njb-85	165	7	38(9	38(9	NUM
njb-85	165	8	):	):	PUNCT
njb-85	165	9	1065	1065	NUM
njb-85	165	10	-	-	SYM
njb-85	165	11	1075	1075	NUM
njb-85	165	12	.	.	PUNCT
njb-85	166	1	6	6	X
njb-85	166	2	.	.	X
njb-85	166	3	mullis	mullis	PROPN
njb-85	166	4	ce	ce	PROPN
njb-85	166	5	,	,	PUNCT
njb-85	166	6	laeyendecker	laeyendecker	PROPN
njb-85	166	7	o	o	PROPN
njb-85	166	8	,	,	PUNCT
njb-85	166	9	reynolds	reynolds	PROPN
njb-85	166	10	sj	sj	PROPN
njb-85	166	11	,	,	PUNCT
njb-85	166	12	ocama	ocama	PROPN
njb-85	166	13	p	p	PROPN
njb-85	166	14	,	,	PUNCT
njb-85	166	15	quinn	quinn	PROPN
njb-85	166	16	j	j	PROPN
njb-85	166	17	,	,	PUNCT
njb-85	166	18	boaz	boaz	PROPN
njb-85	166	19	i	i	PROPN
njb-85	166	20	,	,	PUNCT
njb-85	166	21	et	et	PROPN
njb-85	166	22	al	al	PROPN
njb-85	166	23	:	:	PUNCT
njb-85	166	24	high	high	ADJ
njb-85	166	25	frequency	frequency	NOUN
njb-85	166	26	of	of	ADP
njb-85	166	27	false	false	ADJ
njb-85	166	28	positive	positive	ADJ
njb-85	166	29	hcv	hcv	NOUN
njb-85	166	30	elisa	elisa	PROPN
njb-85	166	31	in	in	ADP
njb-85	166	32	rakai	rakai	PROPN
njb-85	166	33	,	,	PUNCT
njb-85	166	34	uganda	uganda	PROPN
njb-85	166	35	.	.	PUNCT
njb-85	167	1	clinical	clinical	ADJ
njb-85	167	2	infectious	infectious	ADJ
njb-85	167	3	diseases	disease	NOUN
njb-85	167	4	,	,	PUNCT
njb-85	167	5	an	an	DET
njb-85	167	6	official	official	ADJ
njb-85	167	7	publication	publication	NOUN
njb-85	167	8	of	of	ADP
njb-85	167	9	the	the	DET
njb-85	167	10	infectious	infectious	ADJ
njb-85	167	11	diseases	disease	NOUN
njb-85	167	12	society	society	NOUN
njb-85	167	13	of	of	ADP
njb-85	167	14	america	america	PROPN
njb-85	167	15	,	,	PUNCT
njb-85	167	16	2013	2013	NUM
njb-85	167	17	57(12):1747	57(12):1747	NUM
njb-85	167	18	-	-	SYM
njb-85	167	19	1750	1750	NUM
njb-85	167	20	)	)	PUNCT
njb-85	167	21	.	.	PUNCT
njb-85	168	1	7	7	X
njb-85	168	2	.	.	X
njb-85	168	3	rudra	rudra	PROPN
njb-85	168	4	s	s	PROPN
njb-85	168	5	,	,	PUNCT
njb-85	168	6	chakrabarty	chakrabarty	PROPN
njb-85	168	7	p	p	PROPN
njb-85	168	8	,	,	PUNCT
njb-85	168	9	hossain	hossain	PROPN
njb-85	168	10	ma	ma	PROPN
njb-85	168	11	,	,	PUNCT
njb-85	168	12	akhter	akhter	PROPN
njb-85	168	13	h	h	PROPN
njb-85	168	14	,	,	PUNCT
njb-85	168	15	and	and	CCONJ
njb-85	168	16	bhuiyan	bhuiyan	PROPN
njb-85	169	1	mr	mr	PROPN
njb-85	169	2	:	:	PUNCT
njb-85	169	3	seroprevalence	seroprevalence	NOUN
njb-85	169	4	of	of	ADP
njb-85	169	5	hepatitis	hepatitis	PROPN
njb-85	169	6	b	b	PROPN
njb-85	169	7	,	,	PUNCT
njb-85	169	8	hepatitis	hepatitis	PROPN
njb-85	169	9	c	c	PROPN
njb-85	169	10	,	,	PUNCT
njb-85	169	11	hiv	hiv	PROPN
njb-85	169	12	infections	infection	NOUN
njb-85	169	13	in	in	ADP
njb-85	169	14	blood	blood	NOUN
njb-85	169	15	donors	donor	NOUN
njb-85	169	16	of	of	ADP
njb-85	169	17	khulna	khulna	PROPN
njb-85	169	18	,	,	PUNCT
njb-85	169	19	bangladesh	bangladesh	PROPN
njb-85	169	20	.	.	PUNCT
njb-85	170	1	mymensingh	mymensingh	PROPN
njb-85	170	2	medical	medical	PROPN
njb-85	170	3	journal	journal	PROPN
njb-85	170	4	2010	2010	NUM
njb-85	170	5	19(4	19(4	NUM
njb-85	170	6	)	)	PUNCT
njb-85	170	7	:	:	PUNCT
njb-85	170	8	515	515	NUM
njb-85	170	9	-	-	SYM
njb-85	170	10	519	519	NUM
njb-85	170	11	.	.	NOUN
njb-85	170	12	8	8	NUM
njb-85	170	13	.	.	X
njb-85	170	14	nepal	nepal	PROPN
njb-85	170	15	a.	a.	PROPN
njb-85	170	16	and	and	CCONJ
njb-85	170	17	kunwar	kunwar	PROPN
njb-85	170	18	b	b	PROPN
njb-85	170	19	:	:	PUNCT
njb-85	170	20	evidence	evidence	NOUN
njb-85	170	21	of	of	ADP
njb-85	170	22	hepatitis	hepatitis	PROPN
njb-85	170	23	c	c	PROPN
njb-85	170	24	virus	virus	PROPN
njb-85	170	25	infection	infection	NOUN
njb-85	170	26	and	and	CCONJ
njb-85	170	27	associated	associated	ADJ
njb-85	170	28	treatment	treatment	NOUN
njb-85	170	29	in	in	ADP
njb-85	170	30	nepal	nepal	NOUN
njb-85	170	31	.	.	PUNCT
njb-85	171	1	j	j	PROPN
njb-85	171	2	mol	mol	PROPN
njb-85	171	3	biomark	biomark	PROPN
njb-85	171	4	diag	diag	PROPN
njb-85	171	5	,	,	PUNCT
njb-85	171	6	2016	2016	NUM
njb-85	171	7	7	7	NUM
njb-85	171	8	(	(	PUNCT
njb-85	171	9	270):1	270):1	NUM
njb-85	171	10	-	-	SYM
njb-85	171	11	4	4	NUM
njb-85	171	12	.	.	PUNCT
njb-85	171	13	doi	doi	PROPN
njb-85	171	14	:	:	PUNCT
njb-85	171	15	10.4172/2155	10.4172/2155	NUM
njb-85	171	16	-	-	PUNCT
njb-85	171	17	9929.1000270	9929.1000270	NUM
njb-85	171	18	9	9	NUM
njb-85	171	19	.	.	PUNCT
njb-85	172	1	subba	subba	ADJ
njb-85	172	2	nr	nr	PROPN
njb-85	172	3	:	:	PUNCT
njb-85	172	4	managing	manage	VERB
njb-85	172	5	hepatitis	hepatitis	NOUN
njb-85	172	6	outbreak	outbreak	NOUN
njb-85	172	7	in	in	ADP
njb-85	172	8	biratnagar	biratnagar	ADJ
njb-85	172	9	nepal	nepal	NOUN
njb-85	172	10	.	.	PUNCT
njb-85	173	1	science	science	PROPN
njb-85	173	2	journal	journal	PROPN
njb-85	173	3	of	of	ADP
njb-85	173	4	public	public	ADJ
njb-85	173	5	http://www.who.int/	http://www.who.int/	PROPN
njb-85	173	6	nepal	nepal	ADJ
njb-85	173	7	journal	journal	PROPN
njb-85	173	8	of	of	ADP
njb-85	173	9	biotechnology	biotechnology	NOUN
njb-85	173	10	.	.	PUNCT
njb-85	174	1	d	d	X
njb-85	174	2	e	e	PROPN
njb-85	174	3	c	c	PROPN
njb-85	174	4	.	.	PUNCT
njb-85	175	1	2	2	NUM
njb-85	175	2	0	0	NUM
njb-85	175	3	1	1	NUM
njb-85	175	4	8	8	NUM
njb-85	175	5	vol	vol	NOUN
njb-85	175	6	.	.	PROPN
njb-85	176	1	6	6	NUM
njb-85	176	2	,	,	PUNCT
njb-85	176	3	no	no	NOUN
njb-85	176	4	.	.	NOUN
njb-85	176	5	1	1	NUM
njb-85	176	6	:	:	SYM
njb-85	176	7	33	33	NUM
njb-85	176	8	-	-	SYM
njb-85	176	9	38	38	NUM
njb-85	176	10	shah	shah	NOUN
njb-85	176	11	et	et	X
njb-85	176	12	al	al	PROPN
njb-85	176	13	.	.	PUNCT
njb-85	177	1	©	©	PROPN
njb-85	177	2	njb	njb	PROPN
njb-85	177	3	,	,	PUNCT
njb-85	177	4	biotechnology	biotechnology	NOUN
njb-85	177	5	society	society	NOUN
njb-85	177	6	of	of	ADP
njb-85	177	7	nepal	nepal	ADJ
njb-85	177	8	38	38	NUM
njb-85	177	9	nepjol.info/index.php/njb	nepjol.info/index.php/njb	ADJ
njb-85	177	10	health	health	NOUN
njb-85	177	11	,	,	PUNCT
njb-85	177	12	2015	2015	NUM
njb-85	177	13	3(6	3(6	NUM
njb-85	177	14	):	):	PUNCT
njb-85	177	15	808	808	NUM
njb-85	177	16	-	-	SYM
njb-85	177	17	814	814	NUM
njb-85	177	18	.	.	PUNCT
njb-85	178	1	doi	doi	PROPN
njb-85	178	2	:	:	PUNCT
njb-85	178	3	10.11648	10.11648	NUM
njb-85	178	4	/	/	SYM
njb-85	178	5	j.sjph	j.sjph	PROPN
njb-85	178	6	.	.	PUNCT
njb-85	179	1	20150306.12	20150306.12	NUM
njb-85	179	2	10	10	NUM
njb-85	179	3	.	.	PUNCT
njb-85	180	1	tiwari	tiwari	PROPN
njb-85	180	2	br	br	PROPN
njb-85	180	3	.	.	PROPN
njb-85	180	4	,	,	PUNCT
njb-85	180	5	ghimire	ghimire	PROPN
njb-85	180	6	p	p	PROPN
njb-85	180	7	,	,	PUNCT
njb-85	180	8	kandel	kandel	PROPN
njb-85	180	9	sr	sr	PROPN
njb-85	180	10	,	,	PUNCT
njb-85	180	11	and	and	CCONJ
njb-85	180	12	rajkarnikar	rajkarnikar	VERB
njb-85	180	13	m	m	VERB
njb-85	180	14	:	:	PUNCT
njb-85	180	15	seroprevalence	seroprevalence	NOUN
njb-85	180	16	of	of	ADP
njb-85	180	17	hbv	hbv	NOUN
njb-85	180	18	and	and	CCONJ
njb-85	180	19	hcv	hcv	VERB
njb-85	180	20	in	in	ADP
njb-85	180	21	blood	blood	NOUN
njb-85	180	22	donors	donor	NOUN
njb-85	180	23	:	:	PUNCT
njb-85	180	24	a	a	DET
njb-85	180	25	study	study	NOUN
njb-85	180	26	from	from	ADP
njb-85	180	27	regional	regional	ADJ
njb-85	180	28	blood	blood	NOUN
njb-85	180	29	transfusion	transfusion	NOUN
njb-85	180	30	services	service	NOUN
njb-85	180	31	of	of	ADP
njb-85	180	32	nepal	nepal	NOUN
njb-85	180	33	.	.	PUNCT
njb-85	181	1	asian	asian	PROPN
njb-85	181	2	j	j	PROPN
njb-85	181	3	transfus	transfus	PROPN
njb-85	181	4	sci	sci	PROPN
njb-85	181	5	.	.	PUNCT
njb-85	181	6	2010	2010	NUM
njb-85	181	7	4(2	4(2	NUM
njb-85	181	8	):	):	PUNCT
njb-85	181	9	91–93	91–93	PROPN
njb-85	181	10	.	.	PUNCT
njb-85	182	1	doi	doi	PROPN
njb-85	182	2	:	:	PUNCT
njb-85	182	3	10.4103/0973	10.4103/0973	NUM
njb-85	182	4	-	-	SYM
njb-85	182	5	6247.67026	6247.67026	NUM
njb-85	182	6	11	11	NUM
njb-85	182	7	.	.	PUNCT
njb-85	183	1	karki	karki	PROPN
njb-85	183	2	s	s	PROPN
njb-85	183	3	,	,	PUNCT
njb-85	183	4	ghimire	ghimire	PROPN
njb-85	183	5	p	p	PROPN
njb-85	183	6	,	,	PUNCT
njb-85	183	7	tiwari	tiwari	PROPN
njb-85	183	8	br	br	PROPN
njb-85	183	9	,	,	PUNCT
njb-85	183	10	&	&	CCONJ
njb-85	183	11	rajkarnikar	rajkarnikar	PROPN
njb-85	183	12	m	m	VERB
njb-85	183	13	:	:	PUNCT
njb-85	183	14	hbsag	hbsag	PROPN
njb-85	183	15	serosurveillance	serosurveillance	PROPN
njb-85	183	16	among	among	ADP
njb-85	183	17	nepalese	nepalese	ADJ
njb-85	183	18	blood	blood	NOUN
njb-85	183	19	donors	donor	NOUN
njb-85	183	20	.	.	PUNCT
njb-85	184	1	ann	ann	PROPN
njb-85	184	2	trop	trop	PROPN
njb-85	184	3	med	me	VERB
njb-85	184	4	public	public	ADJ
njb-85	184	5	health	health	NOUN
njb-85	184	6	.	.	PUNCT
njb-85	185	1	2008	2008	NUM
njb-85	185	2	11(1):15–18	11(1):15–18	NUM
njb-85	185	3	.	.	PUNCT
njb-85	185	4	12	12	NUM
njb-85	185	5	.	.	PUNCT
njb-85	186	1	gaze	gaze	PROPN
njb-85	186	2	r.	r.	PROPN
njb-85	186	3	de	de	PROPN
njb-85	186	4	,	,	PUNCT
njb-85	186	5	carvalho	carvalho	PROPN
njb-85	186	6	dm	dm	PROPN
njb-85	186	7	,	,	PUNCT
njb-85	186	8	santoro	santoro	PROPN
njb-85	186	9	-	-	PUNCT
njb-85	186	10	lopes	lope	NOUN
njb-85	186	11	g	g	PROPN
njb-85	186	12	,	,	PUNCT
njb-85	186	13	tura	tura	PROPN
njb-85	186	14	lf	lf	PROPN
njb-85	186	15	:	:	PUNCT
njb-85	186	16	from	from	ADP
njb-85	186	17	hepatic	hepatic	ADJ
njb-85	186	18	diseases	disease	NOUN
njb-85	186	19	and	and	CCONJ
njb-85	186	20	jaundice	jaundice	NOUN
njb-85	186	21	to	to	ADP
njb-85	186	22	viral	viral	ADJ
njb-85	186	23	hepatitis	hepatitis	NOUN
njb-85	186	24	:	:	PUNCT
njb-85	186	25	the	the	DET
njb-85	186	26	configuration	configuration	NOUN
njb-85	186	27	of	of	ADP
njb-85	186	28	a	a	DET
njb-85	186	29	kaleidoscope	kaleidoscope	NOUN
njb-85	186	30	.	.	PUNCT
njb-85	187	1	revista	revista	PROPN
njb-85	187	2	de	de	PROPN
njb-85	187	3	saude	saude	PROPN
njb-85	187	4	publica	publica	PROPN
njb-85	187	5	,	,	PUNCT
njb-85	187	6	2013	2013	NUM
njb-85	187	7	47(1	47(1	NUM
njb-85	187	8	):	):	PUNCT
njb-85	187	9	116	116	NUM
njb-85	187	10	-	-	SYM
njb-85	187	11	122	122	NUM
njb-85	187	12	.	.	PUNCT
njb-85	187	13	13	13	NUM
njb-85	187	14	.	.	X
njb-85	188	1	who	who	PRON
njb-85	188	2	:	:	PUNCT
njb-85	188	3	(	(	PUNCT
njb-85	188	4	2013	2013	NUM
njb-85	188	5	)	)	PUNCT
njb-85	188	6	.	.	PUNCT
njb-85	189	1	immunization	immunization	NOUN
njb-85	189	2	,	,	PUNCT
njb-85	189	3	vaccines	vaccine	NOUN
njb-85	189	4	,	,	PUNCT
njb-85	189	5	and	and	CCONJ
njb-85	189	6	biologicals	biological	NOUN
njb-85	189	7	,	,	PUNCT
njb-85	189	8	https://www.who.int/immunization/en/	https://www.who.int/immunization/en/	NOUN
njb-85	189	9	14	14	NUM
njb-85	189	10	.	.	PUNCT
njb-85	190	1	pokheral	pokheral	PROPN
njb-85	190	2	n	n	PROPN
njb-85	190	3	,	,	PUNCT
njb-85	190	4	bhandari	bhandari	PROPN
njb-85	190	5	d	d	PROPN
njb-85	190	6	,	,	PUNCT
njb-85	190	7	and	and	CCONJ
njb-85	190	8	jha	jha	PROPN
njb-85	190	9	b	b	PROPN
njb-85	190	10	:	:	PUNCT
njb-85	190	11	the	the	DET
njb-85	190	12	pattern	pattern	NOUN
njb-85	190	13	of	of	ADP
njb-85	190	14	hepatitis	hepatitis	PROPN
njb-85	190	15	b	b	PROPN
njb-85	190	16	and	and	CCONJ
njb-85	190	17	c	c	NOUN
njb-85	190	18	infections	infection	NOUN
njb-85	190	19	among	among	ADP
njb-85	190	20	patients	patient	NOUN
njb-85	190	21	attending	attend	VERB
njb-85	190	22	a	a	DET
njb-85	190	23	tertiary	tertiary	ADJ
njb-85	190	24	care	care	NOUN
njb-85	190	25	hospital	hospital	NOUN
njb-85	190	26	in	in	ADP
njb-85	190	27	kathmandu	kathmandu	NOUN
njb-85	190	28	,	,	PUNCT
njb-85	190	29	nepal	nepal	ADJ
njb-85	190	30	.	.	PUNCT
njb-85	191	1	j	j	PROPN
njb-85	191	2	inst	inst	ADP
njb-85	191	3	med	med	PROPN
njb-85	191	4	,	,	PUNCT
njb-85	191	5	2016	2016	NUM
njb-85	191	6	38(2):2	38(2):2	NUM
njb-85	191	7	-	-	SYM
njb-85	191	8	3	3	NUM
njb-85	191	9	.	.	NUM
njb-85	191	10	15	15	NUM
njb-85	191	11	.	.	PUNCT
njb-85	191	12	ionita	ionita	PROPN
njb-85	191	13	g	g	PROPN
njb-85	191	14	,	,	PUNCT
njb-85	191	15	malviya	malviya	PROPN
njb-85	191	16	a	a	DET
njb-85	191	17	,	,	PUNCT
njb-85	191	18	rajbhandari	rajbhandari	PROPN
njb-85	191	19	r	r	PROPN
njb-85	191	20	,	,	PUNCT
njb-85	191	21	william	william	PROPN
njb-85	191	22	schluter	schluter	PROPN
njb-85	191	23	w	w	PROPN
njb-85	191	24	sharma	sharma	PROPN
njb-85	191	25	g	g	PROPN
njb-85	191	26	,	,	PUNCT
njb-85	191	27	kakchapati	kakchapati	PROPN
njb-85	191	28	rs	rs	PROPN
njb-85	191	29	,	,	PUNCT
njb-85	191	30	and	and	CCONJ
njb-85	191	31	dixit	dixit	NOUN
njb-85	191	32	s	s	PROPN
njb-85	191	33	:	:	PUNCT
njb-85	191	34	seroprevalence	seroprevalence	NOUN
njb-85	191	35	of	of	ADP
njb-85	191	36	hepatitis	hepatitis	PROPN
njb-85	191	37	b	b	PROPN
njb-85	191	38	virus	virus	PROPN
njb-85	191	39	and	and	CCONJ
njb-85	191	40	hepatitis	hepatitis	PROPN
njb-85	191	41	c	c	PROPN
njb-85	191	42	virus	virus	PROPN
njb-85	191	43	co	co	NOUN
njb-85	191	44	-	-	NOUN
njb-85	191	45	infection	infection	NOUN
njb-85	191	46	among	among	ADP
njb-85	191	47	people	people	NOUN
njb-85	191	48	living	live	VERB
njb-85	191	49	with	with	ADP
njb-85	191	50	hiv	hiv	PROPN
njb-85	191	51	/	/	SYM
njb-85	191	52	aids	aids	PROPN
njb-85	191	53	visiting	visit	VERB
njb-85	191	54	antiretroviral	antiretroviral	ADJ
njb-85	191	55	therapy	therapy	NOUN
njb-85	191	56	centers	center	NOUN
njb-85	191	57	in	in	ADP
njb-85	191	58	nepal	nepal	NOUN
njb-85	191	59	:	:	PUNCT
njb-85	191	60	a	a	DET
njb-85	191	61	first	first	ADJ
njb-85	191	62	nationally	nationally	ADV
njb-85	191	63	representative	representative	ADJ
njb-85	191	64	study	study	NOUN
njb-85	191	65	.	.	PUNCT
njb-85	192	1	intl	intl	PROPN
njb-85	192	2	j	j	PROPN
njb-85	192	3	infect	infect	PROPN
njb-85	192	4	dis	dis	PROPN
njb-85	192	5	.	.	PROPN
njb-85	192	6	2017	2017	NUM
njb-85	193	1	60	60	NUM
njb-85	193	2	:	:	PUNCT
njb-85	193	3	64–69	64–69	NUM
njb-85	193	4	.	.	PUNCT
njb-85	193	5	16	16	NUM
njb-85	193	6	.	.	PUNCT
njb-85	194	1	shedain	shedain	PROPN
njb-85	194	2	pr	pr	PROPN
njb-85	194	3	,	,	PUNCT
njb-85	194	4	devkota	devkota	PROPN
njb-85	194	5	md	md	PROPN
njb-85	194	6	,	,	PUNCT
njb-85	194	7	banjara	banjara	PROPN
njb-85	194	8	mr	mr	PROPN
njb-85	194	9	,	,	PUNCT
njb-85	194	10	ling	ling	PROPN
njb-85	194	11	h	h	PROPN
njb-85	194	12	,	,	PUNCT
njb-85	194	13	dhital	dhital	PROPN
njb-85	194	14	s	s	PROPN
njb-85	194	15	:	:	PUNCT
njb-85	194	16	prevalence	prevalence	NOUN
njb-85	194	17	and	and	CCONJ
njb-85	194	18	risk	risk	NOUN
njb-85	194	19	factors	factor	NOUN
njb-85	194	20	of	of	ADP
njb-85	194	21	hepatitis	hepatitis	PROPN
njb-85	194	22	b	b	PROPN
njb-85	194	23	infection	infection	NOUN
njb-85	194	24	among	among	ADP
njb-85	194	25	mothers	mother	NOUN
njb-85	194	26	and	and	CCONJ
njb-85	194	27	children	child	NOUN
njb-85	194	28	with	with	ADP
njb-85	194	29	hepatitis	hepatitis	PROPN
njb-85	194	30	b	b	PROPN
njb-85	194	31	infected	infect	VERB
njb-85	194	32	mother	mother	NOUN
njb-85	194	33	in	in	ADP
njb-85	194	34	upper	upper	ADJ
njb-85	194	35	dolpa	dolpa	PROPN
njb-85	194	36	,	,	PUNCT
njb-85	194	37	nepal	nepal	ADJ
njb-85	194	38	.	.	PUNCT
njb-85	195	1	bmc	bmc	PROPN
njb-85	195	2	infectious	infectious	ADJ
njb-85	195	3	diseases	disease	NOUN
njb-85	195	4	2017	2017	NUM
njb-85	195	5	17(1	17(1	NUM
njb-85	195	6	):	):	PUNCT
njb-85	195	7	667	667	NUM
njb-85	195	8	.	.	PUNCT
njb-85	196	1	doi:10.1186	doi:10.1186	NOUN
njb-85	196	2	/	/	SYM
njb-85	196	3	s12879	s12879	PROPN
njb-85	196	4	-	-	PUNCT
njb-85	196	5	017	017	NUM
njb-85	196	6	-	-	NUM
njb-85	196	7	2763	2763	NUM
njb-85	196	8	-	-	SYM
njb-85	196	9	4	4	NUM
njb-85	196	10	.	.	NUM
njb-85	196	11	17	17	NUM
njb-85	196	12	.	.	PUNCT
njb-85	197	1	chuang	chuang	PROPN
njb-85	197	2	wl	wl	PROPN
njb-85	197	3	,	,	PUNCT
njb-85	197	4	dai	dai	PROPN
njb-85	197	5	cy	cy	PROPN
njb-85	197	6	,	,	PUNCT
njb-85	197	7	chang	chang	PROPN
njb-85	197	8	wy	wy	PROPN
njb-85	197	9	,	,	PUNCT
njb-85	197	10	lee	lee	PROPN
njb-85	197	11	lp	lp	PROPN
njb-85	197	12	,	,	PUNCT
njb-85	197	13	lin	lin	PROPN
njb-85	197	14	zy	zy	PROPN
njb-85	197	15	,	,	PUNCT
njb-85	197	16	chen	chen	PROPN
njb-85	197	17	sc	sc	PROPN
njb-85	197	18	:	:	PUNCT
njb-85	197	19	viral	viral	ADJ
njb-85	197	20	interaction	interaction	NOUN
njb-85	197	21	and	and	CCONJ
njb-85	197	22	responses	response	NOUN
njb-85	197	23	in	in	ADP
njb-85	197	24	chronic	chronic	PROPN
njb-85	197	25	hepatitis	hepatitis	PROPN
njb-85	197	26	c	c	PROPN
njb-85	197	27	and	and	CCONJ
njb-85	197	28	b	b	NOUN
njb-85	197	29	co	co	ADJ
njb-85	197	30	-	-	ADJ
njb-85	197	31	infected	infect	VERB
njb-85	197	32	patients	patient	NOUN
njb-85	197	33	with	with	ADP
njb-85	197	34	interferon	interferon	NOUN
njb-85	197	35	-	-	PUNCT
njb-85	197	36	alpha	alpha	NOUN
njb-85	197	37	plus	plus	CCONJ
njb-85	197	38	ribavirin	ribavirin	NOUN
njb-85	197	39	combination	combination	NOUN
njb-85	197	40	therapy	therapy	NOUN
njb-85	197	41	.	.	PUNCT
njb-85	198	1	antivir	antivir	PROPN
njb-85	198	2	ther	ther	PROPN
njb-85	198	3	,	,	PUNCT
njb-85	198	4	2005	2005	NUM
njb-85	198	5	10	10	NUM
njb-85	198	6	,	,	PUNCT
njb-85	198	7	125	125	NUM
njb-85	198	8	-	-	SYM
njb-85	198	9	133	133	NUM
njb-85	198	10	.	.	PUNCT
njb-85	199	1	pmid	pmid	NOUN
njb-85	199	2	:	:	PUNCT
njb-85	199	3	15751770	15751770	NUM
njb-85	199	4	18	18	NUM
njb-85	199	5	.	.	PUNCT
njb-85	200	1	supramn	supramn	PROPN
njb-85	200	2	hs	hs	PROPN
njb-85	200	3	,	,	PUNCT
njb-85	200	4	gokhale	gokhale	PROPN
njb-85	200	5	s	s	PROPN
njb-85	200	6	,	,	PUNCT
njb-85	200	7	sathian	sathian	PROPN
njb-85	200	8	,	,	PUNCT
njb-85	200	9	b.	b.	PROPN
njb-85	200	10	et	et	PROPN
njb-85	200	11	al	al	PROPN
njb-85	200	12	(	(	PUNCT
njb-85	200	13	2015	2015	NUM
njb-85	200	14	)	)	PUNCT
njb-85	200	15	.	.	PUNCT
njb-85	201	1	hepatitis	hepatitis	PROPN
njb-85	201	2	b	b	PROPN
njb-85	201	3	virus	virus	PROPN
njb-85	201	4	(	(	PUNCT
njb-85	201	5	hbv	hbv	NOUN
njb-85	201	6	)	)	PUNCT
njb-85	201	7	and	and	CCONJ
njb-85	201	8	hepatitis	hepatitis	PROPN
njb-85	201	9	c	c	PROPN
njb-85	201	10	virus	virus	PROPN
njb-85	201	11	(	(	PUNCT
njb-85	201	12	hcv	hcv	PROPN
njb-85	201	13	)	)	PUNCT
njb-85	201	14	co	co	NOUN
njb-85	201	15	-	-	NOUN
njb-85	201	16	infection	infection	NOUN
njb-85	201	17	among	among	ADP
njb-85	201	18	hiv	hiv	PROPN
njb-85	201	19	infected	infect	VERB
njb-85	201	20	individuals	individual	NOUN
njb-85	201	21	at	at	ADP
njb-85	201	22	tertiary	tertiary	ADJ
njb-85	201	23	care	care	NOUN
njb-85	201	24	hospital	hospital	NOUN
njb-85	201	25	in	in	ADP
njb-85	201	26	western	western	ADJ
njb-85	201	27	nepal	nepal	NOUN
njb-85	201	28	.	.	PUNCT
njb-85	202	1	nep	nep	PROPN
njb-85	202	2	j	j	PROPN
njb-85	202	3	epidemol	epidemol	PROPN
njb-85	202	4	,	,	PUNCT
njb-85	202	5	5(2	5(2	NUM
njb-85	202	6	)	)	PUNCT
njb-85	202	7	,	,	PUNCT
njb-85	202	8	488	488	NUM
njb-85	202	9	-	-	SYM
njb-85	202	10	49	49	NUM
njb-85	202	11	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc2937303/?report=classic	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc2937303/?report=classic	NUM
njb-85	202	12	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc2937303/?report=classic	https://www.ncbi.nlm.nih.gov/pmc/articles/pmc2937303/?report=classic	PUNCT
njb-85	202	13	https://dx.doi.org/10.4103%2f0973-6247.67026	https://dx.doi.org/10.4103%2f0973-6247.67026	INTJ